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 Part I of this Dissertation describes the rhodium catalyzed asymmetric functionalization of 
allylic amines to form chiral products such as β-branched amides and esters, and γ-branched 
amines. We developed a modular synthetic strategy that enables the diversification of a single 
allylic amine scaffold into many value-added products. Chiral, β-branched carbonyl compounds 
are valuable bioactive products as well as useful intermediates in synthetic pathways toward 
complex chiral products. Inspired by the work of Noyori and Otsuka, we envisioned that the 
rhodium-catalyzed isomerization of allylic amines to chiral enamines would serve as a powerful 
platform for the modular functionalization of a general electrophile. Nucleophilic attack onto an 
enamine in the presence of water leads to the formation of a hemiaminal or hemiacetal depending 
on the nucleophile. The hydrogen on the methine carbon in the resulting intermediate is hydridic 
in nature. We hypothesized that the Rh(I) catalyst could perform a dual role in the reaction where 
after the allylic isomerization, it could then reengage the hemiaminal or hemiacetal intermediate 
and dehydrogenate leading to an amide or ester respectively. We found that this reaction proceeded 
with high efficiency in the presence of a suitable hydrogen acceptor and base. The conditions were 
elaborated with a series of nucleophiles to demonstrate the modularity of this synthetic tool. 
 Designing a method with modularity in mind, we were motivated to find an allylic amine 
substrate that could be general with a variety of exogenous amine and alcohol nucleophiles. Noyori 
established that the steric bulk of the diethyl amine group was necessary for good stereoselectivity 
in the allylic isomerization of geranyl diethyl amine, but we found that it prevented the rhodium-
catalyzed dehydrogenation of the resulting intermediate. When using diethyl allylic amines, the 
oxidized amide product was not observed; however, saturated aldehyde was observed, indicating 
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that the isomerization did proceed. We hypothesized that an exogenous, less sterically hindered 
amine could exchange with the diethyl iminium intermediate to allow the oxidation to the amide 
to occur. When we added morpholine to the reaction, we observed formation of a single 
morpholino amide, with no detectable diethyl amide. Diethyl amine is non-competitive even with 
alcohols or hindered -branched amines as nucleophiles. This modularity allows rapid 
diversification of a single prochiral allylic amine into a variety of enantioenriched (90% to 99.9% 
e.e.) amides and esters via largely commercially available nucleophiles. The reaction generally 
affords good yields where yield trends correlate with nucleophile strength. Suitable nucleophiles 
include primary and cyclic secondary amines, anilines, α-branched chiral amines with excellent 
diastereoselectivity, and alkyl and benzyl alcohols. We also explored reductive conditions. By 
introducing formic acid as a hydrogen donor, γ-branched, chiral amines formed as the major 
product. We demonstrated this method for the synthesis of pharmaceuticals such as (R)-
Tolterodine and Terikalant. The development of this synthetic strategy also contributes to a 
broader understanding of the tolerance and scope of rhodium hydride transfer methods. 
 Part II of this Dissertation describes the synthesis of a molecular Möbius strip under alkyne 
metathesis with kinetic diastereoselectivity. In 1858, mathematicians Möbius and Listing 
discovered the Möbius strip, a single-sided, unorientable surface. The intriguing Möbius topology 
would eventually make its way into the consciousness of chemists as a hypothetical molecular 
topology that had never been observed in nature. The first successful synthesis of a Möbius 
aromatic hydrocarbon was not achieved until 2003 by Herges and co-workers, paving the way for 
experimental validation of what was previously only a theoretical understanding of Möbius 
aromaticity. Over the past 17 years, other macrocycles with Möbius topology have been 
synthesized while researchers developed new tools for experimentally probing the aromaticity of 
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these structurally fascinating molecules. Unfortunately, the syntheses of Möbius macrocycles to 
date have been limited by lengthy routes with low overall yields. We demonstrate that a 
cyclooligomerization strategy with alkyne metathesis provides high yields of a Möbius macrocycle 
in up to 84% in a single step. Of two possible diastereomers, only one was observed as a product 
of the reaction. Intriguingly, the major product was kinetically, rather than thermodynamically, 
favored, an unexpected result considering that alkyne metathesis is a reversible process. We 
provide computational justification for the kinetic selectivity which arises from differences in 
strain energy in the transition state of metallacyclobutadiene formation. Through the aid of 
calculations such as electron density of delocalized bonds (EDDB) and anisotropic induced current 
density (ACID), we observed that the Möbius macrocycle does not have global aromaticity but 
rather localized aromaticity in the helicene subunits. This work will facilitate future syntheses of 
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CHAPTER 1: INTRODUCTION TO PART I 
1.1 Importance of Amides and Esters in Biologically Active Compounds and 
their Syntheses 
 Amides and esters are potent functionalities in biological settings and are prevalent in 
pharmaceuticals and agrochemicals (Figure 1.1).1–3 Of the 100 top grossing pharmaceuticals of 
2013, 34 contained either an amide or an ester,3 and most of those moieties were constructed 
through acylation with an acyl chloride or some coupling reagent.4 Figure 1.1 highlights the 
common feature of β-branching that is found in many biologically active amides and esters. The 
syntheses of such compounds are further complicated by this added structural component wherein 
two key steps must be performed independently: setting the stereocenter at the β-position and 
installing the desired carbonyl functionality. The synthetic overhead required to perform these two 
steps in separate transformations can be quite significant particularly if several variations of a 
compound are needed to build a compound library. There has been intense investigation into 
establishing more efficient routes toward amide and ester incorporation into complex molecular 
scaffolds.5,6   
 
Figure 1.1. Examples of amides and esters in biologically active compounds. 
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 A recent patent demonstrates the synthesis of a library of pyrethroid compounds, useful as 
household insecticides, through a diastereoselective 1,4-selective Grignard addition followed by a 
Steglich esterification (Scheme 1.1).7 This strategy is resource intensive in that it requires 
stoichiometric chiral auxiliaries and stoichiometric coupling reagents for the conversion of the acid 
into the ester. Furthermore, the use of Grignard reagents limits the scope of substrates to those 
devoid of functionality that is sensitive to hard organometallic nucleophiles. The synthesis of the 
desired β-branched ester requires at least four chemical transformations. This does not include the 
chemical manipulation that was required to obtain the necessary coupling partners. 
 
Scheme 1.1. Diastereoselective synthesis of pyrethroid compounds. 
 Chiral, β-branched esters can also serve as synthetic precursors to pharmaceuticals 
containing the corresponding carboxylic acid, as is seen in the synthesis of AMG 837 (Scheme 
1.2).8,9 AMG 837 is a GPR40 partial agonist which has shown activity for the treatment of Type 
II diabetes. The target compound is a β-branched carboxylic acid with an internal alkyne at the β-
position. The process scale synthesis published by Amgen is a racemic synthesis involving a chiral 
resolution.8 A methodology that directly generates enantioenriched β-branched esters would 




 The aforementioned examples demonstrate the common synthetic strategies that have been 
applied to the synthesis of amide- and ester-containing pharmaceuticals and agrochemicals. Each 
of these approaches requires several chemical transformations to construct the key β-branched 
carbonyl compound. Many syntheses are either racemic requiring a chiral resolution or 
diastereoselective using stoichiometric chiral auxiliaries. To address this synthetic challenge, 
many researchers have developed catalytic methods for the asymmetric synthesis of chiral, β-
branched carbonyl compounds and for the catalytic construction of amide and ester moieties.  
 
Scheme 1.2. Process route toward AMG 837. 
 
1.1.1 Significant Advances in the Synthesis of Chiral, β-Branched Amides and Esters 
 Many industrial syntheses of β-branched carbonyl compounds have proceeded through the 
chiral resolution of a racemic intermediate; however, several methods have sought to establish 
more general access to this valuable molecular scaffold. In particular, enantioselective 
functionalization of α,β-unsaturated amides and esters have shown the most promise in achieving 
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this goal. The most well-established methods are asymmetric conjugate addition (ACA), 
enantioselective conjugate reduction, and asymmetric hydrogenation. 
  ACA has been widely developed as a method for constructing both β-branched amides 
and esters; however, rendering the CA to α,β-unsaturated amides to be asymmetric has presented 
particularly significant challenges. Amides are the least electrophilic carbonyl compound due to 
the high degree of resonance delocalization of the lone pair on the Lewis basic nitrogen atom into 
the carbonyl. This serves to raise the LUMO of the β-position thereby requiring more forcing 
conditions to effect 1,4-addition of nucleophiles (Scheme 1.3). At the elevated temperatures 
required for these transformations, the uncatalyzed background reaction becomes competitive with 
the enantioselective catalytic reaction leading to an erosion of enantioselectivity.10 In order to 
circumvent this challenge, two major strategies have been devised: placing electron-withdrawing 
substituents on the nitrogen atom or appending a chiral auxiliary to the substrate itself. 
 
Scheme 1.3. Electrophilicities of various carbonyl compounds. 
 Electron-deficient enamides, particularly α,β-unsaturated imides, have been widely 
investigated as surrogate substrates for amides in ACA. Chiral oxazolidinones serve as excellent 
directing groups for the 1,4-cuprate addition to α,β-unsaturated imides (Scheme 1.4).11,12 In 
addition to being electronically activated toward nucleophilic attack, the bidentate coordination of 
the imide to the Cu species establishes a highly organized transition state where one face of the 
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olefin is blocked by the substituent on the auxiliary providing access to a single diastereomer after 
nucleophilic attack. A similar approach has been demonstrated with chiral 1,2-amino alcohol- 
 
Scheme 1.4. Diastereoselective conjugate additions to α,β-unsaturated imides and amides. 
based auxiliaries and Grignard reagents as nucleophiles.13 It should be noted that auxiliary-based 
methods require cleavage of the auxiliary followed by subsequent functionalization of the resulting 
acid to access more general amide or ester products.  
 
Scheme 1.5. Copper-Catalyzed Enantioselective Conjugate Addition 
Catalytic variants of ACA to amides have been enabled by copper and rhodium complexes. 
Pineschi et al. have developed a Cu-phosphoramidite catalyst for the 1,4-addition of dialkyl zinc 
reagents to α,β-unsaturated imides. The reaction is limited to simple unhindered nucleophiles in 
order to achieve high selectivities (Scheme 1.5).14 The first asymmetric rhodium-catalyzed 1,4-
addition to amides was published by Miyaura and Sakuma in 2001.15 In this transformation, a Rh-
BINAP complex utilizes aryl boronic acids as nucleophiles for the Michael addition into a variety 
6 
 
of α,β-unsaturated 2° amides. Yields and enantioselectivities are generally high, though the 
reaction scope is very limited.  
 Very recently, the conjugate addition of Grignard reagents to acyclic α,β-unsaturated 
amides facilitated by a chiral copper catalyst and a Lewis acid activator has been reported (Scheme 
1.6).10 In this transformation, either TMSOTf or BF3•Et2O serve to activate the substrate toward 
nucleophilic attack at cryogenic temperatures where the uncatalyzed nucleophilic attack is not 
kinetically competent. The Lewis acid additive has enabled an unprecedent substrate scope for an 
asymmetric conjugate addition to a variety of α,β-unsaturated amides, although diaryl-substituted 
stereocenters are still not accessible. 
 
Scheme 1.6. Copper-catalyzed enantioselective conjugate addition to α,β-unsaturated amides. 
 The enantioselective conjugate addition (ECA) to esters has been more broadly developed 
than additions to amides, likely due to their increased electrophilicity.16–20 Feringa et al. have 
shown the use of Cu-phosphine complexes along with Grignard reagents for the synthesis of chiral, 
β-branched esters (Scheme 1.7).20 In contrast, Rh-BINAP complexes are known to effect the 1,4-




Scheme 1.7. Copper ECA to α,β-unsaturated esters. 
 In addition to ACA, chiral, β-branched esters can also be accessed from enantioselective 
conjugate reduction. Conjugate reduction is the 1,4-addition of a hydride into a Michael acceptor. 
These reactions are typically mediated by a transition metal catalyst in the presence of a hydride 
source. The most prominent examples of this methodology have been published by Buchwald and 
coworkers and Lipshutz and coworkers (Scheme 1.8).21–26 These methods typically employ a Cu-
phosphine complex along with polymethylhydrosiloxane (PMHS) for the conjugate reduction of 
β-disubstituted enoates. In addition to copper-catalysis, a Rh-PheBOX complex has been applied 
to a similar substrate scope leading to excellent enantioselectivities in most cases.27 More recently, 
a Ni-catalyzed transfer hydrogenation approach has been applied toward the synthesis of products 
containing functional group patterns that are rarely demonstrated within the realm of this 
chemistry, namely β-cyclic and β-ester substituted carbonyl compounds setting both an α- and a 




Scheme 1.8. Copper-catalyzed conjugate reduction of enoates. 
Generally, for enantioselective conjugate reduction, β-alkyl-β-aryl and β,β-dialkyl 
substrates are demonstrated where good steric differentiation between the substituents on the olefin 
is required to obtain high enantioselectivities. This highlights a significant limitation that is general 
to most methods that form β-branched carbonyl compounds as products. Because the chiral 
catalyst must distinguish between the substituents at the β-position, one of the substituents is often 
limited to a small methyl or ethyl group. For this reason, enantioselective routes that might 
establish a β-diaryl stereocenter are vastly underexplored.  
 




Asymmetric hydrogenations of α,β-unsaturated esters and carboxylic acids have been 
extensively studied; however, investigations are typically within the context of catalyst 
development rather than reaction design.28 When new catalysts are discovered, they are usually 
screened with a variety of olefin classes with standard substrates serving as representatives for 
each class. For this reason, catalysts that are capable of asymmetric hydrogenation of enoates are 
only demonstrated on a limited number of substrates. There are, of course, rare exceptions to this 
general trend. In 2012, Andersson et al. demonstrated the hydrogenation of α,β-unsaturated esters 
with a Crabtree-type catalyst yielding complete conversion of starting material and good to 
excellent enantioselectivities in all cases (Scheme 10).29  
 
Scheme 1.10. Iridium-catalyzed hydrogenation of α,β-unsaturated esters. 
Carboxylic acids are generally superior substrates for asymmetric hydrogenations due to 
their ability to form tight coordinations to the electrophilic iridium complexes that typically serve 
as catalysts for the transformations.28 Currently, the most reliable route to utilizing asymmetric 
hydrogenation as a synthetic strategy toward chiral, β-branched carbonyl compounds may be 
through hydrogenation of the α,β-unsaturated carboxylic acid followed by conversion of the acid 
into the ester or amide derivative. Though this route can provide access to excellent 
enantioselectivities, it introduces additional synthetic steps into a sequence and is not tolerant of 
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hydrogenation-sensitive functionalities. Moreover, results with a given catalyst tend to be substrate 
dependent, and extensive screening may be required to identify an appropriate catalyst for the 
substrate of interest. 
Though previous approaches have made strides in enabling the study and mass production 
of important biologically active compounds, we recognize the paucity of methods that would allow 
for a more streamlined synthesis of chiral, β-branched carbonyl compounds. It has been our goal 
to develop a modular, one-pot protocol for the synthesis of chiral, β-branched amides or esters 
from easily accessible starting materials. 
 
1.1.2 Dehydrogenative Strategies for Amidation and Esterification 
 Amide bond formation via stoichiometric coupling of carboxylic acids and amines is the 
most commonly used acylation reaction in the pharmaceutical industry by an astonishing margin.1 
Schneider et al. suggest that this favor shown to stoichiometric amide synthesis is due to the 
operational simplicity of such reactions. However, these strategies often require harsh conditions 
or generate high molecular weight byproducts that are difficult to separate from the desired 
compound. Due to the challenges associated with stoichiometric amidation and esterification, 
catalytic variants have been investigated in recent years.6,30–32 One such strategy involves the 
dehydrogenative coupling of alcohols or aldehydes with exogeneous nucleophiles to form the 
corresponding carbonyl compounds. These reactions can either be acceptorless wherein the only 
byproduct is H2 or transfer hydrogenative with a stoichiometric hydride acceptor acting as the 
terminal oxidant.  
 Ru-pincer complexes sit at the forefront of dehydrogenative coupling catalysis. Pioneered 




35 Several analogs of this catalyst have been developed since the seminal report,36 many of which 
are capable of both amidation and esterification.  
Early esterification reports were limited to the formation of homocoupled (formal 
Tishchenko) products; however, cross-coupling of 1° alcohols with 2° alcohols have more recently 
been disclosed.37 In addition to the cross-coupling of alcohols, transesterification reactions 
utilizing 2° alcohols as nucleophiles have been achieved with high chemoselectivity.38 Amidation 
with both primary39–43 and secondary44–48 amines have been optimized where the steric properties 
of the ligand scaffold play a critical role in achieving high yields (Scheme 1.11). Very recently, 
pincer complexes derived from base metals such as manganese48 and iron47 have been enabled for 
similar amidation procedures. 
 
Scheme 1.11. Catalysts for dehydrogenative amidation and esterification. 
 Transfer hydrogenation has been enabled for the synthesis of both amides and esters under 
mediation of a variety of metal complexes. Transfer hydrogenation approaches commonly utilize 
aldehydes as substrates in the presence of stoichiometric hydrogen acceptors. Dong et al. have 
developed a Ni–NHC complex suitable for the coupling of aromatic and aliphatic aldehydes with 
alcohols, aryl amines, or aliphatic amines with trifluoroacetophenone as a stoichiometric hydrogen 
acceptor (Scheme 1.12).49 Molander et al. have demonstrated the oxidative esterification of 
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aliphatic and aromatic aldehydes under palladium catalysis; however, this method requires solvent 
quantities of alcohol nucleophile.50 
 
Scheme 1.12. Nickel-catalyzed amidation and esterification of aldehydes. 
 Considering the valuable complexity of chiral, β-branched carbonyl compounds and the 
roundabout methods by which they are often synthesized, we have considered the need for more 
streamlined access to these molecular scaffolds. The state-of-the-art methods in enantioselective 
β-branched carbonyl synthesis, even after years of extensive development, are still plagued with a 
fundamental limitation: lack of significant substrate variation. Specifically, current methods only 
provide access to β-dialkyl or β-alkyl-β-aryl substituted products. Furthermore, one of the β-
substituents is almost always a methyl group, and β-diaryl products are virtually never 
demonstrated outside of the context of hydrogenations of α,β-unsaturated carboxylic acids.51 
 
1.2 γ-Branched, Chiral Amines in Biologically Active Compounds 
Aliphatic amines with adjacent stereocenters are prevalent in natural products and 
pharmaceuticals and are often key contributors to their potent biological activity.52 In particular, 
enantiopure γ-branched amines represent an important subclass of bioactive amines, including 
many pharmaceutical agents (Figure 1.2). Despite the generality of this structure, the direct 
synthesis of chiral, γ-branched amines remains underdeveloped compared to the well-established 
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methods for constructing α- and β-branched amines,53–56 as well as distal stereocenters to other 
function groups such as ketones,57 aldehydes,58–61 and amides.62 
 
Figure 1.2. Biologically active molecules containing chiral γ-branched amine moiety.  
1.2.1 Catalytic Methods for Installing γ-Branched Chiral Amines 
Known catalytic approaches to install this subunit often require multistep synthetic 
sequences via chiral, β-branched carbonyl intermediates, which can hinder the rapid generation of 
compound libraries for high throughput screening in medicinal chemistry. For example, transition 
metal-catalyzed asymmetric hydrogenation of α,β-unsaturated acids or esters63–65 affords the 
enantiopure β-branched carbonyl intermediates, followed by a reductive amination to install the 
desired chiral γ-branched amines (Scheme 1.13.1). However, varying substituents at the newly 
introduced stereocenters, such as aryl vs. alkyl, acyclic vs. cyclic, or carbon atom vs. heteroatom, 
often requires different metal/ligand scaffolds to achieve high enantioselectivity.63–65 The redox 
neutral isomerization of allylic amines66,67 or alcohols68–70 provides a solution to this problem; 
however, current methods suffer from very limited substrate scope.60–64 To the best of our 




Scheme 1.13. 1) Asymmetric hydrogenation or isomerization followed by reductive amination for the multistep 
synthesis. 2) Direct synthesis via a Cu—H catalyzed relay hydroamination reaction. 
(Scheme 1.13.2). Buchwald et al. have shown that 3,3-disubstituted allylic esters can undergo an 
enantioselective hydrocupration followed by β-alkoxide elimination and subsequent anti-
Markovnikov hydroamination of the intermediate terminal olefin to afford γ-branched amines in 
one step.71 Although this method demonstrates high enantioselectivity under a ligand-controlled 
hydrocupration of allylic esters, the preparation of electrophilic amines requires additional 
synthetic operations and limits the substrate scope to secondary alkyl amines.71 
 
1.3 Research Hypothesis 
 In each of the examples described above, a chiral catalyst is required to distinguish between 
the steric environments of the substituents on the olefin to select a face from which to deliver a 
nucleophile. Enantioselectivity is often improved when one of the substituents is a methyl group 
because the steric differences between the two β-substituents are more marked. At the outset of 
our investigation, we believed that an intramolecular hydride transfer from an allylic directing 
group would allow us to overcome the common limitations of current methods in favor of 




Scheme 1.14. Facial selectivity of olefin functionalizations. a) Stereochemistry of 1,3-hydride shift is determined 
by directing group and olefin geometry. b) stereochemistry of external nucleophile delivery is determined only by R1 
and R2. 
 Allylic Lewis basic groups appealed to us as a substrate class because we envisioned that 
these would bind the catalyst via a two-point binding mode, constraining the conformational 
freedom of the substrate.72–76 The facial selectivity of the approach of the substrate to the catalyst 
would not depend on the substituents on the disubstituted position of the olefin but rather on the  
combined orientation of the Lewis basic group and olefin. In addition, we have demonstrated that 
an allylic alcohol may be directly converted to an amide via rhodium catalysis77The isomerization 
of an allylic alcohol to form an aldehyde is well-studied,73–76 and we discovered conditions that 
would convert the in situ formed aldehyde into an amide in the presence of a nucleophile, hydrogen 
acceptor, and rhodium catalyst. The method we developed provided access to a variety of amides 
derived from aliphatic or aryl amine nucleophiles; however, when prochiral allylic amines were 
employed, low enantioselectivities were observed (70:30 e.r.) (Scheme 1.15). 
 
Scheme 1.15. Tandem isomerization/amidation of prochiral allylic alcohols. 
 The enantioselective isomerization of allylic alcohols is a known challenge in the literature; 




Scheme 1.16. Asymmetric isomerization of allylic amines. 
 
 
Scheme 1.17. Functionalization of optically pure enamines. a) Proposed enamine exchange of diethyl enamine. b) 
Proposed functionalizations of diethyl enamine intermediate. 
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our amidation methodology asymmetric through the allylic isomerization of some functional group 
that yielded an intermediate that is isoelectronic to an aldehyde, such as an imine. The asymmetric  
isomerization of allylic amines to generate optically pure enamines proceeds with excellent 
enantiocontrol under mediation of a Rh-BINAP complex (Scheme 1.16).72,80–82 Noyori and 
coworkers have demonstrated that allylic diethyl amines are excellent substrates for the 
asymmetric isomerization leading to chiral enamines. Our previous results have demonstrated that 
diethyl amine is not a competent nucleophile for the dehydrogenative amidation of aldehydes, 
likely due to its steric bulk. Considering this, we propose that the addition of exogeneous amine 
nucleophiles to diethyl enamine intermediate (i) might allow enamine exchange to form (ii) 
followed by oxidation enabling a selective, modular synthesis of chiral, β-branched amides 
(Scheme 1.17 a). Furthermore, functionalizing the enamine intermediate with a variety of 
nucleophiles would lead to the formation of several classes of carbonyl compounds from a 
common starting material (Scheme 1.17 b).  
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CHAPTER 2: RHODIUM CATALYZED ISOMERIZATION AND 
AMIDATION OF ALLYLIC AMINES WITH AMINE NUCLEOPHILES TO 
FORM CHIRAL, β-BRANCHED AMIDES 
 
This chapter has been adapted from the following publication: 
Wu, Z.; Laffoon, S. D.; Nguyen, T. T.; McAlpin, J. D.; Hull, K. L. Rhodium-Catalyzed 
Asymmetric Synthesis of β-Branched Amides. Angew. Chem. Int. Ed. 2017, 56, 1371-1375. 
 
2.1 Abstract  
This chapter describes a general asymmetric route for the one-step synthesis of chiral β-
branched amides. A cationic Rh(I)-BINAP catalyst facilitates the highly enantioselective 
isomerization of allylamines and subsequent oxidation following enamine exchange. The enamine 
exchange allows for a rapid and modular synthesis of various amides, including challenging β-
diaryl and β-cyclic from an allylic diethyl amine scaffold. Several combinations of allylic amine 
substrates and amine nucleophiles were investigated in the transformation totaling 37 examples. 
Yields ranged from 38% to 82% and e.r. ranging from 94:6 to >99:1.  
 
2.2 Motivation and Background 
Enantiopure β-branched amides are common motifs in natural products and biologically 
active molecules1 (Figure 2.1) and are useful synthetic intermediates for the construction of γ-
branched chiral amines.2 However, examples of the direct asymmetric synthesis of chiral β- 
branched amides are rare. Chapter 1 of this Thesis details various catalytic approaches to installing 
chiral, β-branched amide functionality Although asymmetric hydrogenation or conjugate addition 
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of α,β-unsaturated carbonyls are common strategies toward β-stereocenters, α,β-unsaturated 
amides intrinsically display low reactivity.3 Only a few examples of 
 
Figure 2.1. Biologically active compounds containing chiral -branched amides. 
unsaturated acyclic amides have been documented, including Co-catalyzed asymmetric reduction4 
and Rh-catalyzed conjugate addition.5 For a general and modular synthesis of enantiopure β-
branched amides, a multistep sequence is often required via carboxylic acid intermediates (Scheme 
2.1).1c For example, asymmetric hydrogenation of β,β-disubstituted 
 
Scheme 2.1. Enantioselective -branched amide syntheses. 
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unsaturated acrylic acid or ester has been extensively studied to reach high conversion and 
excellent enantioselectivity via Rh, Ir, and Ru catalysis (Scheme 2.1a).6 The same chiral acid 
intermediate could be prepared through a copper-catalyzed asymmetric 1,4-addition of an 
alkylzinc to a unsaturated N-acyloxazolidione followed by hydrolysis (Scheme 2.1b).7 For the 
synthesis of the desired amide products, stoichiometric coupling reagents are often required which 
leads to poor atom economy.8  
 
2.3 Investigating Allylic Amine Substrates 
Considering the dearth of approaches for the direct asymmetric synthesis of chiral β-
branched amides, we proposed that allylic alcohols could serve as a chiral aldehyde precursor, 
which upon asymmetric isomerization and subsequent oxidative amidation with an amine, affords 
the desired product in a single step (Scheme 2.1c). The Hull group reported a cationic Rh/BINAP 
complex as an effective catalyst for this transformation, converting primary and secondary amines 
as well as anilines into amides.9 However, only moderate e.r. was observed when using 
trisubstituted allylic alcohols as substrates.10 As an enamine intermediate is formed over the course 
of the reaction, we hypothesized that utilizing Noyori’s asymmetric isomerization of allyl amines, 
a highly enantioselective process and the key step in the Takasago Process, could allow for the 
formation of identical intermediates with improved enantioselectivity.11 To avoid preinstallation 
of the amine functionality on the substrate, we further proposed a domino process: enantioselective 
isomerization of an allylic amine, enamine exchange with an external amine nucleophile, and 
oxidation of enamine to afford enantiopure β-branched amides in a single step (Scheme 2.1d).  
The key challenge for this tandem process is identifying an appropriate allyl amine 
precursor, as it must: isomerize with high enantioselectivity, afford an enamine (ii) which is slow 
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to oxidize and instead undergo enamine exchange with an external amine nucleophile to afford the 
desired intermediate (i) (Scheme 2.2). We hypothesized that acyclic dialkyl amines  
 
Scheme 2.2. Proposed reaction pathway. 
could serve as precursors as they are good substrates in related Rh-catalyzed asymmetric 
isomerization reactions11 and are not reactive in the oxidative amidation of allyl alcohols.9 Several 
allylic dialkyl amines (1a–1d) were screened for this tandem process (Table 2.1). Under slightly 
modified conditions from the allylic alcohol amidation,12 the desired morpholine amide (3a) was 
formed in moderate yields from all the allylic amine precursors. Only cinnamyl dimethylamine  
Table 2.1. Rhodium-catalyzed allylic dialkylamine amidation.a 
 
Entry R Yield of 3a (%)b Yield of 4a-d (%)c 
1 Me 64 9 
2 Et 77 <1% 
3 i-Pr 71 <1% 
4 Bn 74 <1% 
a) General reaction conditions: cinnamyl dialkylamine (1) (0.12 mmol, 1.0 equiv), morpholine (2a) (1.5 equiv), 
CsOAc (1.5 equiv), styrene (1.5 equiv), THF (1.2 M), DI H2O. b) In situ yield determined by GC analysis. c) In situ 
yield determined by NMR.  
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(1a) provided 9% byproduct 4a, consistent with dimethyl amine being an effective nucleophile in 
our allylic alcohol amidation.9 We chose to further optimize this reaction with cinnamyl 
diethylamine (1b), as it forms a low molecular weight byproduct (NHEt2) which is easily removed. 
 
2.4 Optimized Reaction Conditions 
After further optimization of reaction conditions Cs2CO3 proved superior to CsOAc for 
secondary amine nucleophiles and only sub-stoichiometric amount (20 mol%) is required. A 
variety of hydrogen acceptors were examined showing styrene to be superior, as it was reduced 
faster than the substrate. Further, decreasing the equivalents of amine nucleophile (1.05 equiv) led 
to only slightly diminished yields.  
 
2.5 Substrate Scope 
Slight modification of the reaction conditions was required for other amine nucleophiles. 
For less nucleophilic aniline derivatives, excess nucleophile (3.0 equiv) and increased base (0.9 
equiv) were required to prevent unproductive reaction pathways. With primary alkyl amine 
nucleophiles, a stronger base and higher temperature were essential, which presumably aid in the 
conversion of the less electrophilic imine intermediate to the hemiaminal intermediate. 
Additionally, acetone proved to be the better hydrogen acceptor, consistent with our allylic alcohol 
amidation.9 With the optimized conditions in hand, the amine nucleophile scope was investigated 
(Table 2.2): cyclic amines such as piperidine (2b), indoline (2e), and 2-(piperazin-1-yl) pyrimidine 
(2f) and acyclic amines, including dimethyl amine (2c) and N-benzyl methyl amine (2d) all gave 
excellent yields of desired products. Moderate yields were obtained with aniline derivatives (2g–
2j). Electron-deficient (2i) and sterically hindered anilines (2j) afford slightly diminished yields. 
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Primary amines are relatively challenging nucleophiles for this reaction and 3k and 3l were 
obtained in 64% and 39%, respectively. Unsurprisingly, diethyl and dibenzyl amines showed no 
reactivity under optimized conditions, consistent with results in Table 2.1.  
Table 2.2. Scope of amine nucleophiles. 
 
a) Condition a: 2° amines (1.05 equiv), Cs2CO3 (20 mol %), styrene (1.5 equiv), THF/H2O (1:0.2). b) Condition b: 
anilines (3.0 equiv), Cs2CO3 (90 mol %), styrene (1.5 equiv), THF/H2O (1:0.3). c) Condition c: 1° alkyl amine (1.0 
equiv), KOH (2.5 equiv), acetone (1.0 equiv), THF/H2O (1:1), 100 °C. 
 
The enantioselectivity of this transformation was explored under optimized conditions with 
different amine nucleophiles (Table 2.3). Excellent enantioselectivities (>96:4 e.r.) were observed 
in the asymmetric oxidative amidation of (E)-geranyl diethyl amine with morpholine, aniline, and 
benzyl amine, affording 6aa, 6af, and 6ak in fair to excellent yields. Using either (S)-BINAP or 




Focusing our efforts on substrates not previously shown in the Noyori isomerization, the 
scope of prochiral allylamines was next explored (Table 2.4). A variety of substrates were 
transformed to the corresponding β-branched amides with high enantioselectivities in moderate to 
very good yields. Various 3,3-aryl,alkyl allylic diethylamines were investigated (5b–5h); 
stereocenters bearing both small (Me, Et) and large (i-Pr) substituents uniformly give excellent 
enantiomeric ratios (6ba-6da).16 Aryl halides were tolerated under the optimized conditions, 
Table 2.3. Enantioselective isomerization/amidation of (E)-geranyl diethyl amine.  
 
a) For conditions see Table 2.14 Isolated yield, average of two runs. Absolute configuration is assigned by analogy to 
6oa (vide infra). b) With (S)-BINAP. 
although some protodebromination product was observed from aryl bromides (6gg). When 
bdialkyl allylic diethylamines (5i–5l) were exposed to the reaction conditions, chiral amides 
bearing a dialkyl stereocenter were obtained with excellent enantioselectivity, even with minimally 
differentiated substituents (6la, n-Bu vs. n-Pent). 
Additionally, 3,3-diaryl allylic diethylamines also undergo this asymmetric 
isomerization/oxidation reaction. Substrates bearing electron-rich (6ma) and electron-poor (6na) 
aryl substituents afforded good yields and enantiomeric ratios. Heterocycles such as thiophene 
were tolerated and compatible with both secondary cyclic (6oa) and acyclic (6od) amine 
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nucleophiles. Further, a chroman-derived β-cyclic substrate (5p) afforded the chiral amide product 
with excellent enanotioselectivity, demonstrating an improvement over other approaches, for 
example, chiral resolution.16  
The diastereoselectivity of this reaction was investigated with enantiopure amine 
nucleophiles (Table 2.5). When chiral α-branched amines 2m and 2n were used as nucleophiles, 
6bm and 6bn were formed in high e.r. (>99:1) and d.r. (>96:4). Further, both the enantiomer of 
ligand, (R)- or (S)-BINAP, and the enantiomer of amine employed dictate which diastereomer 
Table 2.4. Scope of one-step asymmetric isomerization/amidation of allylic amines. 
 
a) For conditions see Table 2.2.14 Isolated yield, average of two runs. b) Determined from the d.r. of transamidation 
product from 6la.14 c) Absolute configuration of 6oa was determined by X-ray crystallography. 14. d) 96:4 E/Z ratio 
of starting material. 
is formed. This indicates both that the stereocenter α to the amine are unepimerized under the 
reaction conditions, even with the relatively activated chiral benzylic amine (2m), and that it has 
no effect on the selectivity of the isomerization reaction.  
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Table 2.5. Diastereoselectivity with enantiopure amine nucleophiles.14 
 
a) with (R)-BINAP. b) with (S)-BINAP. 
Next the isomerization of allylic amine with proximal stereocenters was examined (Scheme 
2.3). Interestingly, the diastereoselecitivity of the isomerization of 5q and 5r with (±)-BINAP 
favored the formation of (3S,5R)-6qa (56:44 d.r.) and (3S,4S)-6ra (14:85 d.r.), respectively, where 
the closer stereocenter in 5r has a greater effect on the diastereoselectivity of the reaction. 
Excitingly, both 5q and 5r undergo the Rh-catalyzed isomerization/oxidation to afford desired 
products with excellent diastereoselectivities (>97.5:2.5) when enantioenriched ligands are 
employed. The isomerization reaction proved to be ligand-controlled, as the mismatched 
combination of (R)-BINAP and 5r decreased the yield of (3R,4S)-6ra, rather than the 
diastereoselectivity. 
As shown in Scheme 2.4, isotope labelling studies were carried out using H2
18O and D2O 
respectively. The H2
18O labelling study (Scheme 2.4a) confirms that the oxygen in the product 
originates from the water. Similarly, deuterium incorporation at the α-position of the amide was 
observed (Scheme 2.4b), as it was in the allylic alcohol amidation,9 supporting the reversible 





Scheme 2.3. Diastereoselectivity with enantiopure allyl amines. 14 
 
 
Scheme 2.4. Isotope labelling study. 
 
2.6 Conclusion 
We have developed a Rh-catalyzed one-step synthesis of chiral β-branched amides. This 
method allows for the installation of a stereocenter and amide functionality in a single step under 
mild conditions. Excellent enantio- and diastereoselectivity was observed for a variety of allylic 




2.7 Supporting Information  
General Experimental Procedures  
All reactions were carried out in flame-dried (or oven-dried at 140 °C for at least 2 h) 
glassware under an atmosphere of nitrogen unless otherwise indicated. Nitrogen was dried using 
a drying tube equipped with Drierite™ unless otherwise noted. Air- and moisture-sensitive 
reagents were handled in a nitrogen-filled glovebox (working oxygen level ~ 0.1 ppm; working 
water level ~ 0.1 ppm). Column chromatography was performed with silica gel from Grace 
Davison Discovery Sciences (35-75 μm) with a column mixed as a slurry with the eluent and was 
packed, rinsed, and run under air pressure. Analytical thin-layer chromatography (TLC) was 
performed on precoated glass silica gel plates (by EMD Chemicals Inc.) with F-254 indicator. 
Visualization was either by short wave (254 nm) ultraviolet light, or by staining with potassium 
permanganate followed by brief heating on a hot plate or by a heat gun. Distillations were 
performed using a 3 cm shortpath column under reduced pressure or by using a Hickman still at 
ambient pressure.  
Instrumentation 
1H NMR and 13C NMR were recorded on a Varian Unity 400/500 MHz (100/125 MHz 
respectively for 13C) spectrometer, a VXR-500 MHz spectrometer, or a Bruker 500 MHz 
spectrometer equipped with a CryoProbe. Spectra were referenced using either CDCl3 as solvent 
(unless otherwise noted) with the residual solvent peak as the internal standard (1H NMR: δ 7.26 
ppm, 13C NMR: δ 77.16 ppm for CDCl3). Chemical shifts were reported in parts per million and 
multiplicities are as indicated: s (singlet,) d (doublet,) t (triplet,) q (quartet,) p (pentet,) m 
(multiplet,) and br (broad). Coupling constants, J, are reported in Hertz and integration is provided, 
along with assignments, as indicated. Analysis by Gas Chromatography-Mass Spectrometry (GC-
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MS) was performed using a Shimadzu GC-2010 Plus Gas chromatograph fitted with a Shimadzu 
GCMS-QP2010 SE mass spectrometer using electron impact (EI) ionization after analytes traveled 
through a SHRXI–5MS- 30m x 0.25 mm x 0.25 μm column using a helium carrier gas. Data are 
reported in the form of m/z (intensity relative to base peak = 100). Gas Chromatography (GC) was 
performed on a Shimadzu GC-2010 Plus gas chromatograph with SHRXI–MS- 15m x 0.25 mm x 
0.25 μm column with nitrogen carrier gas and a flame ionization detector (FID). Enantiomeric 
ratios were measured via High Performance Liquid Chromatography (HPLC) using a Shimadzu 
Prominence HLPC system with SPD-M20A UV/VIS Photodiode array detector. Low-resolution 
Mass Spectrometry and High Resolution Mass Spectrometry were performed in the Department 
of Chemistry at University of Illinois at Urbana-Champaign. The glove box, MBraun LABmaster 
sp, was maintained under nitrogen atmosphere.  
Materials  
Solvents used for extraction and column chromatography were reagent grade and used as 
received. Reaction solvents tetrahydrofuran (Fisher, unstabilized HPLC ACS grade), diethyl ether 
(Fisher, BHT stabilized ACS grade), methylene chloride (Fisher, unstabilized HPLC grade), 
dimethoxyethane (Fisher, certified ACS), toluene (Fisher, optima ACS grade), 1,4-dioxane 
(Fisher, certified ACS), acetonitrile (Fisher, HPLC grade), and hexanes (Fisher, ACS HPLC grade) 
were dried on a Pure Process Technology Glass Contour Solvent Purification System using 
activated Stainless Steel columns while following manufacture’s recommendations for solvent 
preparation and dispensation unless otherwise noted. All alcohols were distilled and degassed by 
the freeze-pump-thaw method, and were stored under an atmosphere of nitrogen in glove box 
before use. All amines were distilled and degassed by the freeze-pump-thaw method, and were 
40 
 
stored under an atmosphere of nitrogen in glove box before use. All liquid aldehydes were distilled 
prior to use, and ketones, benzophenone and cyclohexanone, were used as received. 
 
2.7.1 Amidation Experimental Procedure, Isolation, and Characterization 
General procedure for Rh-catalyzed isomerization and oxidation of allylic amine with 
secondary amines (General procedure A) 
 
[Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (±)-BINAP or (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), NaBAr4
F (6.4 mg, 0.0072 mmol, 3.0 mol %), and Cs2CO3 (16 mg, 0.048 
mmol, 20 mol %) were added to a 4-mL vial equipped with a stir bar under N2 atmosphere. THF 
(0.2 mL), cinnamyl diethylamine 1a (46 mg, 0.24 mmol, 1.0 equiv), styrene (42 μL, 0.36 mmol, 
1.5 equiv), secondary amine 2 (0.25 mmol, 1.05 equiv), and DI water (0.04 mL) were added to the 
vial sequentially. The resulting solution was stirred for 24 h at 80 °C. The reaction vial was cooled 
to room temperature followed by the addition of diphenylmethane as an internal standard for 
analysis of the crude reaction mixture. The biphasic solution was diluted with EtOAc, dried over 
anhydrous MgSO4, concentrated in vacuo and then purified by silica gel chromatography 






General procedure for Rh-catalyzed isomerization and oxidation of allylic amine with 
primary anilines (General procedure B)  
[Rh(COD)Cl]2 (4.4 mg, 0.009 mmol, 1.5 mol %), (±)-BINAP or (R)-BINAP (11.2 mg, 
0.018 mmol, 3.0 mol %), NaBArF4 (16.0 mg, 0.018 mmol, 3.0 mol %), and Cs2CO3 (175.9 mg, 
0.54 mmol, 0.9 equiv) were added to a 20-mL vial equipped with a stir bar under N2 atmosphere. 
THF (0.5 mL), cinnamyl diethylamine 1a (113.6 mg, 0.60 mmol, 1.0 equiv), styrene (103 μL, 0.54 
mmol, 1.5 equiv), primary aniline 2 (1.8 mmol, 3.0 equiv), and DI water (0.15 mL) were added to 
the vial sequentially. The resulting solution was stirred for 24 h at 80 °C. The reaction vial was 
cooled to room temperature followed by the addition of diphenylmethane as an internal standard 
for analysis of the crude reaction mixture. The biphasic solution was diluted in EtOAc, washed 
with HCl 1N (2 x 20 mL), dried over anhydrous MgSO4, concentrated in vacuo and then purified 
by silica gel chromatography (hexanes/EtOAc) to afford the desired product 3. 
 
General procedure for Rh-catalyzed isomerization and oxidation of allylic amine with alkyl 
primary amines (General procedure C) 
[Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (±)-BINAP or (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), and NaBArF4 (6.4 mg, 0.0072 mmol, 3.0 mol %) were added to a 4-mL 
vial equipped with a stir bar under N2 atmosphere. Cinnamyl diethylamine 1a (57 mg, 0.36 mmol, 
1.25 equiv), primary amine 2 (0.24 mol, 1.0 equiv), acetone (19.4 μL, 0.264 mmol, 1.1 equiv), 
THF (0.2 mL), and 3 M KOH (0.2 mL, 2.5 equiv KOH) were added sequentially to the vial. The 
resulting solution was stirred at 80 °C for 24 h. The reaction vial was cooled to room temperature 
followed by the addition of diphenylmethane as an internal standard for analysis of the crude 
reaction mixture. The biphasic solution was diluted with EtOAc, dried over anhydrous MgSO4, 
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concentrated in vacuo, and purified by silica gel chromatography (hexanes/EtOAc) to afford the 
desired product 3. 
 
Rh-catalyzed isomerization and oxidation of geranyl diethylamine with benzylamine 
(General procedure D) 
[Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (±)-BINAP or (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), and NaBArF4 (6.4 mg, 0.0072 mmol, 3.0 mol %), cinnamyl 
diethylamine 1a (57 mg, 0.36 mmol, 1.25 equiv), and THF (0.2 mL) were added to a 4-mL vial 
equipped with a stir bar in a nitrogen filled glovebox. The vial was stirred at 40 °C for 24 hours. 
The vial was then brought back into the glovebox where KOtBu (40 mg, 0.36 mmol, 1.5 equiv), 
benzylamine (39 µL, 0.36 mmol, 1.5 equiv), acetone (53 µL, 0.72 mmol, 3 equiv) were added. The 
reaction was taken out of the glovebox, DI water (0.2 mL) was added by syringe through a Teflon 
septum, and the reaction stirred at 80 °C for 24 hours. The reaction vial was cooled to room 
temperature followed by the addition of diphenylmethane as an internal standard for analysis of 
the crude reaction mixture. The biphasic solution was diluted with EtOAc, dried over anhydrous 
MgSO4, concentrated in vacuo, and purified by silica gel chromatography (hexanes/EtOAc) to 
afford the desired product 3. 
 
Characterization of Final Compounds 
1-morpholino-3-phenylpropan-1-one C13H17NO2 
81 % isolated yield. Rf = 0.15 (1:1 hexane/EtOAc)  
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 3.68 – 3.57 (m, 4H), 3.55 
– 3.48 (m, 2H), 3.40 – 3.31 (m, 2H), 2.98 (t, J = 7.8 Hz, 2H), 2.61 (t, J = 7.8 Hz, 2H).  
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13C NMR (101 MHz, CDCl3) δ 170.97, 141.14, 128.64, 128.56, 126.37, 66.95, 66.56, 46.06, 
42.03, 34.92, 31.58.  
IR: ν 2927, 2858, 1642, 1432 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C13H17NO2, 220.1338; found, 220.1334. 
 
3-phenyl-1-(piperidin-1-yl)propan-1-one C14H19NO 
80% isolated yield. Rf = 0.05 (5:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 3.61 – 3.51 (m, 2H), 3.44 
– 3.27 (m, 2H), 2.97 (t, J = 8.0 Hz, 2H), 2.62 (t, J = 8.0 Hz, 2H), 1.64 – 1.58 (m, 2H), 1.55 – 1.49 
(m, 2H), 1.49 – 1.43 (m, 2H).   
13C NMR (101 MHz, CDCl3) δ 170.52, 141.57, 128.56, 128.53, 126.18, 46.72, 42.83, 35.31, 
31.73, 26.49, 25.65, 24.63.   
IR: ν 2937, 2856, 1639, 1437 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO, 218.1545; found, 218.1543. 
 
1-(indolin-1-yl)-3-phenylpropan-1-one C17H17NO 
76% isolated yield. Rf = 0.1 (10:1 hexane/EtOAc). mp =110-112 °C   
1H NMR (500 MHz, CDCl3, mixture of amide rotamers) δ 8.26 (d, J = 8.1 Hz, 1H), 7.34 – 7.26 
(m, 4H), 7.24 – 7.14 (m, 3H, overlapping peaks), 7.01 (t, J = 7.3 Hz, 1H), 4.17 (t, J = 8.1 Hz, 0.2H, 
minor rotamer), 3.97 (t, J = 8.5 Hz, 2H, maJor rotamer), 3.15 (t, J = 8.5 Hz, 2H), 3.12 – 3.05 (m, 
2H, maJor rotamer), 2.98 (t, J = 8.0 Hz, 0.2H minor rotamer), 2.74 (dd, J = 8.7, 7.0 Hz, 2H).  
13C NMR (101 MHz, CDCl3) (maJor rotamer) δ 170.48, 143.07, 141.33, 131.16, 128.66, 128.56, 
127.64, 126.30, 124.61, 123.68, 117.10, 48.01, 38.02, 30.85, 28.09.  
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IR: ν 3065, 2929, 1654, 1483 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H18NO, 252.1388; found, 252.1388. 
 
3-phenyl-1-(4-(pyrimidin-2-yl)piperazin-1-yl)propan-1-one C17H20N4O 
63% isolated yield (acid/base workup followed by recrystallization from 
DCM/pentane). mp =74-76 °C   
1H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 4.7 Hz, 2H), 7.33 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 
6.53 (t, J = 4.7 Hz, 1H), 3.84 – 3.76 (m, 2H), 3.74 – 3.67 (m, 4H), 3.47 – 3.40 (m, 2H), 3.01 (t, J 
= 7.8Hz, 2H), 2.68 (t, J = 7.9 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 171.00, 161.55, 157.87, 141.25, 128.66, 128.59, 126.37, 110.53, 
45.44, 43.69, 43.60, 41.54, 35.27, 31.65.  
IR: ν 3030, 2964, 2865, 1632, 1587, 1548, 1496, 1500, 1435, 1355 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H21N4O, 297.1715; found, 297.1720. 
 
N,N-dimethyl-3-phenylpropanamide C11H15NO 
82% isolated yield. Rf = 0.25 (1:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 2H), 7.25 – 7.17 (m, 3H), 2.97 (t, J = 7.6 Hz, 2H), 
2.95 (s, 3H), 2.93 (s, 3H), 2.61 (t, J = 7.9 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 172.29, 141.62, 128.58, 128.54, 126.20, 37.28, 35.56, 35.45, 
31.50.  
IR: ν 2933, 2893, 1645, 1496, 1398 cm-1.   





71% isolated yield. Rf = 0.2 (6:1 hexane/EtOAc)  
1H NMR (400 MHz, CDCl3, mixture of amide rotamers) δ 7.38 – 7.15 (m, 9H), 7.12 – 7.05 (m, 
1H), 4.60 (s, 1.1H), 4.47 (s, 0.8H), 3.09 – 2.97 (m, 2H), 2.96 (s, 1.1H), 2.85 (s, 1.8H), 2.76 – 2.61 
(m, 2H).   
13C NMR (101 MHz, CDCl3, mixture of amide rotamers) δ 172.72, 172.39, 141.50, 141.41, 
137.47, 136.64, 129.03, 128.69, 128.60, 128.58, 128.16, 127.69, 127.43, 126.35, 126.24, 53.37, 
50.98, 35.54, 35.11, 34.90, 34.15, 34.11, 31.68, 31.50.   
IR: ν 3031, 2933, 1643, 1495, 1453 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H20NO, 254.1545; found, 254.1542. 
 
N-benzyl-3-phenylpropanamide C16H17NO 
64% isolated yield. Rf = 0.3 (1.5:1 hexane/EtOAc) mp =77-81 °C   
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.15 (m, 10H), 5.81 (s, broad, 1H), 4.39 (d, J = 5.7 Hz, 2H), 
2.99 (t, J = 7.6 Hz, 2H), 2.51 (t, J = 7.6 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 172.01, 140.87, 138.25, 128.73, 128.64, 128.50, 127.81, 127.52, 
126.34, 43.64, 38.57, 31.82.  
IR: ν 3284, 3028, 1636, 1539, 1218, 693 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H18NO, 240.1388; found, 240.1389. 
 
N-(2-morpholinoethyl)-3-phenylpropanamide C15H22N2O2 
39% isolated yield. mp = 94-95 °C  
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1H NMR (400 MHz, CDCl3) δ 7.29 – 7.17 (m, 5H), 5.89 (s, broad, 1H), 3.65 (t, J = 4.7 Hz, 4H), 
3.30 (q, J = 5.6 Hz, 2H), 2.96 (t, J = 7.6 Hz, 2H), 2.49 (t, J = 7.6 Hz, 2H), 2.40 – 2.35 (m, 6H).  
13C NMR (126 MHz, CDCl3) δ 172.14, 140.98, 128.55, 128.44, 126.27, 66.94, 56.98, 53.30, 
38.50, 35.60, 31.84.  
IR: ν 3307, 2932, 1637, 1546, 1115, 698 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H23N2O2, 263.1760; found, 263.1761. 
 
N-(4-(trifluoromethyl)phenyl)-3-phenylpropanamide C16H14F3NO 
53% isolated yield. Rf = 0.3 (4:1 hexane/EtOAc). mp = 142-145 °C   
1H NMR (500 MHz, CDCl3) δ 7.54 (s, 4H), 7.31 (t, J = 7.6 Hz, 2H), 7.23 (d, J = 7.5 Hz, 3H), 3.06 
(t, J = 7.7 Hz, 2H), 2.69 (t, J = 7.5 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 170.79, 140.82, 140.42, 128.86, 128.48, 126.68, 126.35 (q, JCF = 
3.8 Hz), 126.29 (q, JCF = 32.9 Hz), 124.15 (q, JCF = 272.4 Hz), 125.2, 123.0, 119.4, 39.63, 31.53.  
19F NMR (470 MHz, CDCl3) δ -62.20.   
IR: ν 3327, 3030, 2926, 1672, 1600, 1524, 1408, 1319, 1164, 1065 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H14F3NO, 294.1106; found, 294.1106. 
 
N-(2-methylphenyl)-3-phenylpropanamide C16H17NO 
61% isolated yield. Rf = 0.4 (2:1 hexane/EtOAc). mp = 119-121 °C   
1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 1H), 7.30 (d, J = 7.5 Hz, 2H), 7.20 (m, 6H, 
integration gives 1 extra proton due to solvent peak), 7.06 (t, J = 7.4 Hz, 1H), 6.97 (s, broad, 1H), 
3.06 (t, J = 7.6 Hz, 2H), 2.69 (t, J = 7.6 Hz, 2H), 2.06 (s, 3H).  
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13C NMR (126 MHz, CDCl3) δ 170.55, 140.68, 135.59, 130.50, 129.48, 128.75, 128.51, 126.73, 
126.50, 125.35, 123.53, 39.26, 31.81, 17.66.  
IR: ν 3338, 3289, 3030, 1673, 1601, 1524, 1409, 1320, 1162 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H17NO, 240.1388; found, 240.1387. 
 
N-(4-chlorophenyl)-3-phenylpropanamide C15H14ClNO 
62% isolated yield. Rf = 0.3 (3:1 hexane/EtOAc). mp = 138-139 °C   
1H NMR (500 MHz, CDCl3) δ 7.46 (s, broad, 1H), 7.36 (d, J = 8.5 Hz, 2H), 7.29 (t, J = 7.4 Hz, 
2H), 7.21 (m, 5H), 3.02 (t, J = 7.6 Hz, 2H), 2.64 (t, J = 7.6 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 170.76, 140.51, 136.38, 129.38, 129.02, 128.77, 128.43, 126.56, 
121.39, 39.39, 31.60.  
IR: ν 3299, 3029, 2931, 1658, 1593, 1522, 1491, 1397, 1091 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H14ClNO, 260.0842; found, 260.0838. 
 
N-phenyl-3-phenylpropanamide C15H15NO 
73% isolated yield. Rf = 0.3 (4:1 hexane/EtOAc). mp = 92-93 °C   
1H NMR (500 MHz, CDCl3) δ 7.44 (m, 3H), 7.28 (m, 4H), 7.22 (m, J = 7.6 Hz, 3H), 7.09 (t, J = 
7.4 Hz, 1H), 3.04 (t, J = 7.7 Hz, 2H), 2.65 (t, J = 7.3 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 170.68, 140.71, 137.86, 129.03, 128.72, 128.47, 126.46, 124.40, 
120.13, 39.47, 31.67.  
IR: ν 3323, 2924, 2856, 1651, 1599, 1526, 1440 cm-1.  




 (S)-3,7-dimethyl-N-phenyloct-6-enamide C16H23NO 
61% isolated yield. Rf = 0.4 (4:1 hexane/EtOAc). mp = 46-48 °C  
1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.0 Hz, 2H), 7.43 (s, 1H), 7.30 (t, J = 
7.9 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 5.09 (t, J = 6.8 Hz, 1H), 2.37 (dd, J = 13.2, 5.3 Hz, 1H), 2.07 
(m, 4H), 1.68 (s, 3H), 1.60 (s, 3H), 1.42 (ddt, J = 12.3, 9.6, 5.9 Hz, 1H), 1.26 (m, 1H), 1.00 (d, J 
= 6.2 Hz, 3H).  
13C NMR (101 MHz, CDCl3) δ 171.12, 138.08, 131.72, 129.06, 124.37, 124.29, 120.00, 45.63, 
37.00, 30.70, 29.82, 25.84, 25.61, 19.69, 17.80.  
IR: ν 3291, 2963, 2915, 2849, 1652, 1599, 1534, 1444, 1374 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H23NO, 246.1858; found, 246.1855. 
 
(S)-3,7-dimethyl-1-morpholinooct-6-en-1-one C14H25NO2 
74% isolated yield. Rf = 0.1 (2:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 5.09 (tsept, J = 7.1, 1.4 Hz, 1H), 3.71 – 3.57 (m, 
6H), 3.50 – 3.43 (m, 2H), 2.31 (dd, J = 14.5, 5.8 Hz, 1H), 2.12 (dd, J = 14.5, 8.3 Hz, 1H), 2.07 – 
1.91 (m, 3H), 1.67 (d, J = 1.4 Hz, 3H), 1.60 (s (br), 3H), 1.44 – 1.34 (m, 1H), 1.24 – 1.17 (m, 1H), 
0.96 (d, J = 6.6 Hz, 3H).  
13C NMR (101 MHz, CDCl3) δ 171.40, 131.67, 124.48, 67.16, 66.86, 46.40, 42.02, 40.45, 37.20, 
30.17, 25.85, 25.61, 19.92, 17.86.  
IR: ν 2966, 2927, 2859, 1644, 1434 cm-1.   






47% isolated yield. Rf = 0.3 (3:1 hexane/EtOAc) mp =54-58 °C  
1H NMR (400 MHz, CDCl3) δ 7.37 – 7.25 (m, 5H), 5.72 (s, borad, 1H), 5.08 
(tt, J = 7.2, 1.5 Hz), 4.45 (dd, J = 5.7, 2.9 Hz, 2H), 2.26 – 2.20 (m, 1H), 2.07 – 1.94 (m, 4H), 1.67 
(s, 3H), 1.59 (s, 3H), 1.42 – 1.34 (m, 1H), 1.26 – 1.16 (m, 1H), 0.95 (d, J = 6.2 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 172.51, 138.58, 131.58, 128.76, 127.92, 127.54, 124.43, 44.59, 
43.65, 37.02, 30.60, 25.81, 25.56, 19.68, 17.76.  
IR: ν 3285, 2913, 1631, 1544, 731, 693 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO, 260.2014; found, 260.2013. 
 
(R)-1-morpholino-3-(4-chlorophenyl)butan-1-one C14H18ClNO2 
72% isolated yield. Rf = 0.2 (1:2 hexane/EtOAc).  
1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 8.1 Hz, 2H), 7.16 (d, J = 8.1 Hz, 
2H), 3.57 (m, 5H), 3.33 (m, 4H), 2.57 (dd, J = 14.9, 7.1 Hz, 1H), 2.50 (dd, J = 15.0, 7.2 Hz, 1H), 
1.31 (d, J = 7.0 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.19, 144.71, 132.14, 128.71, 128.39, 66.97, 66.57, 46.24, 
42.04, 41.30, 36.23, 21.86.  
IR: ν 2964, 2926, 2857, 1638, 1493, 1434, 1273, 1223, 1113 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H18ClNO2, 268.1104; found, 268.1101. 
 
(R)-1-morpholino-3-phenylbutan-1-one C14H19NO2 
75% isolated yield. Rf = 0.1 (2:1 hexane/EtOAc)  
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1H NMR (400 MHz, CDCl3) δ 7.34 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 3.72 – 3.57 (m, 2H), 3.57 
– 3.42 (m, 3H), 3.39 – 3.28 (m, 2H), 3.27 – 3.17 (m, 2H), 2.62 (dd, J = 14.5, 7.0 Hz, 1H), 2.50 
(dd, J = 14.5, 7.4 Hz, 1H), 1.35 (d, J = 7.0 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.54, 146.15, 128.67, 127.04, 126.62, 66.96, 66.55, 46.33, 
42.02, 41.54, 37.05, 21.76.  
IR: ν 2967, 2961, 1640, 1429 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO2, 234.1494; found, 234.1492. 
 
(R)-3-(4-bromophenyl)-N-phenylheptanamide C19H22BrNO 
40% isolated yield. Rf = 0.2 (8:1 hexane/EtOAc) mp = 86-89 °C  
1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.31 – 7.26 (m, 
2H), 7.15 – 7.01 (m, 3H), 6.82 (brs, 1H), 3.25 – 3.09 (m, 1H), 2.64 (dd, J = 14.3, 6.3 Hz, 1H), 2.50 
(dd, J = 14.3, 8.4 Hz, 1H), 1.73 (ddt, J = 14.5, 10.4, 10.4, 5.3, 1H), 1.61 (dtd, J = 14.5, 9.8, 5.0 Hz, 
2H), 1.37 – 1.04 (m, 4H), 0.83 (t, J = 7.1 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 169.66, 143.38, 137.63, 131.87, 129.39, 129.09, 124.53, 120.06, 
109.90, 45.70, 42.32, 35.78, 29.67, 22.69, 14.09.  
IR: ν 3249, 2960, 2929, 2860, 1657, 1597, 1550, 1489, 1445 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H23NOBr, 360.0963; found, 360.0958. 
 
(R)-3-(4-methoxyphenyl)-N-phenylbutanamide C17H19NO2 
67% isolated yield. Rf = 0.5 (2:1 hexane/EtOAc). mp = 127-128 °C  
1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.0 Hz, 2H), 7.26 (t, J = 8.4 Hz, 3H, a broad singlet 
overlapping the triplet, total integration is 3), 7.17 (d, J = 8.2 Hz, 2H), 7.07 (t, J = 7.4 Hz, 1H), 
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6.85 (d, J = 8.2 Hz, 2H), 3.78 (s, 3H), 3.33 (h, J = 7.1 Hz, 1H), 2.57 (h, J = 7.2 Hz, 2H), 1.33 (d, 
J = 7.0 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.30, 158.28, 137.85, 137.80, 128.98, 127.84, 124.33, 120.10, 
114.17, 55.38, 47.03, 36.34, 22.02.  
IR: ν 3299, 3000, 2957, 2837, 1651, 1599, 1512, 1442, 1366, 1306, 1183 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H19NO2, 270.1494; found, 270.1489. 
 
(S)-4-methyl-1-morpholino-3-phenylpentan-1-one C16H23NO2 
71% isolated yield. Rf = 0.2 (1:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.23 (m, 2H), 7.22 – 7.13 (m, 3H), 3.65 – 3.52 (m, 2H), 
3.51 – 3.44 (m, 1H), 3.41 – 3.25 (m, 3H), 3.24 – 3.17 (m, 1H), 3.13 – 3.03 (m, 1H), 2.91 (td, J = 
8.6, 5.6 Hz, 1H), 2.67(dd, J = 14.3, 5.5 Hz, 1H), 2.64(dd, J = 14.3, 8.9 Hz, 1H), 1.94 (dsep, J = 
8.4, 6.7 Hz, 1H), 1.01 (d, J = 6.6 Hz, 3H), 0.75 (d, J = 6.7 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 171.02, 143.54, 128.45, 128.34, 126.52, 66.93, 66.56, 50.03, 
46.42, 42.02, 36.95, 32.82, 21.20, 20.79.  
IR: ν 2965, 2930, 2872, 1636, 1453, 1428 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H24NO2, 262.1807; found, 262.1813. 
 
(R)-1-morpholino-3-phenylheptan-1-one C17H25NO2 
77% isolated yield. Rf = 0.1 (2.5:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.16 (m, 3H), 3.69 – 3.55 (m, 2H), 3.51 
– 3.37 (m, 3H), 3.33 – 3.25 (m, 1H), 3.22 – 3.08 (m, 3H), 2.60 (dd, J = 14.4, 7.9 Hz, 1H), 2.52 
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(dd, J = 14.4, 6.5 Hz, 1H), 1.74 (ddt, J = 13.0, 10.3, 5.4 Hz, 1H), 1.65 (dtd, J = 13.1, 9.8, 5.0 Hz, 
1H), 1.36 – 1.04 (m, 4H), 0.82 (t, J = 7.2 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.68, 144.61, 128.61, 127.73, 126.61, 66.94, 66.53, 46.38, 
42.99, 42.01, 40.44, 35.80, 29.84, 22.76, 14.11.  
IR: ν 2936, 2930, 2859, 1640, 1455, 1427 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO2, 276.1964; found, 276.1962. 
 
(R)-1-morpholino-3-phenylpentan-1-one C15H21NO2 
70% isolated yield. Rf = 0.2 (1:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.23 – 7.16 (m, 3H), 3.70 – 3.56 (m, 2H), 3.53 
– 3.37 (m, 3H), 3.35 – 3.26 (m, 1H), 3.24 – 3.10 (m, 2H), 3.08 – 3.02 (m, 1H), 2.60 (dd, J = 14.4, 
7.8 Hz, 1H), 2.54 (dd, J = 14.4, 6.5 Hz, 1H), 1.80 (ddq, J = 14.3, 5.1, 7.3 Hz, 1H), 1.66 (ddq, J = 
14.3, 9.8, 7.3 Hz, 1H), 0.80 (t, J = 7.3 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.71, 144.30, 128.61, 127.80, 126.65, 66.95, 66.54, 46.39, 
44.75, 42.02, 40.11, 29.00, 12.29.  
IR: ν 2964, 2927, 2858, 1638, 1454, 1425 cm-1.   




70% isolated yield. Rf = 0.2 (1:2 hexane/EtOAc)  
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1H NMR (500 MHz, CDCl3) δ  7.29 – 7.25 (m, 2H), 7.23 – 7.12 (m, 2H), 6.84 – 6.81 (m, 2H), 
4.60 (t, J = 7.6 Hz, 1H), 3.76 (s, 3H), 3.58 – 3.50 (m, 4H), 3.38 – 3.29 (m, 4H), 3.01 (d, J = 7.6 
Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ 170.14, 158.25, 144.39, 136.14, 128.87, 128.63, 127.86, 126.56, 
114.00, 66.90, 66.50, 55.34, 46.76, 46.32, 42.11, 38.84.  
IR: ν 2952, 2918, 2851, 1627, 1513, 1242, 1114, 701 cm-1.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H24NO3, 326.1756; found, 326.1752.   
 
(R)-3-cyclohexyl-1-morpholinobutan-1-one C14H25NO2 
79% isolated yield. Rf = 0.1 (2:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 3.70 – 3.58 (m, 6H), 3.50 – 3.43 (m, 2H), 2.37 (dd, J = 14.5, 4.7 
Hz, 1H), 2.08 (dd, J = 14.5, 9.4 Hz, 1H), 1.88 (dqt, J = 9.2, 6.8, 4.6 Hz, 1H), 1.78 – 1.70 (m, 2H), 
1.69 – 1.58 (m, 3H), 1.31 – 1.15 (m, 3H), 1.12 (tt, J = 12.7, 3.3 Hz, 1H), 1.07 – 0.94 (m, 2H), 0.90 
(d, J = 6.8 Hz, 3H).  
13C NMR (101 MHz, CDCl3) δ 171.93, 67.15, 66.85, 46.41, 42.97, 42.06, 37.55, 35.49, 30.54, 
29.07, 26.86, 26.80, 26.75, 16.59.  
IR: ν 2923, 2852, 1642, 1426 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H26NO2, 240.1964; found, 240.1963. 
 
(S)-3-(2-(benzyloxy)ethyl)-1-(piperidin-1-yl)heptan-1-one C21H31NO2 
65% isolated yield. Rf = 0.2 (3:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.30 (m, 3H), 7.30 – 7.25 (m, 2H), 4.48 (s, 2H), 3.60 – 3.48 
(m, 4H), 3.41 – 3.31 (m, 2H), 2.32 (dd, J = 14.7, 6.9 Hz, 1H), 2.25 (dd, J = 14.7, 7.0 Hz, 1H), 2.03 
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(hept, J = 6.4 Hz, 1H), 1.69 (tt, J = 12.8, 6.4 Hz, 1H), 1.63 – 1.57 (m, 3H), 1.56 – 1.46 (m, 4H), 
1.39 – 1.19 (m, 6H), 0.88 (t, J = 6.7 Hz,  3H).  
13C NMR (126 MHz, CDCl3) δ 170.98, 138.78, 128.45, 127.75, 127.59, 73.02, 68.80, 46.97, 
42.79, 38.46, 34.14, 33.94, 32.60, 29.03, 26.73, 25.80, 24.76, 23.12, 14.26.  
IR: ν 2933, 2857, 1640, 1436 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H34NO2, 332.2590; found, 332.2586. 
 
(S)-3-butyl-1-morpholinooctan-1-one C11H20NO2 
73% isolated yield. Rf = 0.2 (2:1 hexane/EtOAc)   
1H NMR (500 MHz, CDCl3) δ 3.68 – 3.64 (m, 4H), 3.64 – 3.60 (m, 2H), 3.47 (t, J = 4.8 Hz, 2H), 
2.22 (d, J = 6.9 Hz, 2H), 1.92 – 1.79 (m, 1H), 1.36 – 1.19 (m, 14H), 0.93 – 0.81 (m, 6H).  
13C NMR (126 MHz, CDCl3) δ δ 171.79, 67.17, 66.87, 46.41, 42.07, 37.97, 35.10, 34.02, 33.76, 
32.32, 28.99, 26.45, 23.16, 22.81, 14.27, 14.24.  
IR: 2958, 2928, 2858, 1647, 1459, 1428 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H32NO2, 270.2433; found, 270.2433. 
 
(R)-3-cyclopropyl-N-phenylbutanamide C13H17NO 
58% isolated yield. Rf = 0.4 (3:1 hexane/EtOAc). mp = 68-70 °C  
1H NMR (500 MHz, CDCl3) δ 7.63 (s, 1H), 7.51 (d, J = 8.0 Hz, 2H), 7.28 (t, J = 7.8 Hz, 2H), 7.07 
(t, J = 7.4 Hz, 1H), 2.45 (dd, J = 13.8, 6.4 Hz, 1H), 2.26 (dd, J = 13.8, 7.8 Hz, 1H), 1.30 (m, 1H), 
1.05 (d, J = 6.7 Hz, 3H), 0.56 (dp, J = 13.4, 4.9, 4.3 Hz, 1H), 0.40 (dd, J = 8.1, 4.3 Hz, 2H), 0.17 
(dd, J = 9.4, 4.7 Hz, 1H), 0.08 (dd, J = 9.2, 4.6 Hz, 1H).  
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13C NMR (126 MHz, CDCl3) δ 171.18, 138.12, 129.02, 124.27, 120.12, 45.77, 36.71, 20.02, 
17.91, 4.31, 3.71.  
IR: ν 3296, 3076, 2959, 2924, 1655, 1599, 1443, 1164 cm-1.   




60% isolated yield. Rf = 0.2 (1:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.33 – 7.28 (m, 
2H), 7.24 – 7.18 (m, 3H), 4.74 (t, J = 7.4 Hz, 1H), 3.76 – 3.42 (m, 5H), 3.41 – 3.32 (m, 3H), 3.06 
(d, J = 7.4 Hz, 2H).   
13C NMR (126 MHz, CDCl3) δ 169.46, 148.17, 143.27, 128.92, 128.90 (q, JCF = 32.5 Hz) 128.27, 
127.95, 127.05, 125.64 (q, JCF = 3.8 Hz), 124.28 (q, JCF = 271.9 Hz), 66.95, 66.54, 47.16, 46.25, 
42.22, 38.55.  
19F NMR (470 MHz, CDCl3) δ -62.48.    
IR: ν 2919, 2855, 1732, 1635, 1324, 1108 cm-1.  
 
(S)-1-morpholino-3-phenyl-3-(thiophen-2-yl)propan-1-one C17H19NO2S 
71% isolated yield. Rf = 0.15 (2:1 hexane/EtOAc) mp = 102-104 °C  
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 4H), 7.25 – 7.20 (m, 1H), 7.15 
(dd, J = 5.1, 1.2 Hz, 1H), 6.92 (dd, J = 5.1, 3.5 Hz, 1H), 6.84 (dt, J = 3.5, 1.0 Hz, 1H, allylic 
coupling with 3° H), 4.90 (t, J = 7.4 Hz, 1H), 3.64 – 3.43 (m, 5H), 3.42 – 3.35 (m, 1H), 3.35 – 3.26 
(m, 2H), 3.09 (dd, J = 14.7, 7.1 Hz, 1H), 3.03 (dd, J = 14.7, 7.7 Hz, 1H).  
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13C NMR (126 MHz, CDCl3) δ 169.43, 148.10, 143.67, 128.78, 127.84, 127.15, 126.82, 124.49, 
124.03, 66.93, 66.57, 46.34, 43.36, 42.21, 40.29.  
IR: 2921, 2859, 2855, 1630, 1437 cm-1.  




52% isolated yield. Rf = 0.2 (5:1 hexane/EtOAc)   
1H NMR (500 MHz, CDCl3, mixture of amide rotamers) δ 7.38 – 7.19 (m, 8H), 7.16 (dd, J = 5.1, 
1.2 Hz, 0.6H, maJor rotamer), 7.13 (dd, J = 5.1, 1.2 Hz, 0.4H, minor rotamer), 7.04 – 7.00 (m, 
1H), 6.99 – 6.96 (m, 1H), 6.92 (dd, J = 5.1, 3.5 Hz, 0.6H, maJor rotamer), 6.89 (dd, J = 5.1, 3.5 
Hz, 0.4H, minor rotamer), 6.85 (dt, J = 3.5, 1.0 Hz, 0.6H, maJor rotamer, allyic coupling), 6.78 
(dt, J = 3.7, 1.0 Hz, 0.4H, minor rotamer, allyic coupling), 4.58 (d, J = 14.7 Hz, 0.7H, maJor 
rotamer), 4.50 (d, J = 14.7 Hz, 0.7H, maJor rotamer), 4.47 (d, J=17 Hz, 0.4H, minor rotamer), 4.43 
(d, J = 16.9 Hz, 0.4H, minor rotamer), δ 2.89 (s, 1.2H, minor rotamer), 2.85 (s, 2.0H, maJor 
rotamer).  
13C NMR (126 MHz, CDCl3, mixture of amide rotamers) δ 170.95, 170.79, 148.48, 148.42, 
143.91, 143.84, 137.18, 136.54, 129.05, 128.74, 128.70, 128.63, 127.94, 127.92, 127.91, 127.73, 
127.32, 126.99, 126.93, 126.78, 126.75, 126.40, 124.49, 124.38, 123.90, 123.87, 53.29, 51.05, 
43.24, 42.92, 40.92, 40.81, 35.11, 34.26.  
IR: 3063, 3031, 2968, 1641, 1437 cm-1.  





63% isolated yield. Rf = 0.1 (1:1 hexane/EtOAc)   
1H NMR (500 MHz, CDCl3) δ 7.13 – 7.09 (m, 2H), 6.86 (td, J = 7.4, 1.2 Hz, 1H), 
6.81 (dd, J = 8.7, 1.4 Hz, 1H), 4.23 (ddd, J = 11.3, 5.4, 3.8 Hz, 1H), 4.16 (ddd, J = 11.1, 9.7, 2.8 
Hz, 1H), 3.77 – 3.58 (m, 5H), 3.58 – 3.32 (m, 4H), 2.76 (dd, J = 15.5, 5.1 Hz, 1H), 2.54 (dd, J = 
15.5, 9.3 Hz, 1H), 2.23 (dddd, J = 13.7, 9.6, 5.7, 3.8 Hz, 1H), 1.85 (dtd, J = 14.0, 5.1, 2.8 Hz, 1H).  
13C NMR (126 MHz, CDCl3) δ 170.01, 154.74, 129.10, 127.98, 125.13, 120.50, 117.20, 67.01, 
66.61, 63.34, 46.18, 42.15, 39.82, 30.44, 27.66.  
IR: 2966, 2927 2860, 1638, 1489 cm-1.  




64% isolated yield. Rf = 0.2 (30% EtOAc/Hex).  
1H NMR (500 MHz, CDCl3) δ 3.93 – 3.85 (m, 1H), 3.73 – 3.56 (m, 6H), 3.46 (t, J = 4.9 Hz, 2H), 
2.33 – 2.28 (m, 1H), 2.20 – 2.07 (m, 2H), 1.57 (s, 1H), 1.51 (ddd, J = 13.2, 8.9, 4.1 Hz, 1H), 1.29 
– 1.17 (m, 2H), 1.13 (dd, J = 6.0, 0.8 Hz, 3H), 0.96 (d, J = 6.2 Hz, 3H), 0.88 (d, J = 0.8 Hz, 9H), 
0.06 (s, 3H), 0.05 (s, 3H).  
13C NMR (125 MHz, CDCl3) δ 171.02, 67.06, 66.79, 66.24, 47.08, 46.36, 41.88, 41.45, 27.03, 
25.89, 24.58, 19.66, 18.06, -4.05, -4.74.  
IR: ν 2958, 2928, 2894, 2856, 1645, 1462, 1429, 1252 cm-1.  






65% isolated yield. Rf = 0.2 (30% EtOAc/Hex).  
1H NMR (500 MHz, CDCl3) δ 3.91 (q, J = 6.2 Hz, 1H), 3.72 – 3.58 (m, 6H), 3.51 – 3.43 (m, 2H), 
2.44 – 2.30 (m, 1H), 2.20 – 1.99 (m, 2H), 1.40 (hept, J = 7.0, 6.6 Hz, 2H), 1.29 – 1.22 (m, 1H), 
1.14 (d, J = 6.0 Hz, 3H), 0.96 (d, J = 6.2 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 6H).  
13C NMR (125 MHz, CDCl3) δ 171.16, 67.18, 67.11, 66.86, 47.15, 46.37, 42.04, 40.62, 27.47, 
26.06, 23.64, 20.54, 18.27, -4.17, -4.49. 
 
(3R,4S)-3-methyl-1-morpholino-4-phenylpentan-1-one C16H23NO2 
46% isolated yield. Rf = 0.1 (3:1 hexane/EtOAc).  
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.22 (m, 2H), 7.20 – 7.13 (m, 3H), 3.70 – 3.38 (m, 6H), 3.28 
– 3.10 (m, 2H), 2.53 (p, J = 7.2 Hz, 1H), 2.20 (dd, J = 14.4, 3.5 Hz, 1H), 2.17 – 2.09 (m, 1H), 1.93 
(dd, J = 14.3, 9.3 Hz, 1H), 1.24 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 6.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3) δ 171.41, 146.37, 128.47, 127.70, 126.30, 67.06, 66.73, 46.12, 
45.43, 41.97, 38.50, 36.97, 18.57, 17.53.  
IR: ν 2966, 2956, 2863, 1640, 1453, 1429 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H24NO2, 262.1807; found, 262.1805. 
 
(3S,4S)-3-methyl-1-morpholino-4-phenylpentan-1-one C16H23NO2 
73% isolated yield. Rf = 0.1 (3:1 hexane/EtOAc).  
59 
 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.21 – 7.14 (m, 3H), 3.70 – 3.54 (m, 6H), 3.29 
– 3.17 (m, 2H), 2.76 (p, J = 6.9 Hz, 1H), 2.35 (dd, J = 14.5, 4.5 Hz, 1H), 2.29 – 2.16 (m, 1H), 2.00 
(dd, J = 14.5, 9.2 Hz, 1H), 1.27 (d, J = 7.1 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H).  
13C NMR (125 MHz, CDCl3) δ 171.50, 145.18, 128.27, 128.07, 126.27, 67.10, 66.76, 46.16, 
44.49, 42.05, 37.06, 36.71, 17.72, 17.50.  
IR: ν 2968, 2927, 2862, 1641, 1453, 1429 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H24NO2, 262.1807; found, 262.1806. 
 
(R)-3-phenyl-N-((R)-1-phenylethyl)butanamide C18H21NO 
44% isolated yield (eluent: 3:1 hexane/EtOAc). Rf = 0.1 (4:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.15 (m, 8H), 7.05 – 6.94 (m, 2H), 5.57 – 5.40 (m, 1H), 5.04 
(p, J = 7.1 Hz, 1H), 3.30 (h, J = 7.1 Hz, 1H), 2.55 – 2.33 (m, 2H), 1.39 (d, J = 6.9 Hz, 3H), 1.32 
(d, J = 7.0 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.71, 145.83, 143.00, 128.76, 128.63, 127.23, 126.99, 126.57, 
126.12, 48.50, 46.12, 37.25, 21.98, 21.70.  
IR: ν 3291, 3067, 3062, 2967, 2929, 2897, 1635, 1547, 1450 cm-1.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H22NO, 268.1701; found, 268.1697. 
 
(S)-3-phenyl-N-((R)-1-phenylethyl)butanamide C18H21NO 
46% isolated yield (eluent: 3:1 hexane/EtOAc). Rf = 0.1 (4:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.27 (m, 4H), 7.25 – 7.20 (m, 4H), 7.19 – 7.16 (m, 2H), 5.39 
– 5.30 (br, 1H), 5.01 (p, J = 7.1 Hz, 1H), 3.29 (h, J = 7.2 Hz, 1H), 2.46 – 2.38 (m, 2H), 1.30 (d, J 
= 6.9, Hz, 3H), 1.24 (d, J = 6.9 Hz, 3H).  
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13C NMR (126 MHz, CDCl3) δ 170.73, 145.92, 143.22, 128.79, 128.74, 127.43, 127.02, 126.64, 
126.26, 48.63, 46.27, 37.47, 21.98, 21.52.  
IR: ν 3277, 3070, 3054, 2964, 2930, 2869, 1633, 1551, 1448 cm-1.   




44% yield. Rf = 0.2 (30% EtOAc/Hex).  
1H NMR (500 MHz, CDCl3 mixture of rotamers) δ 7.36 – 7.23 (m, 8H), 7.22 – 7.16 (m, 2H), 4.53 
(dd, J = 12.0, 15.3 Hz, 2H), 4.42 (s, 1H), 4.26 (tt, J = 6.6, 2.9 Hz, 1H), 3.64 (dd, J = 9.3, 3.3 Hz, 
1H), 3.52 (dq, J = 8.5, 6.6 Hz, 1H), 3.46 – 3.34 (m, 3H), 3.19 – 3.10 (m, 2H), 2.58 – 2.44 (m, 3H), 
2.02 – 1.68 (m, 6H), 1.33 (d, J = 6.9 Hz, 3H), 1.29 (d, J = 7.0 Hz, 1H), 1.26 (s, 1H).  
13C NMR (125 MHz, CDCl3 mixture of rotamers) δ 170.87, 170.75, 146.72, 146.64, 138.75, 
137.98, 128.60, 128.53, 128.46, 127.94, 127.67, 127.60, 127.13, 127.04, 126.36, 126.25, 73.33, 
73.30, 71.11, 70.32, 57.21, 56.58, 47.61, 45.72, 43.90, 43.10, 36.47, 29.84, 28.94, 27.66, 24.26, 
21.93, 21.48, 21.39.  
IR: ν 2957, 2918, 2851, 1630, 1560, 1454, 1411, 1376 cm-1.   




42% yield. Rf = 0.2 (30% EtOAc/Hex).  
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1H NMR (500 MHz, CDCl3 mixture of rotamers) δ 7.41 – 7.27 (m, 6H), 7.25 – 7.22 (m, 2H), 7.21 
– 7.12 (m, 2H), 4.49 (d, J = 13.0 Hz, 1.3H), 4.42 (d, J = 12.0 Hz, 0.7H), 4.34 – 4.27 (m, 0.6H), 
3.73 – 3.66 (m, 0.4H), 3.59 (dd, J = 9.4, 3.3 Hz, 0.6H), 3.45 – 3.29 (m, 3.4H), 3.28 – 3.20 (m, 
1.0H), 2.61 – 2.49 (m, 1.4H), 2.46 (dd, J = 14.7, 8.0 Hz, 0.6H), 2.03 – 1.68 (m, 4H), 1.34 (d, J = 
7.0 Hz, 1.8H), 1.28 (d, J = 7.0 Hz, 1.2H).  
13C NMR (125 MHz, CDCl3, mixture of rotamers) δ 171.21, 170.73, 146.55, 146.28, 138.72, 
137.96, 128.62, 128.50, 128.47, 128.43, 127.98, 127.77, 127.62, 127.58, 127.05, 127.02, 126.35, 
73.45, 73.25, 71.52, 70.03, 56.99, 56.50, 47.54, 45.48, 43.82, 43.50, 37.09, 36.61, 28.62, 27.58, 
24.22, 21.97, 21.70, 21.31.  
IR: ν 2957, 2918, 2851, 1630, 1560, 1454, 1411, 1376 cm-1.   
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2.7.2 HPLC Traces of Isolated Amides 
 












Injection Date  : 3/8/2016 5:39:49 PM            Seq. Line :   1
Sample Name     : ZW3-77A-2                       Location : Vial 21
Acq. Operator   :                                      Inj :   1
Acq. Instrument : Instrument 1                  Inj Volume : 5 µl
Acq. Method     : C:\HPCHEM\1\METHODS\NORMAL\CHIRAL\OJ\ZW3IPA.M
Last changed    : 3/8/2016 4:56:57 PM
Analysis Method : C:\HPCHEM\1\METHODS\NORMAL\CHIRAL\OJ\20IPR-WL.M
Last changed    : 3/9/2016 9:42:07 AM
                  (modified after loading)
Chiralcel OJ-H, 1ml/min, 30C
Normal Phase Chiral
90:10 Hexanes:iPrOH



















                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  10.150 BV    0.2835 4827.35059  251.65883  49.8009
   2  11.328 VB    0.3493 4865.95215  206.69400  50.1991
Totals :                  9693.30273  458.35283
 Results obtained with standard integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\1\DATA\3-77A.D                                              Sample Name: ZW3-77A-2
Instrument 1 3/18/2016 4:24:15 PM Page 1 of 1
=====================================================================
Injection Date  : 3/8/2016 6:01:02 PM       Seq. Line :   2
Sample Name : ZW3-187C-2          Location : Vial 22
Acq. Operator   :                                      Inj :   1
Acq. Instrument : Instrument 1              Inj Volume : 5 µl
Acq. Method   : C:\HPCHEM\1\METHODS\NORMAL\CHIRAL\OJ\ZW3IPA.M
Last changed    : 3/8/2016 4:56:57 PM
An ysis Method : C:\HPCHEM\1\METHODS\NORMAL\CHIRAL\OJ\20IPR-WL.M
Last changed    : 3/18/2016 4:26:01 PM
                (modifie  after loading)
Chiralcel OJ-H, 1ml/min, 30C
Normal Phase Chiral
90:10 Hexanes:iPrOH




















                         Area Percent Report                         
=====================================================================
Sorted By             :      Signal
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  10.356 BV    0.2604 1252.65405   71.64041   3.9129
   2  11.173 VB    0.4241 3.07608e4  1057.20764  96.0871
Totals :                  3.20135e4  1128.84805
 Results obtained with standard integrator!
=====================================================================
                          *** End of Report ***
Data File C:\HPCHEM\1\DATA\3-187C-2.D                                          Sample Name: ZW3-187C-2



































product λmax=240 nm 
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CHAPTER 3: RHODIUM CATALYZED ISOMERIZATION AND 
ESTERIFICATION OF ALLYLIC AMINES WITH ALCOHOL 
NUCLEOPHILES TO FORM CHIRAL, β-BRANCHED ESTERS 
 
This chapter has been adapted from the following publication:  
Laffoon, S. D.; Wu, Z.; Hull, K. L. Rhodium-Catalyzed Asymmetric Synthesis of β-Branched 
Esters from Allylic Amines. Chem. Commun. 2018, 54, 7814–7817.  
 
3.1 Abstract 
Allylic amines are converted to chiral, β-branched esters under rhodium catalysis in the 
presence of alcohol nucleophiles. A cationic Rh(I)/BINAP catalyst facilitates the asymmetric 
isomerization 3,3’-disubstituted allylic amines. The resulting enamine intermediate is then 
oxidized in the presence of nucleophilic alcohols, water, and a hydrogen acceptor to form chiral, 
β-branched esters in a tandem catalytic process. Allylic amines with aliphatic and aromatic vinylic 
substituents are converted to ester products with excellent enantioselectivities in all cases. Several 
alcohol nucleophiles have been utilized in the reaction including 1° and 2° derivatives.  
 
3.2 Motivation and Background 
The installation of esters into complex molecular scaffolds has been the subject of much 
investigation in recent years.1 Chiral, β-branched esters are prevalent moieties in pharmaceuticals, 
fragrances, materials, and agrochemicals (Figure 3.1), and esters themselves serve as versatile 
synthetic handles for further functionalization.2 Inspired by the amidation procedure described in 
Chapter 2, we set out to develop a method that engages alcohol nucleophiles rather than amines to 




Figure 3.1. Biologically active β-branched esters. 
 Traditionally, esters are generated through reactive intermediates, such as acyl halides, or 
carboxylic acids paired with stoichiometric coupling reagents (Steglich esterification) as well as 
via strong acid catalysis (Fischer esterification). Though these approaches generally proceed with 
high conversion, the conditions required to generate acyl halides or strongly acidic conditions are 
not amenable to sensitive functionalities. Stoichiometric coupling reagents generate high 
molecular weight byproducts that can be challenging to separate from the desired product. Early 
reports of catalytic esterification, such as the Tishchenko reaction, generate simple homocoupled 
products (Scheme 3.1a).3 In recent years, the catalytic esterification of aldehydes via transfer 
hydrogenation has emerged as a meaningful alternative to stoichiometric coupling reactions; 
however, many of these reactions require solvent quantities of the alcohol nucleophile and are 
 
Scheme 3.1. Precedent for the catalytic synthesis of chiral, β-branched esters. 
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generally sterically limited such that β-branched esters as products are difficult to obtain in 
synthetically useful yields.4–6  
 Much of the work in generating chiral, β-branched esters has focused on asymmetric 
conjugate reduction7 and enantioselective conjugate addition (ECA)8 to α,β-unsaturated esters 
(Scheme 3.1b) as described in Chapter 1.  The major limitation of such strategies is poor substrate 
scope for individual catalysts. Changes to the substitution pattern of the substrate can require a 
different metal/ligand scaffold,9 and these methods often rely on significant steric differentiation 
between the substituents at the β-position or are dependent on olefin geometry to achieve high 
stereoselectivity.7a,c,e,f  
 
3.3 Optimization of Reaction Conditions 
 To overcome the limitations of previous reports, we drew inspiration from the asymmetric 
isomerization of allylic amines to optically pure enamines, developed by Noyori and Otsuka.10 
Because the enantioselectivity of the isomerization of the allylic amine proceeds via a suprafacial 
1,3-hydride shift and the initial binding of the substrate to the catalyst is facially selective,10e steric 
differentiation between the substituents at the prochiral center is not required to achieve 
enantiopurity. This isomerization approach could pave the way for a critical advance in the 
asymmetric synthesis of β-branched esters. We envisioned the resulting enantioenriched enamines 
undergoing a dehydrogenative coupling with alcohol nucleophiles in the presence of water to 
produce esters (Scheme 3.1c). Furthermore, allylic amines are compelling substrates as they are 
readily accessed in a diastereomerically pure fashion through a variety of methods (Scheme 3.2). 
Experiments described in Chapter 2 reveal that a Rh-BINAP complex with NaBArF4 in 




Scheme 3.2. Synthesis of diastereomerically pure allylic amines. See Supporting Information for details of substrate 
synthesis. 
To modify this method for the synthesis of esters, we believed we could replace amine nucleophiles 
with alcohols; however, there are some inherent challenges with such an approach. Alcohols are 
less nucleophilic than amines, disfavoring the formation of the hemiacetal intermediate necessary 
for the final dehydrogenation.6 For this reason, we were particularly concerned with identifying 
conditions for the selective synthesis of esters over other byproducts such as alcohol nucleophile 
homocoupling, aldol condensation, or deleterious reduction pathways in the presence of a Rh–H 
species. 
 When our catalytic amidation conditions were employed with 1-hexanol as a nucleophile 
instead of an amine, a tertiary amine byproduct 4 was observed along with the desired ester product 
3a, consistent with our earlier hypotheses (Table 3.1). We found that the identity of the solvent 
played a key role in improving the chemoselectivity of the reaction. Changing the solvent from 
THF to DME limited the formation of 4 to trace quantities. Further modification of the reaction 
conditions identified Na3PO4 as an effective base (Table 3.1, entry 4) with styrene as a sufficient 






3.4 Evaluating Reaction Scope 
After optimizing the reaction conditions, we investigated the nucleophile scope of the 
reaction (Table 3.2). A variety of 1° alcohol nucleophiles including 1-hexanol (3a), ethanol (3b), 
and methanol (3c) are well-suited for the reaction providing esters in good yields. Nucleophiles 
containing heterocycles such as a pendant morpholino group (3e) are well-tolerated under the 
 
Table 3.1. Optimization of reaction conditions. 
Entry Base Solvent X 3a yield (%)b 4 yield (%)b 
1 Cs2CO3 THF 3 52 12 
2 Cs2CO3 DME 3 56 <5 
3 Na3PO4 THF 3 79 17 
4 Na3PO4 DME 3 91 <5 
5 Na3PO4 DME 2 82 13 
6 Na3PO4 DME 1.5 71 10.5 
7 Na3PO4 DME 1 49 17 
a) [Rh(cod)Cl]2 (2 mol %), (±)-BINAP (4 mol %), NaBArF4 (4 mol %), 1 (0.12 mmol), 2 (1–3 equiv), styrene (3.0 
equiv), base (50 mol %), solvent (0.100 mL), H2O (1.5 equiv), 80 °C, 24 h. b) In situ yield determined by gas 
chromatography with comparison to diphenyl methane (10 μL) as an internal standard. 
reaction conditions despite the ability of 3° amines to strongly coordinate to many transition metal 
catalysts. Benzyl alcohol and its derivatives demonstrate the effect of electronic variation on the 
yield of the reaction; electron neutral and slightly electron deficient alcohols are most efficient (3f-
3j). More hindered nucleophiles give slightly diminished yields, demonstrating some sensitivity 
to steric hinderance (3k-3m). Unfortunately, phenols are not competent nucleophiles under the 
current reaction conditions. This may be attributed to the competitive binding of the phenol to the 
cationic Rh(I) species.12 
We were pleased to discover that the reaction is amenable to a broad range of substitution 
patterns on the allylic amine (Table 3.3). Several β,β-dialkyl esters, such as those containing silyl  
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Table 3.2. Scope of 1° and 2° alcohols for the esterification of allylic amines. 
 
[a]  [Rh(cod)Cl]2 (2 mol %), (R)-BINAP (4 mol %), NaBArF4 (4 mol %), Na3PO4 (50 mol %), allylic amine (0.12 
mmol), alcohol nucleophile (3.0 equiv), styrene (3.0 equiv), H2O (1.5 equiv), DME (1.2 M), 80 °C, 24 h. [b] with 5.0 
equiv nucleophile. [c] with 2.0 equiv nucleophile. [d] at 100 °C. 
ethers (3n)‡ or distal arenes (3o, 3p), can be accessed from the corresponding allylic amines with 
excellent enantiomeric excess in all cases. Even when the substituents on the starting alkene are 
sterically similar, the catalyst maintains high enantiocontrol (3q). 3,3-diaryl allylic amines show 
good reactivity and enantioselectivity; however, increased catalyst loading and temperature are 
necessary to establish good conversion of starting material to product. Electron-rich furyl rings are 
well-tolerated under the reaction conditions (3r). Excitingly, we have found that substrates 
containing exocyclic alkenes, a substrate class rarely demonstrated for asymmetric synthesis of β- 
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Table 3.3. Scope of allylic amines for asymmetric oxidative esterification. 
 
a) [Rh(cod)Cl]2 (2 mol %), (R)-BINAP (4 mol %), NaBArF4 (4 mol %), Na3PO4 (50 mol %), allylic amine (0.12 mmol), 
alcohol nucleophile (3 equiv), styrene (3.0 equiv), H2O (1.5 equiv), DME (1.2 M), 80 °C, 24 h. b) from the Z isomer 
of 1 (91.7 : 8.3 Z/E) c) with 2.0 equiv nucleophile. d) 68% and 5.5 : 94.5 d.r. with S-BINAP  e) with 5.0 equiv 
nucleophile. f) at 100 °C. g) with (S)-BINAP. h) at 100 °C for 48 h with 8 mol % catalyst. 
substituted carbonyl compounds,7g are reactive leading to good yields and enantioselectivities (3v-
3w). Allylic amines with π-functionality are not only limited to aryl substituents. When a substrate 
containing an enyne is subjected to the reaction conditions, no hydrogenation of the alkyne is 
observed (3x). Finally, the absolute stereochemistry has previously been unambiguously 





3.5 Mechanistic Discussion 
To probe the chemoselectivity of the transformation, we subjected allylic amine 1a to the 
reaction conditions with a 1:1 ratio of 1° alcohol 1-hexanol to a variety of 2° alcohols (Scheme 
3.3). Primary alcohols were preferentially incorporated, with selectivities ranging from 5.3:1 for 
the least sterically hindered cyclopentanol to 16.7:1 for the most sterically hindered α-
hydroxyethylbenzene. In an intramolecular competition study between a 1° and 3° alcohol, the 1° 
alcohol was exclusively incorporated (see Supporting Information). 
 
Scheme 3.3. a) General reaction conditions: see Table 3.2. b) Chemoselectivity determined by 1H NMR of the crude 
reaction mixture. 
Our mechanistic hypothesis draws inspiration from the work of Noyori, Otsuka, and Tani 
(Scheme 3.4a).10 Cationic Rh(I)-BINAP complexes are known to facilitate an isomerization of 
allylic amines to form optically pure enamines. The initial β-hydride elimination to form II is the 
enantiodetermining step.10c,e Under our reaction conditions, the intermediate enamine II can 
participate in several equilibrium-controlled processes with in situ H2O and nucleophile to form a 
Rh-alkoxide species III.13 This intermediate can then undergo a β-hydride elimination to form the 
final ester product IV and a Rh–H species. Styrene acts as a hydrogen acceptor to regenerate the 
active catalyst. Though we believe this process to be redox neutral, a Rh(I)/(III) cycle for the 
oxidation of intermediate III cannot be ruled out. Furthermore, when citronellal was employed as 
the substrate under standard reaction conditions, the yield of the reaction diminished (Scheme 




Scheme 3.4. a) Proposed mechanism. b) Comparison of aldehydes and allylic amines as substrates for the reaction. 
the reaction does not proceed through build-up of large quantities of a discrete aldehyde 
intermediate. In fact, crude NMR reveals evidence of aldehyde decomposition under standard 
conditions (see Supporting Information). Instead, the catalytically formed aldehyde may 
immediately react with the alcohol to yield the final product, or the alcohol may attack the iminium 
intermediate directly without proceeding through the aldehyde. 
 
3.6 Conclusion 
This Chapter describes a method by which chiral, β-branched esters can be synthesized in 
one pot with a broad scope of nucleophiles and substrates. Utilizing an isomerization strategy has 
enabled enantioinduction that is not limited by the steric differentiation of the substituents at the 
prochiral center. This method has been demonstrated for the asymmetric synthesis of β,β-dialkyl, 
β,β-diaryl, and β-alkyl-β-aryl-substituted esters, a breadth of substrate scope not commonly 
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observed in methods for the synthesis of similar compounds. Primary and secondary alcohols are 
competent reaction partners without need for solvent quantities of nucleophile. This method 
performs similarly under a variety of steric environments, giving good to excellent yields with 
excellent enantioselectivities in all cases. 
 
‡ When the desilylated analogue of 6 was subjected to the reaction, only the volatile 4,6-dimethyltetrahydro-2H-
pyran-2-one was observed by GC/MS of the crude reaction mixture. 
 
3.7 Supporting Information 
Table 3.4. Ethereal Solvents for esterification of allylic amines. 
 
Entry Solvent 5ba% yield (GC) 6b% yield (GC) 
1 DME 96 2 
2 Et2O 85 25 
3 THF 83 13 










Table 3.5. Base loading screen for esterification of allylic amines. 
 
Entry Base loading (mol %) 5ba% yield (GC) 6b% yield (GC) 
1 0 49 28 
2 5 63 25 
3 15 83 10 
4 50 89 8 
5 100 90 7 
 
 
Table 3.6. Nucleophile equivalence screen for esterification of allylic amines. 
 
Entry 4a equiv 5ba% yield (GC) 6b% yield (GC) 
1 1.0 49 17 
2 1.5 71 10 
3 2.0 82 13 









Table 3.7. Base screen for esterification of allylic amines. 
 
Entry Base 5ba% yield (GC) 6b% yield (GC) 
1 Na3PO4 84 8 
2 K3PO4 26 5 
3 K2CO3 49 5 
4 NaH2PO4 20 19 
5 Na2HPO4 55 29 
6 Li3PO4 54 30 
 
 
Table 3.8. Time screen for esterification of allylic amines. 
 
Entry Time (h) 5ba% yield (GC) 
1 0.08 2 
2 0.17 3 
3 0.33 6 
4 0.67 9 
5 1 15 
6 2 22 
7 4 45 
8 6 46 
9 12 70 




3.8 Esterification Experimental Procedure, Isolation, and Characterization 
3.8.1 General procedure for Rh-catalyzed isomerization and esterification of allylic amines 
with alcohols. 
 
Under atmosphere of nitrogen, [Rh(cod)Cl]2 (1.2 mg, 0.0024 mmol, 2.0 mol %), (R)-
BINAP (3.0 mg, 0.0048 mmol, 4.0 mol %), NaBArF4 (4.3 mg, 0.0048 mg, 4.0 mol %), and Na3PO4 
(9.8 mg, 0.060 mmol, 50 mol %) were added to a 4-mL vial equipped with a stir bar. Allylic amine 
1b (25.1 mg, 0.12 mmol, 1.0 equiv) was then added to the reaction vial followed by addition of 1-
hexanol 4a (45 µL, 0.36 mmol, 3.0 equiv), styrene (42 µL, 0.36 mmol, 3.0 equiv), and 
dimethoxyethane (0.100 mL, 0.120 M). The vial was then sealed with a plastic cap fitted with a 
PTFE-lined septum and removed from the glovebox. H2O (10.0 µL, 0.18 mmol, 1.5 equiv) was 
added to the reaction mixed via syringe through the septum. The reaction vial was placed on a hot 
plate with stirring at 80 °C for 24 h. The reaction vial was cooled to room temperature followed 
by the addition of diphenylmethane (10.0 µL) as an internal standard for analysis of the crude 
reaction mixture. The crude reaction mixture was diluted with methylene chloride prior to analysis. 
Celite was added to the reaction mixture which was then concentrated in vacuo and purified 
directly via flash column chromatography without further work-up procedures.  
 
3.8.2 Characterization of Final Compounds 
Hexyl (S)-3,7-dimethyloct-6-enoate C16H30O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
10% (5% Et2O/DCM)/Hex. Rf = 0.07  
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26.3 mg of inseparable mixture of product (5ba) and hydrogenated product (5ba’) in a ratio of 8:1. 
Corrected MW = 254.65 g/mol. 5ba (76%); 5ba’ (10%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (t, J = 7.1 Hz, 1H), 4.06 (t, J = 6.7 Hz, 2H), 2.30 (dd, J = 14.6, 
5.9 Hz, 1H), 2.11 (dd, J = 14.6, 8.2 Hz, 1H), 2.06 – 1.90 (m, 3H), 1.68 (s, 3H), 1.61 (d, J = 7.8 Hz, 
4H), 1.40 – 1.13 (m, 9H), 0.94 (d, J = 6.6 Hz, 3H), 0.93 – 0.85 (m, 4H). 
Note: Integration values are higher than expected due to partial hydrogenation of the final product. 
13C NMR (126 MHz, CDCl3) δ 173.54 (5ba), 131.65 (5ba), 124.45 (5ba), 64.49 (5ba), 42.16 
(5ba’), 42.06 (5ba), 39.22 (5ba’), 37.10 (5ba’), 36.94 (5ba), 31.59 (5ba), 30.58 (5ba’), 30.23 
(5ba), 28.79 (5ba), 28.08 (5ba’), 25.86 (5ba), 25.78 (5ba), 25.58 (5ba), 24.80 (5ba’), 22.81 
(5ba’), 22.70, 19.90 (5ba’), 19.78 (5ba), 17.79 (5ba), 14.15 (5ba). 
HRMS: (ESI-TOF) m/z: [M+H+] calculated for C16H31O2, 255.2324; found, 255.2327. 
IR: ν 2936, 2927, 2858, 1735 cm-1. 
 
Isobutyl (S)-3,7-dimethyloct-6-enoate C14H26O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 10% (5% Et2O/DCM)/Hex. Rf = 0.08  
22.3 mg of inseparable mixture of product (5bb) and hydrogenated product (5bb’) in a ratio of 
14:1. Corrected MW = 226.50 g/mol. 5bb (76%); 5bb’ (6%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (tp, J = 7.1, 1.4 Hz, 1H), 3.85 (dd, J = 6.7, 1.0 Hz, 2H), 2.32 
(dd, J = 14.6, 6.0 Hz, 1H), 2.12 (dd, J = 14.6, 8.2 Hz, 1H), 2.07 – 1.85 (m, 4H), 1.68 (d, J = 1.4 
Hz, 3H), 1.60 (s, 3H), 1.42 – 1.11 (m, 4H), 0.95 (d, J = 6.6 Hz, 3H), 0.93 (d, J = 6.7 Hz, 6H), 0.86 
(dd, J = 6.6, 0.8 Hz, 1H). 
Note: Integration values are higher than expected due to partial hydrogenation of the final product. 
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13C NMR (126 MHz, CDCl3) δ 173.53 (5bb), 131.67 (5bb), 124.44 (5bb), 70.52 (5bb), 42.15 
(5bb’), 42.06 (5bb), 39.22 (5bb’), 37.12 (5bb’), 36.94 (5bb), 30.59 (5bb’), 30.21 (5bb), 28.08 
(5bb’), 27.88 (5bb), 25.86 (5bb), 25.58 (5bb), 24.80 (5bb’), 22.81 (5bb’), 22.72 (5bb’), 19.92 
(5bb’), 19.80 (5bb), 19.28 (5bb), 17.79 (5bb). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H26O2, 249.1831; found, 249.1835. 
IR: ν 2961, 2916, 2875, 2850, 1735 cm-1 
 
Ethyl (S)-3,7-dimethyloct-6-enoate C12H22O2  
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
20% (5% Et2O/DCM)/Hex. Rf = 0.08  
16.2 mg of inseparable mixture of product (5bc) and hydrogenated product (5bc’) in a ratio of 7:1. 
Corrected MW = 198.55 g/mol. 5bc (60%); 5bc’ (8%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (tdt, J = 7.1, 2.8, 1.4 Hz, 1H), 4.13 (q, J = 7.1 Hz, 2H), 2.30 
(dd, J = 14.6, 6.0 Hz, 1H), 2.10 (dd, J = 14.6, 8.2 Hz, 1H), 2.05 – 1.90 (m, 3H), 1.68 (d, J = 1.3 
Hz, 3H), 1.60 (s, 3H), 1.40 – 1.11 (m, 7H), 0.94 (d, J = 6.7 Hz, 3H), 0.86 (dd, J = 6.6, 0.9 Hz, 1H) 
(5bc’). 
Note: Integration values are higher than expected due to partial hydrogenation of the final product. 
13C NMR (126 MHz, CDCl3) δ 173.44 (5bc), 131.67 (5bc), 124.45 (5bc), 60.24 (5bc), 42.13 
(5bc’), 42.02 (5bc), 39.21 (5bc’), 37.11 (5bc’), 36.94 (5bc), 30.55 (5bc’), 30.20 (5bc), 29.86 
(5bc’), 28.07 (5bc’), 25.86 (5bc), 25.58 (5bc), 24.79 (5bc’), 22.81 (5bc’), 22.72 (5bc’), 19.89 
(5bc’), 19.76 (5bc), 17.79 (5bc), 14.44 (5bc). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C12H22O2, 197.1542; found, 197.1541. 




Methyl (S)-3,7-dimethyloct-6-enoate C11H20O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
10% (5% Et2O/DCM)/Hex. Rf = 0.9  
15.9 mg of inseparable mixture of product (5bd) and hydrogenated product (5bd’) in a ratio of 
6:1. Corrected MW = 184.54 g/mol. 5bd (62%); 5bd’ (9%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (ddq, J = 8.5, 5.7, 1.4 Hz, 1H), 3.67 (s, 3H), 2.32 (dd, J = 
14.7, 5.9 Hz, 1H), 2.12 (dd, J = 14.7, 8.3 Hz, 1H), 2.06 – 1.91 (m, 3H), 1.68 (d, J = 1.4 Hz, 3H), 
1.60 (s, 3H), 1.39 – 1.12 (m, 3H), 0.94 (d, J = 6.7 Hz, 3H), 0.86 (dd, J = 6.6, 1.0 Hz, 1H) (5bd’). 
Note: Integration values are inflated due to presence of the hydrogenated product. 
13C NMR (126 MHz, CDCl3) δ 173.88 (5bd), 131.71 (5bd), 124.41 (5bd), 51.52 (5bd), 41.86 
(5bd’), 41.75 (5bd), 39.19 (5bd’), 37.11 (5bd’), 36.93 (5bd), 30.53 (5bd’), 30.20 (5bd), 28.07 
(5bd’), 25.86 (5bd), 25.58 (5bd), 24.80 (5bd’), 22.81 (5bd’), 22.72 (5bd’), 19.91 (5bd’), 19.78 
(5bd), 17.79 (5bd). 
IR: ν 2956, 2920, 2852, 1739 cm-1.  
 
Benzyl (S)-3,7-dimethyloct-6-enoate C17H24O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 10% (5% Et2O/DCM)/Hex. Rf = 0.1  
25.0 mg (5be); 80% yield  
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.29 (m, 5H), 5.12 (s, 2H), 5.07 (tdq, J = 7.0, 2.8, 1.3 Hz, 
1H), 2.37 (dd, J = 14.7, 6.0 Hz, 1H), 2.17 (dd, J = 14.8, 8.2 Hz, 1H), 2.05 – 1.90 (m, 3H), 1.67 (d, 
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J = 1.4 Hz, 3H), 1.59 (s, 3H), 1.35 (dddd, J = 13.4, 9.5, 6.5, 5.8 Hz, 1H), 1.22 (dddd, J = 13.6, 9.3, 
7.9, 6.2 Hz, 1H), 0.94 (d, J = 6.6 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.22, 136.29, 131.69, 128.68, 128.34, 128.29, 124.39, 66.18, 
41.95, 36.91, 30.22, 25.86, 25.55, 19.77, 17.79. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H24O2, 283.1674; found, 283.1667. 
IR: ν 2957, 2925, 2855, 1730 cm-1.  
 
4-(trifluoromethyl)benzyl (S)-3,7-dimethyloct-6-enoate C18H23F3O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.1 
23.2 mg of inseparable mixture of product (5bf) and hydrogenated product (5bf’) in a ratio of 7:1. 
Corrected MW = 328.64 g/mol. Product yield (51%); byproduct yield (8%). 
1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 7.9 Hz, 2H), 5.16 (s, 2H), 
5.06 (ddt, J = 8.5, 5.8, 1.4 Hz, 1H), 2.38 (dd, J = 14.8, 5.9 Hz, 1H), 2.19 (dd, J = 14.8, 8.1, Hz, 
1H), 1.98 (tq, J = 14.2, 7.6, 7.0 Hz, 3H), 1.67 (s, 3H), 1.58 (s, 3H), 1.56 – 1.42 (m, 1H), 1.35 (ddt, 
J = 12.5, 9.5, 6.1 Hz, 1H), 1.30 – 1.06 (m, 2H), 0.95 (dd, J = 6.7, 0.9 Hz, 3H), 0.85 (dd, J = 6.5, 
0.8 Hz, 1H) (5bf’). 
Note: integration values are inflated due to presence of hydrogenated byproduct. 
13C NMR (126 MHz, CDCl3) δ 173.01 (5bf), 140.28 (5bf), 131.79 (5bf), 130.47 (q, J = 32.6 Hz) 
(5bf), 128.29 (5bf), 125.65 (q, J = 3.8 Hz) (5bf), 124.27 (5bf), 124.16 (q, J = 272.1 Hz) (5bf), 
65.20 (5bf), 41.92 (5bf), 41.82 (5bf), 39.17 (5bf’), 37.05 (5bf’), 36.88 (5bf), 30.59 (5bf’), 30.22 
(5bf), 28.05 (5bf’), 25.84 (5bf), 25.54 (5bf), 24.77 (5bf’), 22.79 (5bf’), 22.70 (5bf’), 19.92 (5bf’), 
19.79 (5bf), 17.79 (5bf). 
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19F NMR (471 MHz, CDCl3) δ -62.65. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H23F3O2, 351.1548; found, 351.1545. 
IR: ν 2959, 2918, 2855, 1738 cm-1. 
 
4-chlorobenzyl (S)-3-(3-phenylpropyl)heptanoate C23H29ClO2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.11  
37.6 mg (5tg); 84% yield. 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.24 (m, 6H), 7.20 – 7.13 (m, 3H), 5.05 (s, 2H), 2.56 (t, J = 
7.8 Hz, 2H), 2.28 (dd, J = 6.9, 2.3 Hz, 2H), 1.89 (hept, J = 6.2 Hz, 1H), 1.59 (p, J = 8.0 Hz, 2H), 
1.40 – 1.15 (m, 8H), 0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.36, 142.63, 134.79, 134.22, 129.82, 128.86, 128.49, 128.41, 
125.84, 65.33, 39.28, 36.27, 35.16, 33.70, 33.66, 28.86, 28.59, 23.03, 14.19. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C23H29ClO2, 395.1754; found, 395.1759. 
IR: ν 2945, 2926, 2856, 1733 cm-1.  




Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 30% (5% 
Et2O/DCM)/Hex. Rf = 0.15  
24.5 mg (5uh); 60% yield. 
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1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 0.0 Hz, 2H), 7.20 – 7.13 (m, 3H), 6.84 – 6.75 (m, 3H), 
5.96 (s, 2H), 5.00 (s, 2H), 2.62 – 2.52 (m, 2H), 2.32 (dd, J = 14.8, 6.2 Hz, 1H), 2.15 (dd, J = 14.7, 
8.0 Hz, 1H), 1.99 (tq, J = 13.6, 7.0 Hz, 1H), 1.70 – 1.54 (m, 2H), 1.36 (ddt, J = 13.4, 10.9, 5.6 Hz, 
1H), 1.28 – 1.19 (m, 1H), 0.93 (d, J = 6.6 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.18, 147.92, 147.71, 142.66, 130.03, 128.50, 128.41, 125.82, 
122.40, 109.18, 108.37, 101.29, 66.16, 41.97, 36.43, 36.16, 30.48, 28.97, 19.86. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H24O4, 363.1586; found, 363.1584. 
IR: ν 2920, 2852, 1731, 1243, 1039 cm-1.  
Specific optical rotation: -3.5958°, C = 1.580g/100mL, 23.2 °C, CHCl3, 589 nm. 
 
4-fluorobenzyl (S)-3-(3-phenylpropyl)heptanoate C23H29FO2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.11  
34.2 mg (5ti); 80% yield. 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.26 (m, 4H), 7.20 – 7.13 (m, 3H), 7.06 – 7.01 (m, 2H), 5.05 
(s, 2H), 2.55 (t, J = 7.8 Hz, 2H), 2.27 (dd, J = 6.9, 2.1 Hz, 2H), 1.89 (hept, J = 6.2 Hz, 1H), 1.59 
(p, J = 8.0 Hz, 2H), 1.40 – 1.16 (m, 8H), 0.85 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.41, 162.75 (d, J = 246.7 Hz), 142.65, 132.14 (d, J = 3.3 Hz), 
130.42 (d, J = 8.35 Hz), 128.45 (d, J = 10.0 Hz), 125.83, 115.58 (d, J = 21.6 Hz), 65.44, 39.32, 
36.27, 35.16, 33.71, 33.66, 28.85, 28.59, 23.03, 14.19. 
19F NMR (471 MHz, CDCl3) δ -113.79. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C23H29FO2, 379.2049; found, 379.2057. 
IR: ν 2945, 2928, 2857, 1734 cm-1.  
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Specific optical rotation: -1.3800°, C = 1.40g/100mL, 23.2 °C, CHCl3, 589 nm. 
 
Cyclopentyl (S)-3,7-dimethyloct-6-enoate C15H26O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
20% (5% Et2O/DCM)/Hex. Rf = 0.1  
21.5 mg of inseparable mixture of product (5bJ) and hydrogenated product (5bJ’) in a ratio of 8:1. 
Corrected MW = 238.61 g/mol. 5bJ (66%); 5bJ’ (9%). 
1H NMR (500 MHz, CDCl3) δ 5.16 (tt, J = 5.7, 2.7 Hz, 1H), 5.09 (dddd, J = 7.1, 5.7, 2.9, 1.5 Hz, 
1H), 2.26 (dd, J = 14.4, 6.1 Hz, 1H), 2.07 (dd, J = 14.5, 8.1 Hz, 1H), 2.04 – 1.79 (m, 5H), 1.76 – 
1.63 (m, 7H), 1.63 – 1.52 (m, 5H), 1.39 – 1.11 (m, 4H), 0.94 (d, J = 6.7 Hz, 3H), 0.86 (d, J = 6.6 
Hz, 1H) (5bJ’). 
Note: Integration values are inflated due to presence of the hydrogenated product. 
13C NMR (126 MHz, CDCl3) δ 173.25 (5bJ), 131.64 (5bJ), 124.48 (5bJ), 42.39 (5bJ’), 42.30 
(5bJ), 39.24 (5bJ’), 37.09 (5bJ’), 36.92 (5bJ), 32.85 (5bJ), 32.81 (5bJ), 30.63 (5bJ’), 30.26 
(5bJ), 28.08 (5bJ’), 25.86 (5bJ), 25.57 (5bJ), 24.78 (5bJ’), 23.87 (5bJ), 22.81 (5bJ’), 22.73 
(5bJ’), 19.87 (5bJ’), 19.74 (5bJ), 17.79 (5bJ). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H26O2, 237.1855; found, 237.1846. 
IR: ν 2957, 2918, 2856, 2849, 1729 cm-1. 
 
Cyclohexyl (S)-3,7-dimethyloct-6-enoate C16H28O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
20% (5% Et2O/DCM)/Hex. Rf = 0.1 
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19.1 mg of inseparable mixture of product (5bk) and hydrogenated product (5bk’) in a ratio of 
8:1. 
Corrected MW = 252.62 g/mol. 5bk (56%); 5bk’ (7%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (ddt, J = 7.2, 5.7, 1.5 Hz, 1H), 4.77 (tt, J = 8.9, 3.8 Hz, 1H), 
2.28 (dd, J = 14.4, 6.1 Hz, 1H), 2.09 (dd, J = 14.4, 8.1 Hz, 1H), 2.05 – 1.91 (m, 3H), 1.88 – 1.78 
(m, 2H), 1.77 – 1.69 (m, 2H), 1.68 (s, 3H), 1.60 (s, 3H), 1.58 – 1.50 (m, 2H), 1.46 – 1.11 (m, 9H), 
0.94 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.6 Hz, 1H) (5bk’). 
Note: Integration values are higher than expected due to partial hydrogenation of the final product. 
13C NMR (126 MHz, CDCl3) δ 172.86 (5bk), 131.59 (5bk), 124.47 (5bk), 72.38 (5bk), 42.46 
(5bk’), 42.37 (5bk), 39.21 (5bk’), 37.07 (5bk’), 36.90 (5bk), 31.84 (5bk), 31.80 (5bk), 30.64 
(5bk’), 30.27 (5bk), 28.04 (5bk’), 25.83 (5bk), 25.55 (5bk), 24.76 (5bk’), 23.90 (5bk), 22.78 
(5bk’), 22.70 (5bk’), 19.81 (5bk’), 19.69 (5bk), 17.77 (5bk). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H28O2, 251.2011; found, 251.2017. 
IR: ν 2930, 2859, 1730 cm-1. 
 
Isopropyl (S)-3,7-dimethyloct-6-enoate C13H24O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
10% (5% Et2O/DCM)/Hex. Rf = 0.7  
11.0 mg of inseparable mixture of product (5bl) and hydrogenated product (5bl’) in a ratio of 6:1. 
Corrected MW = 212.60 g/mol. 5bl (37%); 5bl’ (6%). 
1H NMR (500 MHz, CDCl3) δ 5.09 (tdt, J = 7.1, 2.9, 1.4 Hz, 1H), 5.01 (hept, J = 6.3 Hz, 1H), 
2.27 (dd, J = 14.5, 6.0 Hz, 1H), 2.07 (dd, J = 14.4, 8.2 Hz, 1H), 2.04 – 1.92 (m, 3H), 1.68 (d, J = 
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1.3 Hz, 3H), 1.60 (s, 3H), 1.39 – 1.27 (m, 3H), 1.23 (d, J = 6.3 Hz, 6H), 0.94 (d, J = 6.7 Hz, 3H), 
0.86 (d, J = 6.5 Hz, 1H) (5bl’). 
Note: Integration values are inflated due to presence of the hydrogenated product. 
13C NMR (126 MHz, CDCl3) δ 172.96 (5bl), 131.63 (5bl), 124.49 (5bl), 67.43 (5bl), 42.45 (5bl), 
42.35 (5bl), 39.23 (5bl’), 37.10 (5bl’), 36.94 (5bl), 30.61 (5bl’), 30.26 (5bl), 29.86 (5bl’), 28.07 
(5bl’), 25.86 (5bl), 25.57 (5bl), 24.78 (5bl’), 22.81 (5bl’), 22.73 (5bl’), 22.05 (5bl), 22.02 (5bl), 
19.83 (5bl’), 19.71 (5bl), 17.79 (5bl). 
IR: ν 2962, 2920, 2854, 1731 cm-1.  
 
Hexyl (R)-3-phenylbutanoate C16H24O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.9  
21.8 mg (5da); 73% yield. 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.24 – 7.17 (m, 3H), 4.01 (t, J = 6.7 Hz, 2H), 
3.28 (h, J = 7.1 Hz, 1H), 2.62 (dd, J = 15.0, 7.0 Hz, 1H), 2.54 (dd, J = 15.0, 8.1 Hz, 1H), 1.57 – 
1.50 (m, 2H), 1.32 – 1.22 (m, 9H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.64, 145.90, 128.61, 126.89, 126.52, 77.41, 77.16, 76.91, 
64.65, 43.16, 36.71, 31.56, 28.71, 25.69, 22.67, 22.04, 14.16. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H24O2, 271.1674; found, 271.1685. 
IR: ν 2956, 2930, 2858, 1733, 1165 cm-1.  






Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 20% (5% 
Et2O/DCM)/Hex. Rf = 0.09  
28.0 mg (5un); 64% yield. 
1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.31 – 7.26 (m, 
2H), 7.20 – 7.13 (m, 3H), 5.15 (s, 2H), 2.64 – 2.52 (m, 2H), 2.37 (dd, J = 14.8, 6.1 Hz, 1H), 2.19 
(dd, J = 14.9, 8.0 Hz, 1H), 2.01 (ddt, J = 20.4, 13.7, 6.8 Hz, 1H), 1.72 – 1.54 (m, 2H), 1.37 (ddt, J 
= 13.3, 10.8, 5.6 Hz, 1H), 1.25 (dddd, J = 13.3, 10.5, 7.7, 5.4 Hz, 1H), 0.94 (d, J = 6.6 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.97, 142.57, 140.25, 130.48 (q, J = 32.5 Hz), 128.49, 128.43, 
128.42, 128.30, 125.86, 125.66 (q, J = 3.82 Hz), 124.16 (q, J = 272.18 Hz), 65.21, 41.81, 36.42, 
36.14, 30.47, 28.95, 19.87. 
19F NMR (471 MHz, CDCl3) δ -62.64. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H23F3O2, 387.1548; found, 387.1546. 
IR: ν 2927, 2851, 1736, 1323, 1124, 1067 cm-1.  




Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 20% (5% 
Et2O/DCM)/Hex. Rf = 0.1  
28.2 mg (5re); 67% yield. 
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1H NMR (500 MHz, CDCl3) δ 7.42 – 7.28 (m, 5H), 5.11 (dd, J = 22.5, 12.4 Hz, 2H), 3.86 (dddt, 
J = 7.9, 5.9, 4.6, 1.9 Hz, 1H), 2.36 (q, J = 9.2 Hz, 1H), 2.22 – 2.11 (m, 1H), 1.48 (ddd, J = 13.2, 
8.6, 4.4 Hz, 1H), 1.18 (dq, J = 13.7, 4.3 Hz, 1H), 1.11 (d, J = 6.0 Hz, 3H), 0.93 (d, J = 6.2 Hz, 3H), 
0.87 (s, 9H), 0.04 (d, J = 4.0 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 172.94, 136.30, 128.66, 128.32, 128.25, 66.39, 66.15, 46.84, 
42.65, 27.22, 26.03, 24.57, 19.77, 18.22, -3.95, -4.66. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H34O3Si, 373.2175; found, 373.2170. 
IR: ν 2955, 2929, 2896, 2856, 1736, 1255, 1155, 1065, 835, 774 cm-1.  
Specific optical rotation: -12.4766°, C = 1.27g/100mL, 23.1 °C, CHCl3, 589 nm. 
 
Isobutyl (S)-3-methyl-6-phenylhexanoate C17H26O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.08  
26.8 mg (5ub); 85% yield. 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.20 – 7.15 (m, 3H), 3.84 (d, J = 6.7 Hz, 2H), 
2.66 – 2.53 (m, 2H), 2.30 (dd, J = 14.6, 6.1 Hz, 1H), 2.12 (dd, J = 14.6, 8.0 Hz, 1H), 1.99 (dq, J = 
14.0, 7.7, 7.2 Hz, 1H), 1.91 (dp, J = 13.4, 6.7 Hz, 1H), 1.72 – 1.55 (m, 2H), 1.38 (ddt, J = 13.4, 
11.0, 5.6 Hz, 1H), 1.25 (dtt, J = 10.5, 7.8, 5.4 Hz, 1H), 0.94 (d, J = 6.7 Hz, 3H), 0.93 (d, J = 6.7 
Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 173.49, 142.69, 128.51, 128.41, 125.82, 77.41, 77.16, 76.91, 
70.52, 42.06, 36.48, 36.20, 30.48, 29.02, 27.87, 19.86, 19.28. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26O2, 285.1831; found, 285.1827. 
IR: ν 2959, 2931, 2873, 1733 cm-1.  
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Specific optical rotation: -5.9194°, C = 1.265g/100mL, 23.1 °C, CHCl3, 589 nm. 
 
hexyl 3-phenyl-3-(p-tolyl)propanoate C22H28O2 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.12 
32.7 mg (5va); 84% yield. 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.20 (m, 4H), 7.17 (tt, J = 7.0, 1.8 Hz, 1H), 7.13 (td, J = 8.2, 
2.1 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 4.51 (t, J = 8.1 Hz, 1H), 3.96 (t, J = 6.6 Hz, 2H), 3.03 (d, J 
= 8.1 Hz, 2H), 2.29 (s, 3H), 1.46 (p, J = 6.8 Hz, 2H), 1.36 – 1.14 (m, 6H), 0.87 (t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.12, 143.90, 140.67, 136.16, 129.36, 128.65, 127.76, 127.66, 
126.57, 77.41, 77.16, 76.91, 64.77, 46.89, 41.09, 31.55, 28.66, 25.63, 22.66, 21.13, 14.17. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C22H28O2, 325.2168; found, 325.2169. 
IR: ν 2937, 2925, 2857, 1732 cm-1. 
Specific optical rotation: -1.5571°, C = 2.24g/100mL, 23.1 °C, CHCl3, 589 nm. 
 
Hexyl (S)-3-(furan-2-yl)-3-phenylpropanoate C19H24O3  
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 30% (5% Et2O/DCM)/Hex. Rf = 0.1  
20.9 mg (5wa); 58%  
yield. 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 4H), 7.25 – 7.20 (m, 2H), 6.28 (dt, J = 3.0, 1.4 Hz, 
1H), 6.05 (dt, J = 3.1, 1.0 Hz, 1H), 4.55 (t, J = 7.9 Hz, 1H), 4.00 (t, J = 6.7 Hz, 2H), 3.09 (dd, J = 
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15.5, 7.9 Hz, 1H), 2.90 (dd, J = 15.5, 7.9 Hz, 1H), 1.53 – 1.47 (m, 2H), 1.33 – 1.19 (m, 6H), 0.88 
(t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 171.60, 156.40, 141.82, 141.30, 128.73, 127.87, 127.16, 110.22, 
105.83, 77.41, 77.16, 76.91, 64.92, 41.61, 39.97, 31.54, 28.65, 25.63, 22.67, 14.16. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H24O3, 323.1623; found, 323.1623. 
IR: ν 2956, 2922, 2852, 1733, 1154 cm-1.  
Specific optical rotation: +41.8023°, C = 2.030g/100mL, 23.2 °C, CHCl3, 589 nm. 
 
Hexyl (R)-3-(4-methoxyphenyl)butanoate C17H26O3 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 30% (5% Et2O/DCM)/Hex. Rf = 0.2  
23.4 mg (5fa); 70% yield. 
1H NMR (500 MHz, CDCl3) δ 7.17 – 7.11 (m, 2H), 6.85 – 6.81 (m, 2H), 4.00 (t, J = 6.7 Hz, 2H), 
3.78 (s, 3H), 3.23 (h, J = 7.2 Hz, 1H), 2.57 (dd, J = 14.9, 7.3 Hz, 1H), 2.51 (dd, J = 14.9, 8.0 Hz, 
1H), 1.57 – 1.49 (m, 2H), 1.32 – 1.20 (m, 9H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.71, 158.20, 138.01, 127.80, 113.97, 64.62, 55.37, 43.42, 
35.94, 31.57, 28.72, 25.70, 22.67, 22.22, 14.16. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26O3, 301.1780; found, 301.1781. 
IR: ν 2956, 2927, 2857, 1732, 1514, 1247 cm-1.  
Specific optical rotation: -18.6362°, C = 1.27g/100mL, 23.1 °C, CHCl3, 589 nm. 
 
Cyclopentyl (R)-3-phenylbutanoate C15H20O2 
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Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 30% (5% 
Et2O/DCM)/Hex. Rf = 0.12  
17.8 mg (5dJ); 64% yield 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.24 – 7.16 (m, 3H), 5.09 (tt, J = 6.1, 2.9 Hz, 
1H), 3.25 (h, J = 7.2 Hz, 1H), 2.58 (dd, J = 14.8, 7.4 Hz, 1H), 2.51 (dd, J = 14.8, 7.9 Hz, 1H), 1.81 
– 1.71 (m, 2H), 1.66 – 1.47 (m, 6H), 1.29 (d, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.35, 145.87, 128.56, 126.93, 126.49, 43.37, 36.86, 32.73, 
32.71, 23.81, 22.12. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H20O2, 255.1361; found, 255.1362. 
IR: ν 2962, 2919, 2873, 2850, 1728 cm-1. 
Specific optical rotation: -18.2237°, C = 1.49g/100mL, CHCl3, 22.8 °C, 589 nm 
 
Hexyl (R)-2-(chroman-4-yl)acetate C17H24O3 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. Eluent: 
30% (5% Et2O/DCM)/Hex. Rf = 0.1 
21.6 mg (5qa); 65% yield.  
1H NMR (500 MHz, CDCl3) δ 7.14 – 7.08 (m, 2H), 6.86 (td, J = 7.5, 1.3 Hz, 1H), 6.80 (dd, J = 
8.1, 1.3 Hz, 1H), 4.23 – 4.14 (m, 2H), 4.12 (td, J = 6.8, 0.9 Hz, 2H), 3.36 (dq, J = 10.3, 5.2 Hz, 
1H), 2.80 (dd, J = 15.5, 4.8 Hz, 1H), 2.53 (dd, J = 15.5, 10.0 Hz, 1H), 2.16 (dddd, J = 14.3, 8.7, 
5.8, 4.2 Hz, 1H), 1.85 (dtd, J = 14.0, 5.4, 3.2 Hz, 1H), 1.64 (dq, J = 8.1, 6.7 Hz, 2H), 1.39 – 1.23 
(m, 7H), 0.90 (t, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.39, 154.69, 128.86, 127.97, 124.75, 120.54, 117.21, 64.99, 
63.34, 41.55, 31.56, 30.68, 28.74, 27.52, 25.75, 22.69, 14.15. 
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HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H24O3, 299.1623; found, 299.1633. 
IR: ν 2938, 2926, 2857, 1731, 1224, 1162 cm-1. 




Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 10% (5% Et2O/DCM)/Hex. Rf = 0.1  
29.1 mg (5xa); 84% yield. 
1H NMR (500 MHz, CDCl3) δ 7.17 – 7.04 (m, 4H), 4.06 (t, J = 6.7 Hz, 2H), 3.52 – 3.43 (m, 1H), 
2.95 – 2.87 (m, 1H), 2.86 – 2.82 (m, 1H), 2.80 (dd, J = 15.1, 6.7 Hz, 1H), 2.70 (dd, J = 15.1, 8.9 
Hz, 1H), 1.96 – 1.84 (m, 1H), 1.83 – 1.69 (m, 3H), 1.65 – 1.47 (m, 4H), 1.38 – 1.19 (m, 6H), 0.89 
(t, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.08, 144.07, 142.71, 129.87, 126.37, 126.24, 64.71, 40.82, 
38.84, 36.17, 33.51, 31.56, 29.86, 28.74, 27.95, 25.73, 22.69, 14.15.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H28O2, 289.2168; found, 289.2161. 
IR: ν 2922, 2853, 1733 cm-1.  







Hexyl (S)-3-((triisopropylsilyl)ethynyl)heptanoate C24H46O2Si 
Isolation: 60 mL silica gel, dry load on celite. Load column with DCM. 
Eluent: 20% (5% Et2O/DCM)/Hex. Rf = 0.3 
33.3 mg (5ya); 70% yield 
1H NMR (500 MHz, CDCl3) δ 4.07 (td, J = 6.8, 1.6 Hz, 2H), 2.94 – 2.84 (m, 1H), 2.53 (dd, J = 
15.2, 7.7 Hz, 1H), 2.43 (dd, J = 15.2, 7.2 Hz, 1H), 1.61 (dt, J = 8.3, 6.8 Hz, 2H), 1.55 – 1.39 (m, 
5H), 1.39 – 1.24 (m, 9H), 1.06 – 1.03 (m, 18H), 1.01 – 0.97 (m, 1H), 0.89 (td, J = 7.2, 2.7 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 171.84, 110.62, 81.66, 64.88, 40.74, 34.47, 31.61, 29.49, 29.42, 
28.74, 25.77, 22.69, 22.49, 18.75, 14.16, 14.14, 11.37. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H47O2Si, 395.3345; found, 395.3353. 
IR: ν 2929, 2864, 2167, 1739, 1463, 1162 cm-1. 
 
3-hydroxy-3-methylbutyl (S)-3-methyl-6-phenylhexanoate C18H28O3 
Isolation: 60 mL silica gel, dry load on celite. Eluent: (10% to 20%) 
EtOAc/Hex. Rf = 0.3 
26.0 mg (5uo); 74% yield. 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.27 (m, 2H), 7.20 – 7.15 (m, 3H), 4.24 (t, J = 6.9 Hz, 2H), 
2.59 (ddd, J = 8.4, 6.8, 3.7 Hz, 2H), 2.29 (dd, J = 14.7, 6.0 Hz, 1H), 2.11 (dd, J = 14.8, 8.1 Hz, 
1H), 1.98 (dq, J = 14.0, 7.2 Hz, 1H), 1.82 (t, J = 6.8 Hz, 2H), 1.72 – 1.56 (m, 2H), 1.56 – 1.53 (m, 
2H), 1.37 (ddt, J = 13.4, 10.8, 5.6 Hz, 1H), 1.26 (s, 6H), 0.94 (d, J = 6.7 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 173.30, 142.64, 128.51, 128.42, 125.83, 70.21, 61.37, 42.05, 
41.73, 36.45, 36.16, 30.43, 29.79, 28.98, 19.86. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H28O3Na, 315.1936; found, 315.1929. 
IR: ν 3442 (br), 2966, 2930, 2855, 1732, 1148 cm-1.
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3.8.3 HPLC Traces of Isolated Esters 
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3.9 Allylic Amine Synthesis and Characterization 
(E)-N,N-diethyl-3,7-dimethylocta-2,6-dien-1-amine 
Synthesized according to literature precedent.1 
1H NMR (500 MHz, CDCl3) δ 5.28 – 5.21 (m, 1H), 5.08 (tt, J = 6.9, 1.5 Hz, 1H), 3.05 (d, J = 6.9 
Hz, 2H), 2.51 (q, J = 7.2 Hz, 4H), 2.09 (q, J = 7.4 Hz, 2H), 2.05 – 1.99 (m, 2H), 1.67 (s, 3H), 1.63 
(s, 3H), 1.59 (s, 3H), 1.03 (t, J = 7.1 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 137.73, 131.57, 124.38, 121.99, 50.71, 46.81, 39.99, 26.59, 25.85, 
17.82, 16.44, 11.98. 
 
(E)-N,N-diethyl-3-methyl-6-phenylhex-2-en-1-amine: Zircocene dichloride (5.80 g, 20.0 mmol, 
1.0 equiv) was added to a dry 250-mL round-bottomed flask under N2 atmosphere followed by 40 
mL dry methylene chloride. The mixture was cooled to 0 °C with stirring. Trimethylaluminum (2 
M in Hexanes) (30 mL, 60.0 mmol, 3.0 equiv) was added slowly via syringe. The reaction mixture 
stirred at 0 °C for 10 min. The reaction mixture turned yellow after stirring. 5-phenyl-1-pentyne 
(3.0 mL, 20.0 mmol) was then added to the reaction mixture via syringe. After addition of the 
alkyne, the flask was warmed to rt and stirred overnight. The reaction flask was cooled to 0 °C 
followed by addition of N-ethyl-N-methyleneethanaminium chloride (2.42 g, 20 mmol, 1.0 equiv) 
in 10 mL dry methylene chloride (N-ethyl-N-methyleneethanaminium chloride solution was made 
in a N2 glovebox). The reaction mixture stirred for an additional 2.5 h, after which it was quenched 
at 0 °C with sat. NH4Cl. The crude reaction mixture was filtered over celite. The filtrate was dried 
with anhydrous Na2SO4, filtered, and the solvent was removed in vacuo. The crude oil was purified 
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via flash column chromatography on silica gel with 1% MeOH/10% Et2O/89% (3% NH3/DCM). 
The product was then distilled at reduced pressure (106–108 °C at 0.176 Torr) to yield 1.45 g 
(33%) of a clear, colorless oil. 
 
(E)-N,N-diethyl-3-methyl-6-phenylhex-2-en-1-amine C17H27N 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.27 (m, 2H), 7.20 – 7.15 (m, 3H), 
5.29 (tq, J = 6.8, 1.3 Hz, 1H), 3.07 (d, J = 6.8 Hz, 2H), 2.61 – 2.56 (m, 2H), 2.51 (q, J = 7.2 Hz, 
4H), 2.06 (t, J = 7.5 Hz, 2H), 1.79 – 1.71 (m, 2H), 1.64 (s, 3H), 1.03 (t, J = 7.2 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 142.78, 137.61, 128.56, 128.39, 125.77, 122.18, 50.67, 46.85, 




Synthesized according to literature precedent.1 
1H NMR (500 MHz, CDCl3) δ 5.28 (td, J = 6.6, 1.5 Hz, 1H), 3.93 (dt, J = 6.9, 5.9 Hz, 1H), 3.06 
(d, J = 6.8 Hz, 2H), 2.51 (q, J = 7.1 Hz, 4H), 2.22 (dd, J = 13.1, 6.0 Hz, 1H), 2.06 (dd, J = 13.1, 
6.8 Hz, 1H), 1.65 (s, 3H), 1.10 (d, J = 6.0 Hz, 3H), 1.03 (t, J = 7.2 Hz, 6H), 0.88 (s, 9H), 0.04 (d, 
J = 7.4 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 135.12, 124.68, 67.64, 50.67, 50.42, 46.86, 26.02, 23.57, 18.31, 
17.16, 11.95, -4.40, -4.63. 
 
(E)-N,N-diethyl-3-(4-methoxyphenyl)but-2-en-1-amine C15H23NO 
Synthesized according to literature precedent.1 
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1H NMR (500 MHz, CDCl3) δ 7.36 – 7.33 (m, 2H), 6.87 – 6.83 (m, 2H), 5.86 – 5.80 (m, 1H), 
3.81 (s, 3H), 3.26 (dd, J = 6.7, 1.0 Hz, 2H), 2.58 (q, J = 7.1 Hz, 4H), 2.04 (s, 3H), 1.07 (t, J = 7.1 
Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 158.76, 136.23, 136.01, 126.80, 124.29, 113.68, 55.44, 51.53, 
47.14, 16.24, 12.06. 
 
(E)-N,N-diethyl-3-phenylbut-2-en-1-amine C14H21N 
Synthesized according to literature precedent.1 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.39 (m, 2H), 7.34 – 7.29 (m, 2H), 7.25 – 7.21 (m, 1H), 
5.91 (tq, J = 6.6, 1.4 Hz, 1H), 3.28 (dd, J = 6.6, 1.0 Hz, 2H), 2.58 (q, J = 7.2 Hz, 4H), 2.07 (d, J 
= 1.2 Hz, 3H), 1.07 (t, J = 7.1 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 143.68, 136.65, 128.33, 126.92, 125.95, 125.79, 51.53, 47.19, 
16.23, 12.08. 
 
Allylic diethylamine substrate 1v was synthesized by the following method and the starting vinyl 
bromide was synthesized according to our previous report.1  
Procedure: To a 50-ml round bottomed flask charged with a stir bar under inert atmosphere was 
added Pd(OAc)2 (11 mg, 0.050 mmol, 1.0 mol %), PPh3 (26 mg, 0.10 mmol, 2.0 mol %), KOH 
(0.560 g, 10 mmol, 2.0 equiv), starting material vinyl bromide (1.34g, 5 mmol, 1.0 equiv), 4-
methyl boronic acid (0.880 g, 6.5 mmol, 1.3 equiv), 5 mL THF and 5 mL MeOH. The reaction 
was stirred at rt overnight followed by dilution with EtOAc, and washed by 1N NaOH solution 
 
1Wu, Z.; Laffoon, S. D.; Nguyen, T. T.; McAlpin, J. D.; Hull, K. L. “Rhodium-Catalyzed 




and brine. The organic lay was then dried over MgSO4, concentrated in vacuo, purified by Al2O3 
column chromatography: 200 g Al2O3 + 12 g H2O, 30 : 1 hexanes/ EtOAc with 0.5 % MeOH as 
eluent.  The product was collected in 70% yield. 
 
(E)-N,N-diethyl-3-phenyl-3-(p-tolyl)prop-2-en-1-amine C20H25N 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.33 (m, 2H), 7.34 – 7.29 (m, 1H), 
7.18 – 7.12 (m, 4H), 7.10 – 7.06 (m, 2H), 6.19 (t, J = 6.7 Hz, 1H), 3.15 (d, 
J = 6.8 Hz, 2H), 2.52 (q, J = 7.2 Hz, 4H), 2.32 (s, 3H), 0.96 (t, J = 7.1 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 143.24, 140.11, 139.65, 137.01, 129.97, 128.96, 128.21, 127.27, 
127.15, 126.55, 51.86, 47.13, 21.20, 11.96. 
 
Synthesized according the procedure cited for 1v. 
(E)-N,N-diethyl-3-(furan-2-yl)-3-phenylprop-2-en-1-amine C17H21NO 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.32 (m, 4H), 7.25 – 7.22 (m, 2H), 6.40 
(t, J = 7.0 Hz, 1H), 6.31 (dd, J = 3.3, 1.8 Hz, 1H), 5.80 (d, J = 3.3 Hz, 1H), 
3.14 (d, J = 7.0 Hz, 2H), 2.52 (q, J = 7.1 Hz, 4H), 0.96 (t, J = 7.2 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 155.34, 142.06, 137.29, 133.58, 129.75, 128.25, 127.67, 124.13, 











(E)-2-(chroman-4-ylidene)-N,N-diethylethan-1-amine: 2-iodophenol (4.4 g, 20 mmol), K2CO3 
(2.8 g, 20 mmol, 1.0 equiv), 3-bromo-1-propanol (1.8 mL, 20 mmol, 1.0 equiv), and acetone (20 
mL) were added to a dried 250-mL round-bottomed flask equipped with a stir bar. A reflux 
condenser, and the reaction mixture was stirred at reflux overnight. The reaction flask was then 
cooled to room temperature. The crude reaction mixture was washed with DI H2O and extracted 
with EtOAc. The aqueous layer was back-extracted with methylene chloride. The combined 
organic layers were dried over MgSO4. The mixture was filtered to remove solids, and the solvent 
was removed in vacuo. The crude product was used without further purification. 
 A 500-mL round-bottomed flask with stir bar (not dried) was charged with 3-(2-
iodophenoxy)propan-1-ol (5.6 g, 20 mmol), NaHCO3 (4 g, 47.6 mmol, 2.4 equiv), and wash 
bottle grade methylene chloride (100 mL). The reaction mixture was cooled to 0 °C with stirring. 
Dess-Martin periodinane (17 g, 40 mmol, 2.0 equiv) was added to the stirring reaction mixture in 
one portion, and the reaction continued stirring for 2.5 h. The reaction mixture was warmed to 
room temperature and filtered over a bed of celite. The filtrate was washed with sat. NaHCO3. The 
combined aqueous layers were extracted with methylene chloride. The combined organic layers 
were dried over Na2SO4, filtered, and the solvent was removed in vacuo. The crude product was 
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purified via flash column chromatography over silica gel with 10% to 20% to 30% EtOAc/Hex. 
The product was obtained as an orange oil (4.2 g, 76% yield). 
 A 250-mL round-bottomed flask was equipped with a magnetic stir bar and dried. NaH 
(60% dispersion in mineral oil) (0.63 g, 15.75 mmol, 1.05 equiv) was added to the flask and then 
placed under N2 atmosphere. Dry THF (25 mL) was added to the flask via syringe. The reaction 
flask was then cooled to 0 °C. Diethyl (2-(diethylamino)-2-oxoethyl)phosphonate was added 
dropwise via syringe. The reaction mixture was stirred until clear. 3-(2-iodophenoxy)propanal 
was then added to the reaction flask and stirred overnight while slowly warming to room 
temperature. The reaction mixture was cooled to 0 °C and then quenched with sat. NH4Cl. The 
solids were filtered and the filtrate was extracted with EtOAc. The combined organic layers were 
dried over MgSO4, filtered, and the solvent was removed in vacuo. The crude oil was purified via 
silica gel flash column chromatography (10% to 50% EtOAc/Hex gradient). 
 A dry 250-mL 3-necked flask equipped with a stir bar was charged with Pd(PPh3)4 (1.2 g, 
1 mmol, 0.20 equiv) under N2 atmosphere. Triethylamine (7 mL, 50 mmol, 10 equiv), (E)-N,N-
diethyl-5-(2-iodophenoxy)pent-2-enamide (1.9 g, 5 mmol), and MeCN (50 mL) were then added 
to the reaction flask sequentially via syringe. The flask was topped with a reflux condenser and 
heated to reflux overnight. The reaction mixture was then cooled to room temperature, and the 
solvent was removed in vacuo. The crude oil was washed with DI H2O and extracted with 
methylene chloride. The combined organic layers were dried over MgSO4, filtered, and the solvent 
was removed in vacuo. The crude oil was used without further purification. 
 A dry 100-mL round-bottomed flask equipped with a stir bar was dried and placed under 
N2 atmosphere. To the flask was added dry THF (4 mL) and dry toluene (8 mL) followed by (E)-
2-(chroman-4-ylidene)-N,N-diethylacetamide (0.98 g, 4 mmol). The reaction solution was 
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cooled to 0 °C. Red-AL (3.5 M in toluene) (2.4 mL, 7.2 mmol, 1.8 equiv) was added dropwise via 
syringe. The reaction flask was warmed to room temperature and stirred for 2.25 h. The reaction 
solution was cooled to 0 °C and quenched with NaOH (5 M aq.) The crude reaction mixture was 
extracted with EtOAc. The combined organic layers were dried over Na2SO4, filtered, and the 
solvent was removed in vacuo. The crude product was purified via silica gel flash column 
chromatography [1% MeOH/10% Et2O/89% (3% to 7% NH3 in DCM)]. The product was obtained 
in 0.583 g, 63%.  
 
(E)-2-(chroman-4-ylidene)-N,N-diethylethan-1-amine C15H21NO 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 8.0, 1.6 Hz, 1H), 7.13 (ddd, J = 8.2, 
7.2, 1.6 Hz, 1H), 6.89 (ddd, J = 7.9, 7.2, 1.3 Hz, 1H), 6.83 (dd, J = 8.2, 1.3 Hz, 1H), 6.15 (tt, J = 
6.8, 1.8 Hz, 1H), 4.20 (dd, J = 6.1, 5.3 Hz, 2H), 3.25 (d, J = 6.9 Hz, 2H), 2.69 (ddt, J = 6.6, 4.9, 
1.3 Hz, 2H), 2.57 (q, J = 7.2 Hz, 4H), 1.07 (t, J = 7.2 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 154.50, 130.23, 128.77, 124.11, 122.72, 120.94, 120.04, 117.59, 














1H NMR (500 MHz, CDCl3) δ 7.17 – 7.09 (m, 3H), 7.02 – 6.97 (m, 1H), 5.64 (t, J = 6.8 Hz, 1H), 
3.00 (d, J = 6.8 Hz, 2H), 2.77 – 2.67 (m, 2H), 2.47 (q, J = 7.1 Hz, 4H), 2.33 – 2.24 (m, 2H), 1.85 
(p, J = 5.9 Hz, 2H), 1.72 – 1.61 (m, 2H), 0.92 (t, J = 7.1 Hz, 6H).  
13C NMR (125 MHz, CDCl3) δ 145.62, 141.73, 141.18, 129.12, 128.98, 126.92, 125.59, 124.99, 
51.08, 46.81, 38.10, 36.63, 33.30, 27.87, 11.76. 
 
 
(E)-N,N-diethyl-3-(3-phenylpropyl)hept-2-en-1-amine: CuI (1.1 g, 5.4 mmol, 0.54 equiv) and 
Et2O (40 mL) were added to a dry 100-mL Schlenk flask equipped with a stir bar under atmosphere 
of N2. The flask was cooled to –45 °C. n-butyl lithium (1.6 M in hexanes) (6 mL, 9 mmol, 0.9 
equiv) was added to the reaction flask via syringe. The reaction mixture stirred at temperature for 
30 min. 5-phenyl-1-pentyne was then added to the reaction mixture via syringe. The reaction was 
stirred at –45 °C for an additional 10 min after which it was warmed to –20 °C and stirred for an 
additional 2 h. The flask was then cooled to –45 °C, and N-ethyl-N-
((phenylthio)methyl)ethanamine was added to the reaction mixture via syringe. The flask was 
warmed to room temperature and allowed to stir overnight. The reaction mixture was then cooled 
to 0 °C and quenched with sat. NH4Cl then NH4OH (1 M aq.). The crude reaction mixture was 
filtered. The filtrate was extracted with EtOAc, dried over MgSO4, and the solvent was removed 
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in vacuo. The crude oil was dissolved in Et2O and extracted with HCl (1 M) x3. The combined 
aqueous layers were basified with 10% NaOH (aq.) and extracted with methylene chloride. The 
combined organic layers were dried over MgSO4, filtered, and the solvent was removed in vacuo. 
The crude oil was purified via basic alumina flash column chromatography (12 g DI H2O in 300 g 
basic alumina; 1% to 10% MeOH/5% to 10% Et2O/pet. ether). The product was purified again via 
silica gel flash column chromatography [1% MeOH/10% Et2O/89%(1% to 7% NH3 in DCM)]. 
The product was obtained in 22% yield, 1.90 g.  
(E)-N,N-diethyl-3-(3-phenylpropyl)hept-2-en-1-amine C20H33N 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H), 7.20 – 7.15 (m, 3H), 
5.26 (t, J = 6.7 Hz, 1H), 3.07 (d, J = 6.7 Hz, 2H), 2.62 – 2.57 (m, 2H), 2.51 (q, J = 7.1 Hz, 4H), 
2.11 – 1.98 (m, 4H), 1.78 – 1.69 (m, 2H), 1.35 – 1.26 (m, 4H), 1.03 (t, J = 7.1 Hz, 6H), 0.93 – 
0.86 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 142.83, 141.96, 128.55, 128.40, 125.77, 122.43, 50.49, 46.87, 
36.76, 35.81, 30.89, 30.32, 30.02, 23.01, 14.19, 12.03. 
 
 
(Z)-N,N-diethyl-3-((triisopropylsilyl)ethynyl)hept-2-en-1-amine: A dry 250-mL 3-necked 
round bottomed flask was equipped with a stir bar and addition funnel and placed under N2 
atmosphere. 1-hexyne (3.4 mL, 30.0 mmol) and 40 mL THF were added to the flask via syringe. 
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The flask was cooled to –78 °C followed by the addition of nBuLi (1.6 M in Hex) (18.8 mL, 1 
equiv, 30 mmol) over 10 minutes. The reaction mixture was stirred for 1 h. Paraformaldehyde 
(1.4 g, 1.4 equiv, 42.0 mmol) was added to the reaction flask in one portion under positive pressure 
of N2. The flask was then warmed to rt and stirred overnight. After cooling to 0 °C, the reaction 
was quenched with sat. NH4Cl and extracted with EtOAc. The combined organic layers were dried 
over MgSO4, filtered, and the solvent was removed in vacuo. The crude oil was distilled (7 torr, 
bp = 60-65 °C). Yield = 2.77g, 82% 
A dry 500-mL round bottomed flask was equipped with a stir bar and placed under N2. 100 
mL THF was added to the flask via syringe followed by Red-AL (3.5 M in Toluene) (17.9 mL, 1.7 
equiv, 62.7 mmol). The reaction flask was cooled to 0 °C. Hept-2-yn-1-ol (36.9 mmol) was diluted 
in 20 mL THF and transferred to the reaction flask via syringe. The reaction was warmed to rt and 
stirred for 4 h. The reaction mixture was then cooled to –10 °C followed by the addition of 
anhydrous EtOAc (10.1 mL, 2.8 equiv, 103.3 mmol). The reaction mixture was stirred for 25 min. 
The reaction was then cooled to –78 °C, then I2 (18.7 g, 2 equiv, 73.8 mmol) was added in two 
portions against positive pressure N2. The reaction mixture was stirred for an additional 1 h. 50 
mL sat. sodium potassium tartrate was added to the reaction flask via syringe followed by 90 mL 
sat. Na2S2O3. The mixture was stirred until clear then extracted with EtOAc. The combined organic 
layers were dried over MgSO4, filtered, and then the solvent was removed in vacuo. The crude oil 
was purified via silica gel flash column chromatography (5% to 25% EtOAc/Hex). The product 
was obtained in 8.8 g, 99% yield. 
A dry 500-mL round bottomed flask was equipped with a stir bar and placed under N2. 
Triethylamine (15.3 mL, 3 equiv, 110.1 mmol) and 140 mL methylene chloride were transferred 
to the flask via syringe followed by (Z)-3-iodohept-2-en-1-ol (36.7 mmol). The flask was cooled 
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to 0 °C, and methanesulfonyl chloride (8.5 mL, 3 equiv, 110.1 mmol) was added. The reaction 
mixture was stirred at 0 °C for 7 h. Methanesulfonyl chloride (5.7 mL, 2 equiv, 73.4 mmol) was 
added to the reaction flask at 0 °C. The reaction was then warmed to rt and allowed to stir 
overnight. The reaction mixture was diluted with methylene chloride under ambient atmosphere 
then washed with 1 M HCl, sat. NaHCO3, then brine. The organic layer was dried over MgSO4, 
filtered and the solvent was removed in vacuo. The crude oil was purified via silica gel flash 
column chromatography. The product was obtained in 89% yield (8.45 g). 
A 500-mL round bottomed flask was equipped with a stir bar and charged with K2CO3 
(11.3 g, 2.5 equiv, 81.8 mmol), diethylamine (4.1 mL, 1.2 equiv, 39.2 mmol), and (Z)-1-chloro-
3-iodohept-2-ene (32.7 mmol). The flask was fitted with a reflux condenser, and the reaction 
mixture was heated to reflux overnight. The flask was then cooled to rt, and the reaction mixture 
was washed with DI H2O and extracted with EtOAc. The combined organic layers were dried over 
MgSO4, filtered, and the solvent was removed in vacuo. The crude product was distilled (0.18 
Torr, 60-70 °C) and obtained in 86% yield. 
A dry 500-mL round bottomed flask was dried and equipped with a stir bar. In a N2 filled 
glove box, PdCl2(PPh3)2 (70.2 mg, 0.02 equiv, 0.1 mmol) and CuI (19.0 mg, 0.02 equiv, 0.1 mmol) 
were transferred to the flask. The flask was fitted with a septum, removed from the glove box, and 
placed on a standard Schlenk line under N2 atmosphere. Diethylamine (10 mL) was added to the 
flask via syringe. (Z)-N,N-diethyl-3-iodohept-2-en-1-amine (1.48 g, 5 mmol) was transferred to 
the flask, and the reaction mixture was stirred for 10 min. Ethynyltriisopropylsilane (1.4 mL, 1.2 
equiv, 6 mmol) was added to the reaction mixture via syringe, and the reaction continued to stir at 
rt overnight. The crude reaction mixture was filtered over celite then concentrated in vacuo. The 
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crude oil was purified by basic alumina flash column chromatography (100 g Al2O3 + 6 g H2O). 




1H NMR (500 MHz, CDCl3) δ 5.79 (tt, J = 7.0, 1.2 Hz, 1H), 3.37 (d, J = 7.0 Hz, 
2H), 2.54 (q, J = 7.2 Hz, 4H), 2.15 (td, J = 7.3, 1.1 Hz, 2H), 1.52 (tt, J = 8.5, 6.7 Hz, 2H), 1.31 (dq, 
J = 14.6, 7.3 Hz, 2H), 1.10 – 1.08 (m, 21H), 1.04 (t, J = 7.1 Hz, 6H), 0.89 (t, J = 7.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 134.96, 126.05, 105.45, 95.60, 52.94, 47.14, 36.97, 30.47, 22.02, 
18.81, 14.04, 12.06, 11.47. 
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CHAPTER 4: TANDEM ASYMMETRIC ALLYLIC AMINE 
ISOMERIZATION AND REDUCTIVE AMINATION UNDER RHODIUM 
CATALYSIS 
 
This chapter has been adapted from the following publication: 
Wu, Z.; Laffoon, S. D.; Hull, K. L. Asymmetric Synthesis of γ-Branched Amines via Rhodium-
Catalyzed Reductive Amination. Nat. Commun. 2018, 9, 1185.  
 
4.1 Abstract 
This chapter describes the development of a general asymmetric route for the one-pot 
synthesis of chiral γ-branched amines through the highly enantioselective isomerization of 
allylamines, followed by enamine exchange and subsequent chemoselective reduction. This 
protocol is suitable for establishing various tertiary stereocenters, including those containing 
dialkyl, diaryl, cyclic, trifluoromethyl, difluoromethyl, and silyl substituents, which allows for a 
rapid and modular synthesis of many chiral γ-branched amines. To demonstrate the synthetic 
utility, Terikalant and Tolterodine are synthesized using this method with high levels of 
enantioselectivity. 
 
4.2 Motivation and Background 
Chapters 2 and 3 describe the one-step synthesis of chiral, β-branched amides and esters 
via Rh-catalyzed enantioselective isomerization of allylic amines, followed by enamine exchange, 
and subsequent oxidation.1 The slow oxidation of the more sterically hindered diethyl enamine (i, 
when R=ethyl, Figure 4.2a) compared to facile oxidation of enamine (ii) leads to exclusive 
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formation of the desired amide product (iii). Based on this report, we proposed that chiral enamine 
intermediate (ii) could instead be reduced to afford the valuable enantiopure γ-branched amine (v).  
 
Figure 4.1. Design of a tandem asymmetric isomerization—enamine exchange—reduction process. The 
chemoselectivity is determined by the relative reduction rate of intermediates i and ii. When R = ethyl, exclusive 
formation of β-branched amide iii is observed in the presence of hydrogen acceptor. b, One-pot synthesis of chiral γ-
branched amine from allylic amine, exogenous amine nucleophile, and hydrogen donor. 
We report herein a nucleophilic amination of allylic amines with exogenous amine 
nucleophiles to afford chiral, γ-branched amines via a transfer hydrogenation (Figure 4.1b). Both 
primary and secondary alkyl/aryl amines are effective nucleophiles, coupling with allylic 
diethylamine precursors to afford various γ-branched amine products with excellent 
enantioselectivities in a two-step one-pot manner. 
 
4.3 Developing Conditions for Reductive Amination  
To establish a method for the selective conversion of allylic amines to enantiopure γ-
branched amines, we began our investigation by examining a variety of hydrogen donors in the 
reductive amination of geranyl diethylamine (1a) with morpholine (2b) under slightly modified 
conditions from our previous report.21 Compared to the oxidative process, the reduction is more  
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Table 4.1. Selected optimization of reductive amination of allylic amines.a 
 
Entry 1 R, R’ T (°C) X Hydrogen donor Yield 3a (%)b Yield 3a’ (%)b 
1 1a Et, Et 40 1.2 iPrOH < 1 c 5 
2 1a Et, Et 40 1.2 MeOH < 1 c 2 
3 1a Et, Et 40 1.2 HCO2NH4 12 20 
4 1a Et, Et 40 1.2 HCOOH 88 (96.2:3.8 er) 10 
5 1a Et, Et 60 2.0 HCOOH 87 8 
6 1a Et, Et 60 3.0 HCOOH 88 5 
7 1b Me, Me 80 1.2 HCOOH 53 (96.4:3.6 er) 43 
8 1c i-Pr, i-Pr 80 1.2 HCOOH 80 (77.6:22.4 er) < 1 
9 1d Cy, H 80 1.2 HCOOH 44 28 
a) General reaction conditions: geranyl amine (1) (0.12 mmol, 1.0 equiv, E/Z = 97.5:2.5), morpholine (2a), hydrogen 
donor (3.0 equiv), THF (1.2 M). The absolute configuration of 3a was assigned by analogy. b) In situ yield determined 
by GC or NMR analysis. c) Enamine of 3a was observed as the major product. er: enantiometric ratio. 
challenging as the hydrogenated starting material (Figure 4.1a, iv) was often observed as the major 
byproduct in the amidation reaction.1 Therefore, an appropriate selection of a hydrogen donor and 
starting material (R group) to allow for the rapid and chemoselective reduction of intermediate (ii) 
was the key challenge in our investigation. No conversion of 1a was observed in the presence of 
H2 donors, presumably due to protonation of the basic allylic nitrogen atom or coordination to the 
cationic catalyst, thereby impeding the initiation of the 1,3-hydride shift.2 Sequential addition of 
the hydrogen donor after the isomerization/enamine exchange step led to higher conversion of 
starting material, with HCO2H showing superior reactivity and selectivity (Table 4.1, entries 1-4). 
Increasing the equivalency of amine nucleophile improved the ratio of 3a/3a’, but did not increase 
the yield of the desired product 3a (Table 4.1, entries 4-6). Different allylic amine precursors (1b-
d) were then tested to compare both chemo- and enantioselectivity (Table 4.1, entries 7-9). 
Elevated temperature was required to achieve high conversion for these substrates. Less sterically 
hindered dimethylamino substate 1b afforded poor chemoselectivity and high enantioselectivity; 
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however, bulkier allylic diisopropylamine 1c showed greater chemoselectivity but poor 
enantioselectivity. Secondary amine precursor 1d was less reactive and selective under these 
conditions. 
 
4.4 Expanding Reaction Scope 
With these optimized conditions in hand, the amine nucleophile scope was investigated 
(Figure 4.2). Secondary cyclic amines such as morpholine (3a), Boc-protected piperazine (3b), 
tetrahydroisoquinoline (3c) and 2-(piperazin-1-yl) pyrimidine (3d) all gave similarly excellent 
yields and enantiometric ratios. Without the addition of amine, 3e could be obtained in high yield 
and e.r. Surprisingly, more sterically hindered acyclic dialkyl amines 3f and 3g (compared to 
diethylamine) were effective nucleophiles in this reaction, indicating that the volatility of the 
resulting diethylamine byproduct is likely playing a larger role than steric hindrance in determining  
the chemoselectivity (vide infra). Enantiopure α-branched amine 2g afforded the desired product 
3g and 3g’ with high e.r. (>97:3) and d.r. (>20:1), demonstrating that the isomerization is not 
affected by the chirality of the nucleophile, but is instead controlled by the ligand. Importantly, no 
racemization of the chiral amine nucleophile occurred under the reaction conditions. 
Under slightly modified conditions, primary aryl and alkyl amines were coupled with 
allylic diethylamine electrophiles to afford the chiral secondary amines, respectively. In these 
cases, NaBH4 proved to be a superior reductant than HCO2H. Both electron rich (3i) and poor (3j) 
anilines afforded the desired chiral amines with identically excellent enantiomeric ratios. In the 
presence of primary alkyl amines (with the exception of tBuNH2 2m), the isomerization of allylic 
diethylamine was completely prohibited; therefore, a sequential addition of nucleophile was 
required to reach high yields. Primary alkyl amines, α to 1°(3k), 2°(3l), and 3° (3m) carbons, all 
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afforded desired products with moderate to good yields and excellent enantioselectivity. A 
nucleophile containing a tethered tertiary nitrogen atom (3n) was well tolerated. 
A survey of 3,3-disubstituted allylic amine electrophiles revealed that a wide variety of 
tertiary stereocenters can be installed under these reductive amination conditions (Figure 4.3). 
Several 3,3-aryl,alkyl allylic diethylamines (5a-c) were tested and all afforded products with good 
yields and enantioselectivities. An ortho substituent on the aryl ring (5c) has no effect on the 
enantioselectivity of the isomerization, and the standard reaction conditions were amenable to aryl 
bromides, with no proteodebromination byproducts observed. The use of β,β-dialkyl allylic 
 
Figure 4.2. Scope of amine nucleophiles for the reductive amination of allylamine. a) General reaction conditions: 
1a (0.24 mmol, 1.0 equiv, E/Z = 97.5:2.5, 40 °C for 1st step) or 1b (0.24 mmol, 1.0 equiv, E/Z > 99:1, 60 °C for 1st 
step) nucleophile 2 (1.2 equiv), hydrogen donor (3.0 equiv), THF (1.2 M). b) For 3a-3g, HCO2H used as H2 donor at 
60 °C for 2nd step; For 3h-3n, NaBH4 (1.5 equiv) used as reductant at 0°C to rt for 2nd step. c) 2d and 2e added together 
with HCO2H. d) No nucleophile added. e) (S)-BINAP used. f) 2k, 2l, and 2n added after isomerization. See 




Figure 4.3. Scope of allylamine. a) General reaction conditions: allylic diethylamine 4 (0.24 mmol, 1.0 equiv, E/Z > 
99:1 unless otherwise noted), nucleophile 2 (1.2 equiv), HCO2H (3.0 equiv), THF (1.2 M). b) Substrate E/Z = 96.7:3.3. 
c) Substrate Z/E > 99:1. d) 1,4-dioxane used. e) Substrate Z/E=95.6:4.4. f) Toluene used. See supplemental methods 
for details. The absolute configuration of product is determined by alkene configuration. 
diethylamine (5d-f) was successful, enabling the highly enantioselective synthesis of γ-dialkyl 
amines, even with minimally differentiated substituents (5d, n-Pent vs n-Bu). When more 
challenging 3,3-diaryl allylic diethylamines (5j-i) were subjected to the reaction conditions, amine 
products bearing γ-diaryl stereocenters, a common moiety in pharmaceutical agents, can be formed 
with excellent enantioselectivity.3–6 Substrates bearing electron-rich (5h) and electron-poor (5i) 
aryl substituents afforded good yields and excellent enantiomeric ratios. This method can be used 
to set stereocenters containing sterically and electronically similar phenyl and para-tolyl groups 
with excellent selectivity (5g, 96.5:3.5 er). Chiral γ-cyclic amines containing five-, six-, and seven-
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membered rings (5j-l) could be obtained as well with high enantioselectivity under identical 
conditions.7,8 
Due to the superior reactivity and broad substrate tolerance of this catalyst, we sought to 
further develop this method for the construction of highly valuable stereocenters containing CF3, 
CF2H, and SiR3 substituents (Figure 4.3). In order to effect suitable conversion, modification of 
the reaction solvent and increased temperatures were required. This may be attributed to the 
difficult isomerization of the more hindered allylic amines. Under these new conditions, difficult 
to synthesize enantiopure γ-trifluromethylated (5m-o) and difluoromethylated (5p) amines can be 
accessed with moderate to good yields and excellent enantioselectivities.9,10 It is worth noting that 
the (Z)-CF3 allylic amine (5b) was slightly more reactive under these conditions compared to the 
(E)-isomer (5n), as higher conversion was observed for 5m. Phenyldimethylsilyl substituted allylic 
diethylamines (5q) afforded good yields and enantioselectivities under these conditions as well. It 
is noteworthy that the chiral silyl group can be installed, as this can be converted to a range of 
functionalities.11 
This methodology was applied in the enantioselective syntheses of biologically active 
Terikalant and Tolterodine as illustrated in Figure 4.4. Substrate 4k and nucleophile 2o were 
prepared according to literature procedures. The presence of 2o proved to inhibit the isomerization 
of allylic amine 4k. Therefore, the addition of nucleophile along with formic acid after the 
isomerization step was found effective, giving 75% yield as well as excellent e.r. (96.7:3.3) for 
Terikalant (Figure 4.5a), a significant improvement over the current synthesis utilizing chiral 
resolution.12 A highly enantioselective synthesis of (R)-Tolterodine was then demonstrated in 
Figure 4.5b.13–15 The (E)-vinyl bromide 6, prepared from trans-cinnamyl chloride,16 was coupled 
with aryl boronic acid 7 to afford the diastereopure (Z)-allylic amine 8 in 91% yield. A sequential 
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addition of catalyst, hydrogen donor, and strong acid afforded the desired (R)-Tolterodine in 88% 
overall yield and 96.0:4.0 e.r. Although diisopropylamine was not a sufficient nucleophile to 
perform the enamine exchange with the diethyl enamine, the isomerization of allylic 
diisopropylamine 8 also proceeds in a highly enantioselective fashion. It is worth noting that the 
reaction was carried out on the 1.0 mmol scale with half the catalyst loading compared to the 
aminations performed on the smaller scale. Compared to state-of-the-art Tolterodine synthesis, 
which requires the ortho-hydroxyl substituent to direct the asymmetric hydrogenation,15 our 
method allows for a modular and rapid synthesis of Tolterodine derivatives, including those 
without the ortho-hydroxyl functionality (5g-i). 
 
Figure 4.4. Synthetic application of rhodium-catalyzed asymmetric reductive amination of allylamines. a, 
Enantioselective synthesis of Terikalant from allylic diethylamine 4k. b, Enantioselective and modular synthesis of 






4.5 Investigating Reaction Selectivity 
To gain insight into the overall selectivity of this tandem process, a series of control 
reactions were carried out under optimized conditions (Figure 4.5a-d). The selectivity of the 
enamine exchange step was first investigated. In general, less sterically hindered amine 
nucleophiles (compared to diethylamine) led to higher selectivity of desired product enamine 9 
over the diethylenamine 10a (Figure 4.5a). For sterically similar dibutylamine and dibenzylamine, 
9 was found to be the major product, presumably due to a combination of the relative amine 
volatilities, stoichiometry of the reaction, and enamine stability. When equimolar amounts of 
nucleophile and substrate were subjected to the reaction conditions, similar product distributions 
were observed regardless of the permutation of allylic amine versus nucleophile (Figure 4.5b). 
This implies that the exchanging product distribution is controlled by a thermodynamic 
equilibrium under standard reaction conditions. When the nucleophiles and hydrogen donor were 
added simultaneously into the reaction after the isomerization step (Figure 4.5c), the observed 
selectivities are similar to those shown in Figure 4.6a, indicating that the exchange step is faster 
than the reduction. Finally, various secondary amine nucleophiles were studied under standard 
conditions (Figure 4.5d). Higher selectivities were observed compared to those in Figure 4.5a, 
implying that the reduction of desired enamine intermediates is faster than the diethylenamine 10a. 
Therefore, the chemoselectivity of this two-step one-pot reaction comes from both steps, favoring 
the desired product. A proposed mechanism is shown in Figure 4.6: the basic nitrogen atom of the 
allylic amine substrate coordinates to the cationic rhodium to form A, followed by β-hydride 
elimination and re-insertion of in situ generated conjugated iminium B to afford the chiral enamine 
C. A thermally controlled enamine exchange leads to D, which then undergoes subsequent transfer 




Figure 4.5. Control experiments and proposed catalytic cycles. a, Selectivity of the enamine exchange step. b, 
Thermodynamic equilibrium for the enamine exchange. c, Selectivity of the transfer hydrogenation step (simultaneous 
addition of amine and hydrogen donor). d, Chemoselectivity for various secondary amine nucleophiles under standard 
conditions. e, Proposed catalytic cycles: enantioselective isomerization and transfer hydrogenation, X=BAr4F. 
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mechanism is proposed, as lower conversion was observed in the absence of metal catalyst when 
investigating the reduction of pre-made enamine. An in situ formed rhodium formate species F 
can undergo decarboxylation to generate Rh hydride species G.17,18 Subsequent iminium E inserts 
into Rh–H G to give the desired chiral γ-branched amine and regenerate rhodium formate F. 
 
 
Figure 4.6. Proposed reaction mechanism. 
 
4.6 Conclusion 
We have developed conditions for a highly enantioselective, modular synthesis of chiral γ-
branched amines. This method enables a rapid assembly of various stereocenters as well as amine 
functionalities via a tandem isomerization–enamine exchange–transfer hydrogenation process. 
Stereocenters bearing diaryl, cyclic, fluoroalkyl and silyl substituents are established using same 





4.7 Supporting Information 
4.7.1 Direct asymmetric synthesis of γ-branched amines  
[Rh(COD)Cl]2 (2.0 mg, 1.5 mol %), (R)-BINAP (4.5 mg, 3.0 mol %), NaBAr4
F (6.4 mg, , 
3.0 mol %), and THF (0.2 mL) were added to a oven-dried 4 mL vial equipped with a stir bar in 
the glove box under nitrogen atmosphere. To the vial was added sequentially allylic diethylamine 
(1, 0.24 mmol, 1.0 equiv), and secondary amine (2, 0.29 mmol, 1.2 equiv). The resulting solution 
was allowed to stir for 22 h at 40 °C (unless otherwise noted). After 22 h, formic acid (0.36 mmol, 
3.0 equiv) was added into reaction vial via syringe and the reaction was allowed to stir for another 
2 h at 60 °C (unless otherwise noted). The reaction crude was quenched by the addition of DCM, 
concentrated in vacuo and then purified by basic alumina chromatography to afford the desired 
product 3. 
 
4.7.2 General procedure for trisubstituted allylic amine synthesis 
Allylic diethylamine substrates 1a-1e, 4a, 4b, 4d, 4f, 4i, 4k were synthesized according to our 
previous report. The 1H and 13C NMRs are marched with literature.19 
Allylic diethylamine substrates 4c and 4e were synthesized by following method, modified from 
our previous report.19 
 
Procedure: To a dry 100 mL schlenk flask was charged with a stir bar and 0.292 g Cp2ZrCl2 (1 
mmol, 20 mmol %), purged with nitrogen followed by the addition of 25 mL DCM. Cooled to -10 
°C, 7.5 mL 2 M AlMe3/hexanes solution (15 mmol, 3.0 equiv) was added slowly. The reaction 
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was allowed to stir at -10 °C for 15 min followed by the slow addition of 168 L H2O (8.2 mmol, 
1.65 equiv). The resµting mixture was stirred vigorously at -10 °C for 20 min then added the alkyne 
(5 mmol, 1.0 equiv). The reaction flask was then was then warmed up to rt and stir overnight. A 
solution of the iminium chloride salt (10 mmol, 2 equiv) in 5 mL dry DCM was added slowly to 
the flask at 0 °C, then reaction was warmed up to rt and stir for another 3 hrs . The reaction is 
quenched by careful addition of 2 M NaOH solution at 0 °C, then filtered through ceilite and 
washed with warm DCM. The resulting mixture was then extract by DCM three time and combined 
organic layers were dried by Na2SO4, concentrated in vacuo, and distilled under vacuum to afford 
desired allylic diethylamines.  
 
4.7.3 Synthesis and Characterization of Allylic Amines 
 (E)-3-(5-bromo-2-fluorophenyl)-N,N-diethylbut-2-en-1-amine (4c), 
prepared according to previously described procedure in 60% yield. 
1H NMR (500 MHz, CDCl3) δ: 7.36 (dd, J = 6.8, 2.6 Hz, 1H), 7.30 (ddd, J 
= 8.7, 4.3, 2.6 Hz, 1H), 6.90 (dd, J = 10.2, 8.7 Hz, 1H), 5.73 (t, J = 6.6 Hz, 1H), 3.25 (d, J = 6.6 
Hz, 2H), 2.58 (q, J = 7.2 Hz, 4H), 2.01 (s, 3H), 1.07 (t, J = 7.1 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 159.06 (d, J = 247.5 Hz), 134.53 (d, J = 15.7 Hz), 132.48 (d, J = 
4.6 Hz), 132.32 , 131.08 (d, J = 8.4 Hz), 130.28 , 117.57 (d, J = 24.6 Hz), 116.46 (d, J = 3.4 Hz), 
50.92 , 47.20 , 17.20 (d, J = 3.8 Hz), 12.09. 
 
 (E)-3-cyclopropyl-N,N-diethylbut-2-en-1-amine (4e), prepared according 







1H NMR (500 MHz, CDCl3) δ: 5.29 (t, J = 6.8 Hz, 3H), 3.05 (d, J = 6.8 Hz, 2H), 2.49 (q, J = 7.2 
Hz, 4H), 1.54 (s, 3H), 1.42 – 1.33 (m, 1H), 1.02 (t, J = 7.2 Hz, 6H), 0.57 – 0.51 (m, 2H), 0.46 – 
0.42 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ: 138.44, 120.19, 50.66, 46.81, 19.01, 14.54, 11.91, 4.61. 
 
Allylic diethylamine substrate 4g was synthesized by following method20 and the starting vinyl 
bromide was synthesized according to our previous report19 and literature.20 
 
Procedure: To a 50 ml round bottom flask was charged with a stir bar and 11 mg Pd(OAc)2 (0.050 
mmol, 1.0 mol %), 26 mg PPh3 (0.10 mmol, 2.0 mol %), 0.560 g KOH (10 mmol, 2.0 equiv), 
starting material vinyl bromide (1.34g, 5 mmol, 1.0 equiv) ,0.880 g 4-methyl boronic acid (6.5 
mmol, 1.3 equiv) and 5 mL THF and 5 mL MeOH. The reaction was stirred at rt overnight followed 
by dilution with EtOAc, and washed by 1 N NaOH solution and brine. The organic layer was then 
dried over MgSO4, concentrated in vacuo, purified by Al2O3 column chromatography: 200 g Al2O3 
+ 12 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% MeOH as eluent.  
 
 (E)-N,N-diethyl-3-phenyl-3-(p-tolyl)prop-2-en-1-amine (4g), 
prepared according to previously described procedure in 70% yield. 
1H NMR (500 MHz, CDCl3) δ:  7.40 – 7.34 (m, 2H), 7.33 – 7.28 (m, 
1H), 7.20 – 7.12 (m, 4H), 7.11 – 7.05 (m, 2H), 6.19 (t, J = 6.7 Hz, 1H), 3.15 (d, J = 6.7 Hz, 2H), 




13C NMR (125 MHz, CDCl3) δ: 143.23, 140.11, 139.65, 137.01, 129.97, 128.96, 128.21, 127.27, 
127.15, 126.55, 51.86, 47.13, 21.20, 11.96. 
 
The cyclic allylic diethylamine substrates 4j and 4l were synthesized by following method21 and 
the starting diethyl (2-(diethylamino)-2-oxoethyl) phosphonate was synthesized according to our 
previous report19 and literature.21 
 
Olefination: A dry 100mL round-bottom flask was charged with a stir bar and 0.48g NaH (60 wt 
%, 12 mmol, 1.2 equiv), purged with nitrogen followed by the addition of 15 mL toluene. Cooled 
to 0 °C, diethyl (2-(diethylamino)-2-oxoethyl)phosphonate was added dropwise (2.8 mL, 12 
mmol, 1.2 equiv). The reaction was allowed to stir at 0 °C for 30 min until the solution become 
clear. Ketone was added dropwise (10 mmol, 1.0 equiv) to the reaction over 5 min, then warmed 
up to 80 °C, stirring overnight. The reaction was quenched with sat. NH4Cl solution, and the 
aqueous layer was extracted with DCM three times. The combined organic layers were dried over 
MgSO4, and purified by silica column chromatography.  
Reduction: To a dry 20 mL round-bottom flask was charged with a stir bar, purged with N2 three 
times, followed by the addition of unsaturated amide (4.0 mmol), dry THF (3 mL) and dry toluene 
(6 mL, V(tol)/V(THF)=2). The flask was then cooled in ice bath, and added RedAl solution (2.0 
equiv, 3.5 M) dropwised. The reaction was allowed to stir at 0 °C for 2 hours then warmed up to 
rt for another 4 hours. The reaction crude was cooled in ice bath and quenched by the addition of 
10 mL 5 M NaOH solution and 20 mL toluene. After stirring for 30 minutes, the crude was 
transferred to a separatory funnel. Organic layer was separated, washed by 5 M NaOH solution 
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prepared according to previously described procedure at 25% overall yield.  
1H NMR (500 MHz, CDCl3) δ: 7.51 – 7.44 (m, 1H), 7.25 – 7.23 (m, 1H), 
7.21 – 7.14 (m, 2H), 6.05 (ddd, J = 7.0, 4.3, 2.6 Hz, 1H), 3.25 (d, J = 6.8 Hz, 2H), 3.06 – 2.90 
(m, 2H), 2.80 – 2.71 (m, 2H), 2.58 (q, J = 7.2 Hz, 4H), 1.07 (t, J = 7.2 Hz, 6H).  
13C NMR (125 MHz, CDCl3) δ: 146.06, 144.18, 141.52, 127.87, 126.57, 125.38, 120.33, 116.74, 
52.33, 47.08, 30.28, 28.12, 12.04. 
 
(Z)-N,N-diethyl-2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-
ylidene)ethan-1-amine (4l), prepared according to previously described 
procedure at 46% overall yield.  
1H NMR (500 MHz, CDCl3) δ: 7.17 – 7.09 (m, 3H), 7.02 – 6.97 (m, 1H), 
5.64 (t, J = 6.8 Hz, 1H), 3.00 (d, J = 6.8 Hz, 2H), 2.77 – 2.67 (m, 2H), 2.47 (q, J = 7.1 Hz, 4H), 
2.33 – 2.24 (m, 2H), 1.85 (p, J = 5.9 Hz, 2H), 1.72 – 1.61 (m, 2H), 0.92 (t, J = 7.1 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 145.62, 141.73, 141.18, 129.12, 128.98, 126.92, 125.59, 124.99, 
51.08, 46.81, 38.10, 36.63, 33.30, 27.87, 11.76.ppm. 
 
The (E)-selective β-CF3 or CF2H substituted allylic diethylamine substrates 4m, 4o, and 4p were 










Olefination: A dry 100mL round-bottom flask was charged with a stir bar and 0.60 g NaH (60 wt 
%, 15 mmol, 1.5 equiv), purged with nitrogen followed by the addition of 30 mL THF. Cooled to 
0 °C, ethyl 2-(diethoxyphosphoryl)acetate was added dropwise (3.0 mL, 15 mmol, 1.5 equiv). The 
reaction was allowed to stir at 0 °C for 30 min until the solution become clear. Fluoroakyl ketone 
was added dropwise (10 mmol, 1.0 equiv) to the reaction over 5 min, then warmed up to 50 °C, 
stirring overnight. The reaction was quenched with sat. NH4Cl solution, and the aqueous layer was 
extracted with DCM three times. The combined organic layers were dried over MgSO4, 
concentrated in vacuo and purified by silica column chromatography to affored (E)-RF-substituted 
allylic ester. (Yields: 60% to 80% for desired isomer) 
Reduction: To a dry 250 mL round-bottom flask was charged with a stir bar, purged with N2 three 
times, followed by the addition of unsaturated ester (4.8 mmol), dry THF (24 mL). The flask was 
then cooled in ice bath, then added DIBAL-H solution (2.5 equiv, 1 M in hexanes) dropwise. The 
reaction was allowed to stir at 0 °C for 2 hours then quenched by the addition of 10 mL sat. 
Rochelle salt solution. After stirring at rt overnight, the crude was extracted with Et2O three times, 
combined organic lay dried over MgSO4, concentrated in vacuo and used for next step without 
further purification.  
Chlorination: To a dry 50 mL round-bottom flask was charged with a stir bar, purged with N2 
three times, followed by the addition of allylic alcohol (4.6 mmol), dry DCM (20 mL), and 1.9 mL 
Et3 N (13.8 mmol, 3.0 equiv). The flask was then cooled in ice bath, then added MeSO2Cl (13.8 
mmol, 3.0 equiv) dropwise. The reaction was allowed to stir at 0 °C for 5 hours followed by the 
addition of another 2.0 equiv of MeSO2Cl. The resulting mixture was then warmed up to rt, and 
stirred overnight. The reaction crude was diluted in DCM, washed sequentially with 1 N HCl 
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solution, sat. NaHCO3 solution and brine. The organic layer was then dried over MgSO4, 
concentrated in vacuo and purified by silica column chromatography to affored the corresponding 
allylic chloride. (Yield: 85% to 95%, two steps) 
SN2: To a dry 50 mL round-bottom flask was charged with a stir bar, allylic chloride (4.0 mmol), 
HNEt2 (6.0 mmol, 1.5 equiv), K2CO3 (10 mmol, 2.5 equiv), and 22 mL acetone. The reaction 
mixture was then refluxed under N2 at 70 °C overnight. The reaction crude was then filtered 
through celite, concentrated in vacuo to remove solvent, re-diluted in Et2O, extracted with 1 N HCl 
three time. The aqueous layer was then basified by the addition of 3 N NaOH solution, (pH>11) 
and extracted with DCM three times. The combined DCM layers were MgSO4, concentrated in 
vacuo and distilled under vacuum to afford the desired allylic amines (Yields: 82% to 88%) 
 
(E)-N,N-diethyl-4,4,4-trifluoro-3-phenylbut-2-en-1-amine (4m), 
prepared according to previously described procedure.  
1H NMR (500 MHz, CDCl3) δ: 7.44 – 7.36 (m, 3H), 7.25 – 7.21 (m, 2H), 
6.55 (ddt, J = 6.6, 5.0, 1.6 Hz, 1H), 3.13 – 2.94 (m, 2H), 2.46 (q, J = 7.1 Hz, 4H), 0.95 (t, J = 7.1 
Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 134.83 (q, J = 5.3 Hz), 132.38 (q, J = 29.7 Hz), 132.04, 129.52, 
128.57, 128.40, 123.22 (q, J = 273.2 Hz), 50.39, 47.12, 11.81. 
19F NMR (471 MHz, CDCl3) δ -65.91 (d, J = 1.9 Hz).  
 
(E)-3-benzyl-N,N-diethyl-4,4,4-trifluorobut-2-en-1-amine (4o), prepared 












1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.27 (m, 2H), 7.24 – 7.20 (m, 1H), 7.19 – 7.16 (m, 2H), 
6.45 (t, J = 6.2 Hz, 1H), 3.60 (s, 2H), 3.18 (dq, J = 5.1, 2.4 Hz, 2H), 2.49 (q, J = 7.1 Hz, 4H), 
1.00 (t, J = 7.1 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 137.92, 135.13 (q, J = 5.8 Hz), 129.40 (q, J = 28.6 Hz), 128.77, 
128.33, 126.71, 124.30 (q, J = 273.4 Hz), 50.52, 47.45, 31.89, 12.11. 
19F NMR (471 MHz, CDCl3) δ: -67.01 (d, J = 2.2 Hz). 
 
(E)-3-benzyl-N,N-diethyl-4,4-difluorobut-2-en-1-amine (4p), prepared 
according to previously described procedure.  
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.26 (m, 2H), 7.22 – 7.17 (m, 3H), 
6.10 – 6.05 (m, 1H), 5.99 (t, J = 56.1 Hz, 1H), 3.57 (s, 2H), 3.17 (dt, J = 6.8, 3.7 Hz, 2H), 2.49 
(q, J = 7.1 Hz, 3H), 1.00 (t, J = 7.2 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 138.58, 134.22 (t, J = 9.9 Hz), 133.73 (t, J = 20.5 Hz), 128.63, 
128.51, 126.41, 117.00 (t, J = 237.6 Hz), 50.37, 47.25, 31.10 (t, J = 1.8 Hz), 11.96. 
19F NMR (471 MHz, CDCl3) δ:  -114.38 (d, J = 55.8 Hz).  
The (Z)-selective β-CF3 substituted allylic diethylamine substrates 4n was synthesized by 
following method.23  
 
Olefination: A dry 50 mL round-bottom flask was charged with a stir bar and 1.76 g KHMDS (8.8 
mmol, 1.1 equiv) and 2.56 g 18-crown-6 (9.6 mmol, 1.2 equiv) purged with nitrogen followed by 
the addition of 15 mL THF. Cooled to -78 °C, ethyl 2-(bis(2,2,2-
trifluoroethoxy)phosphoryl)acetate was added dropwise (8.8 mmol, 1.1 equiv). The reaction was 







1.0 equiv) to the reaction, stirred at -78 °C for another 3 h then warmed up to rt, quenched with 
sat. NH4Cl solution, and the aqueous layer was extracted with DCM three times. The combined 
organic layers were dried over MgSO4, concentrated in vacuo and purified by silica column 
chromatography to affored (Z)-RF-substituted allylic ester at 58% yield. 
Reduction, Chlorination, and SN2 were carried out under same conditions as described above.  
 
(Z)-N,N-diethyl-4,4,4-trifluoro-3-phenylbut-2-en-1-amine (4n), prepared 
according to previously described procedure. Purity: Z/E=22:1. 
1H NMR (500 MHz, CDCl3) δ: δ 7.42 – 7.30 (m, 5H), 6.19 (td, J = 6.2, 0.9 
Hz, 1H), 3.49 (dq, J = 5.8, 2.8 Hz, 2H), 2.58 (q, J = 7.1 Hz, 4H), 1.07 (t, J = 7.1 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 140.93 (q, J = 2.8 Hz), 136.28 (q, J = 1.8 Hz), 132.15 (q, J = 
30.5 Hz), 128.41, 128.29, 128.15, 124.03 (q, J = 275.7 Hz), 51.29 (q, J = 2.4 Hz), 47.49, 12.09. 
19F NMR (471 MHz, CDCl3) δ: -57.30 (d, J = 3.1 Hz).  
 
 
β-Silyl substituted allylic diethylamine substrate 4q was synthesized by following method, 
modified from literature.24 
 
Hydroalumination:6 To a dry 100 mL schlenk flask was charged with a stir bar, purged with N2 
three times, followed by the addition of dry THF (30 mL) and 2.8 mL RedAl solution (8.5 mmol, 
1.7 equiv). The flask was then cooled in ice bath, then added 5 mL THF solution of 3-phenyl-2-







for 4 hours. Then, the reaction flask was then cooled to –10 °C followed by the slow addition of 
2.0 mL EtOAc to quench excess Red-Al then stirred at -10 °C for another 15 min. The resulting 
mixture was then cooled to –78 °C, followed by the addition of I2 (10 mmol, 2.0 equiv) in one 
portion under nitrogen flow. The reaction crude was then allowed to stir at –78 °C for another hour 
before being quenched by 15 mL sat. Rochelle salt solution and 25 mL sat. Na2S2O3 solution at 0 
°C. The biphasic mixture was then stirred vigorously at rt overnight, and extracted by Et2O three 
times. The combined organic layer was then dried over MgSO4, concentrated in vacuo and used 
for next step without further purification. 
Chlorination and SN2 were carried out under same conditions as described above. 
Vinyl silane synthesis: To a dry 200 mL schlenk flask was charged with a stir bar, purged with 
N2 three times, followed by the addition of dry THF (25 mL) and starting vinyl iodine (5.0 mmol, 
1.0 equiv). The flask was then cooled to –78 °C, followed by the slow addition of nBuLi (12 mmol, 
2.4 equiv) over 10 min. The resulting crude was allowed to stir at –78 °C for another 30 min, before 
the addition of chloro(dimethyl)phenylsilane (15 mmol, 3.0 equiv). The resulting mixture was 
allowed to stir at –78 °C for another 2 hours followed by being quenched with sat. NaHCO3 
solution, extracted by Et2O three times. The combined organic layer was then dried over MgSO4, 
concentrated in vacuo and further purified by Al2O3 column chromatography. 
 
(Z)-3-(dimethyl(phenyl)silyl)-N,N-diethyl-3-phenylprop-2-en-1-amine 
(4q), prepared according to previously described procedure.  
1H NMR (500 MHz, CDCl3) δ: δ 7.62 – 7.55 (m, 2H), 7.35 (dd, J = 4.8, 1.9 
Hz, 3H), 7.29 – 7.23 (m, 2H), 7.21 – 7.14 (m, 1H), 7.12 – 7.05 (m, 2H), 6.33 (t, J = 6.3 Hz, 1H), 







13C NMR (125 MHz, CDCl3) δ: 146.66, 146.50, 142.37, 139.34, 133.99, 129.11, 128.02, 127.97, 
127.72, 125.73, 54.79, 46.89, 12.04, -0.34. 
 
4.7.4 General procedure for Rh-catalyzed reductive amination of allylic diethylamine with 
secondary amine nucleophiles (General procedure A) 
 
General procedure A: [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), NaBAr4
F (6.4 mg, 0.0072 mmol, 3.0 mol %), and THF (0.2 mL) were 
added to a 4 mL vial equipped with a stir bar in the glove box under nitrogen atmosphere. To the 
vial was added sequentially allylic diethylamine (1, 0.24 mmol, 1.0 equiv), and secondary amine 
(2, 0.29 mmol, 1.2 equiv). The resulting solution was allowed to stir for 22 h at 40 °C (unless 
otherwise noted). After 22 h, formic acid (0.36 mmol, 3.0 equiv) was added into reaction vial via 
syringe and the reaction was allowed to stir for another 2 h at 60 °C (unless otherwise noted). The 
reaction crude was quenched by the addition of DCM, concentrated in vacuo and then purified by 
basic alumina chromatography to afford the desired product 3. 
 
General procedure for Rh-catalyzed reductive amination of allylic diethylamine with aryl 




General procedure B: [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), NaBAr4
F (6.4 mg, 0.0072 mmol, 3.0 mol %), and THF (0.2 mL) were 
added to a 4 mL vial equipped with a stir bar in the glove box under nitrogen atmosphere. To the 
vial was added sequentially allylic diethylamine (1, 0.24 mmol, 1.0 equiv), and aryl amine (2, 0.29 
mmol, 1.2 equiv). The resulting solution was allowed to stir for 22 h at 40 °C (unless otherwise 
noted). After 22 h, the reaction vial was cooled to 0 °C followed by the addition of NaBH4 (0.18 
mmol, 1.5 equiv) and 1.0 ml MeOH. The resulting mixture was allowed to stir at 0 °C for 1 h then 
warmed up to rt for another 1 h. The crude reaction was quenched by the addition of DCM, 
concentrated in vacuo and then re-dissolved in DCM, washed with sat. NaHCO3 solution. The 
organic layer was dried over MgSO4, concentrated in vacuo, and purified by silica gel 
chromatography to afford the desired product 3. 
 
General procedure for Rh-catalyzed reductive amination of allylic diethylamine with 
primary alkyl amine nucleophiles (General procedure C) 
 
General procedure C: [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (R)-BINAP (4.5 mg, 
0.0072 mmol, 3.0 mol %), NaBAr4
F (6.4 mg, 0.0072 mmol, 3.0 mol %), THF (0.2 mL), and allylic 
diethylamine (1, 0.24 mmol, 1.0 equiv) were added to a 4 mL vial equipped with a stir bar in the 
glove box under nitrogen atmosphere. The resulting solution was allowed to stir for 6 h at 40 °C 
(unless otherwise noted), followed by the addition of primary alkyl amine (2, 0.29 mmol, 1.2 
equiv) then continued stirring at 60 °C for another 12 h. After 12 h, the reaction vial was cooled 
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to 0 °C followed by the addition of NaBH4 (0.18 mmol, 1.5 equiv) and 1.0 ml MeOH. The resulting 
mixture was allowed to stir at 0 °C for 1 h then warmed up to rt for another 1 h. The reaction crude 
was then quenched by the addition of DCM, concentrated in vacuo and then re-dissolved in DCM, 
washed with sat. NaHCO3 solution. The organic layer was dried over MgSO4, concentrated in 
vacuo, and purified by basic alumina chromatography to afford the desired product 3. 
 
4.7.5 Characterization of Final Compounds 
(S)-4-(3,7-dimethyloct-6-en-1-yl)morpholine (3a): Prepared according to 
General procedure A from geranyl diethyl amine (1a) with morpholine (2a) 
in 80% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 5.09 (t, J = 7.1 Hz, 1H), 3.71 (t, J = 4.7 Hz, 4H), 2.49 – 2.39 (m, 
4H), 2.40 – 2.26 (m, 2H), 2.08 – 1.87 (m, 2H), 1.68 (s, 3H), 1.60 (s, 3H), 1.52 (ddt, J = 12.5, 10.3, 
5.5 Hz, 1H), 1.48 – 1.40 (m, 1H), 1.37 – 1.27 (m, 2H), 1.17 (m, 1H), 0.89 (d, J = 6.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 131.33, 124.93, 67.19, 57.41, 54.07, 37.37, 33.72, 31.19, 25.86, 
25.62, 19.86, 17.80. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H28NO, 226.2171; found, 226.2175.  
 
tert-butyl (S)-4-(3,7-dimethyloct-6-en-1-yl)piperazine-1-carboxylate 
(3b): Prepared according to General procedure A from geranyl diethyl 

















Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH as eluent.  
1H NMR (500 MHz, CDCl3) δ: 5.08 (t, J = 7.0 Hz, 1H), 3.43 (m, 4H), 2.46 – 2.22 (m, 6H), 2.09 – 
1.85 (m, 2H), 1.68 (s, 3H), 1.59 (s, 3H), 1.55 – 1.49 (m, 2H), 1.45 (s, 9H), 1.31 (m, 2H), 1.22 – 
1.10 (m, 1H), 0.88 (d, J = 6.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 154.91, 131.34, 124.91, 79.68, 56.98, 53.31, 37.35, 33.94, 31.20, 
28.58, 25.86, 25.61, 19.84, 17.80.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H37N2O2, 325.2855; found, 325.2850.  
Nucleophiles 2c and 2d were observed to slow down the isomerization of allylic amine 1a, 




(3c): Prepared according to modified General procedure A from geranyl 
diethyl amine (1a) with 1,2,3,4-tetrahydroisoquinoline (2c) in 66% 
isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 30 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.16 – 7.07 (m, 3H), 7.05 – 6.97 (m, 1H), 5.11 (t, J = 6.9 Hz, 1H), 









2.10 – 1.88 (m, 2H), 1.69 (s, 3H), 1.67 – 1.63 (m, 1H), 1.61 (s, 3H), 1.55 – 1.48 (m, 1H), 1.46 – 
1.32 (m, 2H), 1.24 – 1.15 (m, 1H), 0.93 (d, J = 6.6 Hz, 3H).. 
13C NMR (125 MHz, CDCl3) δ: 135.09, 134.53, 131.30, 128.76, 126.73, 126.17, 125.66, 125.00, 
56.73, 56.49, 51.25, 37.44, 34.39, 31.27, 29.30, 25.88, 25.66, 19.91, 17.82. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H30N, 272.2378; found, 272.2377.  
 
(S)-2-(4-(3,7-dimethyloct-6-en-1-yl)piperazin-1-yl)pyrimidine 
(3d): Prepared according to modified General procedure A from 
geranyl diethyl amine (1a) with 2-(piperazin-1-yl)pyrimidine (2d) in 
83% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.30 (d, J = 4.7 Hz, 2H), 6.47 (t, J = 4.7 Hz, 1H), 5.09 (t, J = 7.0 
Hz, 1H), 3.92 – 3.76 (br, 4H), 2.54 – 2.45 (br, 4H), 2.44 – 2.30 (m, 2H), 2.09 – 1.87 (m, 2H), 1.68 
(s, 3H), 1.60 (s, 3H), 1.58 – 1.53 (m, 1H), 1.51 – 1.43 (m, 1H), 1.39 – 1.29 (m, 2H), 1.22 – 1.13 
(m, 1H), 0.90 (d, J = 6.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 161.83, 157.83, 131.34, 124.93, 190.91 57.10, 53.41, 43.84, 
37.37, 34.01, 31.27, 25.87, 25.63, 19.87, 17.81.  













(S)-N,N-diethyl-3,7-dimethyloct-6-en-1-amine (3e): Prepared according 
to General procedure A from geranyl diethyl amine (1a) without any 
nucleophilic amine added in 83% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 5.09 (t, J = 7.1 Hz, 1H), 2.51 (q, J = 7.1, 4H), 2.46 – 2.36 (m, 2H), 
1.97 (qq, J = 14.5, 7.1 Hz, 2H), 1.67 (d, J = 1.6 Hz, 3H), 1.59 (s, 3H), 1.53 – 1.38 (m, 2H), 1.36 – 
1.21 (m, 2H), 1.16 (m, 1H), 1.01 (t, J = 7.1 Hz, 6H), 0.88 (d, J = 6.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 131.21, 125.05, 50.97, 47.05, 37.44, 34.01, 31.31, 25.87, 25.66, 
19.90, 17.77, 11.84. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H30N, 212.2378; found, 212.2385.  
 
(S)-N,N-dibenzyl-3,7-dimethyloct-6-en-1-amine (3f): Prepared according 
to General procedure A from geranyl diethyl amine (1a) with dibenzylamine 
(2f) in 70% isolated yield.  
Column Chromatography Condition: silica gel, 20 : 1 hexanes/ EtOAc as 
eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.39 – 7.34 (m, 4H), 7.33 – 7.28 (m, 4H), 7.24 – 7.18 (m, 2H), 
5.06 (tq, J = 7.1, 1.4 Hz, 1H), 3.58 (d, J = 13.7 Hz, 2H), 3.50 (d, J = 13.7 Hz, 2H), 2.43 (t, J = 7.3 
Hz, 2H), 2.04 – 1.83 (m, 2H), 1.67 (brs, 3H), 1.57 (brs, 4H, overlap), 1.52 – 1.42 (m, 1H), 1.37 – 
1.27 (m, 1H), 1.27 – 1.17 (m, 1H), 1.13 – 1.00 (m, 1H), 0.76 (d, J = 6.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 140.17, 131.13, 128.93, 128.24, 126.83, 125.08, 58.42, 51.44, 


















HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H34N, 336.2691; found, 336.2695.  
 
(R)-N-methyl-3-phenyl-N-((S)-1-phenylethyl)butan-1-amine (3g): 
Prepared according to General procedure A from (E)-N,N-diethyl-3-
phenylbut-2-en-1-amine (1b) with (S)-N-methyl-1-phenylethan-1-amine 
(2g) and (R)-BNIAP as ligand in 64% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 30 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δδ 7.31 – 7.23 (m, 5H), 7.23 – 7.19 (m, 2H), 7.19 – 7.12 (m, 3H), 
3.52 (q, J = 6.8 Hz, 1H), 2.70 (h, J = 7.1 Hz, 1H), 2.38 (ddd, J = 12.6, 9.4, 6.0 Hz, 1H), 2.18 (ddd, 
J = 12.5, 9.3, 5.3 Hz, 1H), 2.13 (s, 3H), 1.79 (dddd, J = 13.3, 9.4, 8.0, 5.3 Hz, 1H), 1.71 (ddt, J = 
13.4, 9.3, 6.2 Hz, 1H), 1.30 (d, J = 6.8 Hz, 3H), 1.20 (d, J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 147.74, 144.08, 128.42, 128.16, 127.82, 127.08, 126.77, 125.94, 
63.22, 52.72, 38.47, 37.96, 35.76, 22.66, 18.24. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H26N, 268.2065; found, 268.2073.  
 
(S)-N-methyl-3-phenyl-N-((S)-1-phenylethyl)butan-1-amine (3g’): 
Prepared according to General procedure A from (E)-N,N-diethyl-3-
phenylbut-2-en-1-amine (1b) with (S)-N-methyl-1-phenylethan-1-amine 
(2g) and (S)-BNIAP as ligand in 60% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 





















1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.26 (m, 3H), 7.25 – 7.18 (m, 4H), 7.17 – 7.11 (m, 3H), 
3.49 (q, J = 6.7 Hz, 1H), 2.70 (h, J = 7.0 Hz, 1H), 2.36 – 2.20 (m, 2H), 2.12 (s, 3H), 1.81 – 1.67 
(m, 2H), 1.26 (d, J = 6.8 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 147.77, 144.23, 128.41, 128.19, 127.80, 127.07, 126.79, 125.93, 
63.34, 52.58, 38.60, 37.79, 35.65, 22.48, 18.55.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H26N, 268.2065; found, 268.2066.  
 
(S)-N-(3,7-dimethyloct-6-en-1-yl)aniline (3h): Prepared according to 
General procedure B from geranyl diethyl amine (1a) with aniline (2h) in 
81% isolated yield.  
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc 
as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.22 – 7.11 (m, 2H), 6.75 – 6.66 (m, 1H), 6.64 – 6.58 (m, 2H), 
5.11 (t, J = 7.0 Hz, 1H), 3.60 (brs, 1H), 3.26 – 3.00 (m, 2H), 2.12 – 1.91 (m, 2H), 1.70 (s, 3H), 
1.68 – 1.63 (m, 1H), 1.61 (s, 3H), 1.59 – 1.54 (m, 1H), 1.49 – 1.34 (m, 2H), 1.28 – 1.17 (m, 1H), 
0.95 (d, J = 6.6 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 148.64, 131.49, 129.36, 124.79, 117.27, 112.87, 42.12, 37.24, 
36.84, 30.58, 25.88, 25.62, 19.75, 17.83.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H26N, 232.2065; found, 232.2064.  
 
(S)-N-(3,7-dimethyloct-6-en-1-yl)benzo[d][1,3]dioxol-5-amine (3i): 
Prepared according to General procedure B from geranyl diethyl amine 




















Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 6.65 (d, J = 8.2 Hz, 1H), 6.24 (d, J = 2.3 Hz, 1H), 6.04 (dd, J = 
8.3, 2.3 Hz, 1H), 5.85 (s, 2H), 5.12 (t, J = 7.0 Hz, 1H), 3.35 (brs, 1H), 3.15 – 2.91 (m, 2H), 2.13 – 
1.88 (m, 2H), 1.69 (s, 3H), 1.66 – 1.62 (m, 1H), 1.61 (s, 3H), 1.57 – 1.50 (m, 1H), 1.46 – 1.31 (m, 
2H), 1.28 – 1.14 (m, 1H), 0.94 (d, J = 6.5 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 148.46, 144.52, 139.55, 131.49, 124.78, 108.75, 104.44, 100.65, 
96.00, 43.15, 37.24, 36.85, 30.58, 25.88, 25.61, 19.75, 17.83. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO2, 276.1964; found, 276.1961.  
 
(S)-N-(3,7-dimethyloct-6-en-1-yl)-4-(trifluoromethyl)aniline (3j): 
Prepared according to General procedure B from geranyl diethyl amine 
(1a) with 4-trifluoro-methyl aniline (2j) in 61% isolated yield (as a 
mixture of 12:1 desired product and hydrogenated product). 
Column Chromatography Condition: silica gel, 99 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.32 (d, J = 8.6 Hz, 2H), 6.51 (d, J = 8.4 Hz, 2H), 5.05 – 4.99 
(m, 1H), 3.87 (brs, 1H), 3.21 – 2.84 (m, 2H), 2.06 – 1.80 (m, 2H), 1.62 (d, J = 1.3 Hz, 3H), 1.60 – 
1.55 (m, 1H), 1.53 (d, J = 1.4 Hz, 3H), 1.51 – 1.45 (m, 1H), 1.44 – 1.35 (m, 1H), 1.34 – 1.25 (m, 
1H), 1.17 – 1.10 (m, 1H), 0.88 (d, J = 6.6 Hz, 3H).. 
13C NMR (125 MHz, CDCl3) δ: 151.04, 131.72, 126.82 (q, J = 3.8 Hz), 125.28 (q, J = 270.2 Hz), 
124.75, 118.72 (q, J = 32.7 Hz), 111.92, 41.76, 37.26, 36.63, 30.59, 25.98, 25.69, 19.80, 17.93. 
19F NMR (471 MHz, CDCl3) δ: -61.30. 











(S)-N-benzyl-3,7-dimethyloct-6-en-1-amine (3k): Prepared according to 
General procedure C from geranyl diethyl amine (1a) with benzylamine (2k) 
in 70% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 20 : 1 
hexanes/ EtOAc with 0.5% MeOH to 10 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.30 (m, 4H), 7.26 – 7.21 (m, 1H), 5.09 (dddd, J = 7.1, 5.7, 
2.9, 1.4 Hz, 1H), 3.79 (s, 2H), 2.72 – 2.58 (m, 2H), 2.06 – 1.88 (m, 2H), 1.68 (d, J = 1.3 Hz, 3H), 
1.59 (s, 3H), 1.56 – 1.44 (m, 2H), 1.39 – 1.28 (m, 2H), 1.21 – 1.10 (m, 1H), 0.88 (d, J = 6.5 Hz, 
3H). 
13C NMR (125 MHz, CDCl3) δ: 140.70, 131.31, 128.51, 128.25, 127.00, 124.97, 54.35, 47.60, 
37.43, 37.38, 30.77, 25.87, 25.64, 19.78, 17.80.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H28N, 246.2222; found, 246.2228.  
 
(R)-N-((R)-1-cyclohexylethyl)-3-phenylbutan-1-amine (3l): 
Prepared according to General procedure C from (E)-N,N-diethyl-3-
phenylbut-2-en-1-amine (1b) with (R)-1-cyclohexylethan-1-amine (2l) 
in 61% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.32 – 7.27 (m, 2H), 7.22 – 7.15 (m, 3H), 2.77 (h, J = 7.1 Hz, 
1H), 2.63 – 2.53 (m, 1H), 2.42 – 2.29 (m, 2H), 1.80 – 1.68 (m, 4H), 1.67 – 1.57 (m, 3H), 1.25 (d, 

















13C NMR (125 MHz, CDCl3) δ: 147.49, 128.49, 127.07, 126.06, 57.93, 46.03, 43.12, 39.00, 38.35, 
30.07, 28.09, 26.92, 26.80, 26.66, 22.74, 16.87. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H30N, 260.2378; found, 260.2381.  
 
(R)-N-(tert-butyl)-3-phenylbutan-1-amine (3m): Prepared according to 
General procedure B from (E)-N,N-diethyl-3-phenylbut-2-en-1-amine (1b) 
with t-butylamine (2m) in 58% isolated yield.  
Column Chromatography Condition: silical gel, 30 : 1 hexanes/ EtOAc to 10 : 1 hexanes/ 
EtOAc as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.39 – 7.30 (m, 3H), 7.26 – 7.19 (m, 2H), 2.84 (h, J = 7.0 Hz, 1H), 
2.62 – 2.43 (m, 2H), 1.87 – 1.75 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H), 1.08 (s, 9H). 
13C NMR (125 MHz, CDCl3) δ: 147.38, 128.47, 127.07, 126.06, 50.34, 40.91, 39.60, 38.34, 29.16, 
22.80. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H24N, 206.1909; found, 206.1913.  
 
(S)-3,7-dimethyl-N-(2-morpholinoethyl)oct-6-en-1-amine (3n): 
Prepared according to General procedure C from geranyl diethyl amine 
(1a) with 2-morpholinoethan-1-amine (2n) in 66% isolated yield.  
Purification: No column chromatography needed. Reaction crude was concentrated to remove 
solvent then re-dissolve in Et2O followed by an acid/base extraction to afford the desired product 
3n. 
1H NMR (500 MHz, CDCl3) δ: δ 5.09 (ddt, J = 8.9, 7.2, 1.6 Hz, 1H), 3.93 – 3.48 (m, 4H), 2.71 (t, 


















(m, 4H), 1.96 (m, 2H), 1.81 (brs, 1H), 1.67 (d, J = 1.6 Hz, 3H), 1.59 (s, 3H), 1.57 – 1.44 (m, 2H), 
1.40 – 1.28 (m, 2H), 1.18 – 1.11 (m, 1H), 0.88 (d, J = 6.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 131.32, 124.92, 67.18, 58.42, 53.91, 48.14, 46.35, 37.36, 37.32, 
30.80, 25.86, 25.64, 19.74, 17.79. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H33 N2O, 269.2593; found, 269.2593. 
 
(R)-4-(3-phenylbutyl)morpholine (5a): Prepared according to General 
procedure A from (E)-N,N-diethyl-3-phenylbut-2-en-1-amine (4a) with 
morpholine (2a) in 77% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.27 (m, 2H), 7.22 – 7.15 (m, 3H), 3.69 (t, J = 4.7 Hz, 4H), 
2.75 (h, J = 7.1 Hz, 1H), 2.47 – 2.33 (m, 4H), 2.27 (ddd, J = 12.1, 8.5, 6.5 Hz, 1H), 2.19 (ddd, J = 
12.1, 8.6, 6.6 Hz, 1H), 1.83 – 1.73 (m, 2H), 1.26 (d, J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 147.30, 128.51, 127.08, 126.13, 67.18, 57.45, 53.94, 38.24, 35.18, 
22.64. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H22NO, 220.1701; found, 220.1706. 
(R)-4-(3-phenylheptyl)morpholine (5b): Prepared according to General 
procedure A from (E)-N,N-diethyl-3-phenylhept-2-en-1-amine (4b) with 
morpholine (2a) in 86% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 















1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.25 (m, 2H), 7.21 – 7.16 (m, 1H), 7.15 – 7.10 (m, 2H), 
3.68 (t, J = 4.7 Hz, 4H), 2.53 (tt, J = 9.7, 5.4 Hz, 1H), 2.43 – 2.29 (m, 4H), 2.21 (ddd, J = 12.1, 
10.2, 5.8 Hz, 1H), 2.10 (ddd, J = 12.1, 10.2, 4.9 Hz, 1H), 1.85 (ddt, J = 13.1, 10.5, 5.4 Hz, 1H), 
1.76 – 1.68 (m, 1H), 1.67 – 1.50 (m, 2H), 1.38 – 1.00 (m, 4H), 0.82 (t, J = 7.2 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 145.76, 128.41, 127.73, 126.08, 67.17, 57.46, 53.94, 44.27, 36.96, 
33.75, 29.89, 22.88, 14.15. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H28NO, 262.2171; found, 262.2177. 
 
(R)-4-(3-(5-bromo-2-fluorophenyl)butyl)morpholine (5c): Prepared 
according to General procedure A from (E)-3-(5-bromo-2-fluorophenyl)-
N,N-diethylbut-2-en-1-amine (4c) with morpholine (2a) in 74% isolated 
yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 (dd, J = 6.5, 2.5 Hz, 1H), 7.29 – 7.22 (m, 1H), 6.88 (dd, J = 
9.9, 8.6 Hz, 1H), 3.68 (t, J = 4.7 Hz, 4H), 3.08 (h, J = 7.0 Hz, 1H), 2.44 – 2.34 (m, 4H), 2.29 (ddd, 
J = 12.3, 9.2, 6.0 Hz, 1H), 2.22 (ddd, J = 12.2, 9.3, 5.9 Hz, 1H), 1.86 – 1.68 (m, 2H), 1.25 (d, J = 
6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 159.90 (d, J = 245.2 Hz), 136.23 (d, J = 16.3 Hz), 131.19 (d, J = 
5.4 Hz), 130.34 (d, J = 8.4 Hz), 117.31 (d, J = 24.8 Hz), 116.79 (d, J = 3.2 Hz), 67.11, 57.06, 53.87, 
33.80, 31.15, 31.14, 20.93. 











Prepared according to General procedure A from (E)-3-butyl-N,N-
diethyloct-2-en-1-amine (4d) with (S)-N-methyl-1-phenylethan-1-
amine (2g) in 61% isolated yield. [α]D
23 = -21.09 (c = 1.05) 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 
MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.29 (m, 4H), 7.24 – 7.20 (m, 1H), 3.55 (q, J = 6.7 Hz, 1H), 
2.40 (ddd, J = 12.5, 9.8, 6.0 Hz, 1H), 2.29 – 2.20 (m, 1H), 2.18 (s, 3H), 1.45 – 1.38 (m, 2H), 1.36 
(d, J = 6.8 Hz, 3H), 1.32 – 1.22 (m, 6H), 1.22 – 1.10 (m, 9H), 0.87 (t, J = 7.1 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 144.35, 128.19, 127.82, 126.81, 63.55, 52.39, 38.79, 35.89, 33.82, 
33.60, 32.47, 31.03, 28.96, 26.41, 23.25, 22.85, 18.91, 14.29, 14.28. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H38N, 304.3004; found, 304.3006. 
 
(R)-N,N-dibenzyl-3-cyclopropylbutan-1-amine (5e): Prepared according 
to General procedure A from (E)-3-cyclopropyl-N,N-diethylbut-2-en-1-
amine (4e) with dibenzylamine (2f) in 69% isolated yield.  
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.37 (d, J = 7.1 Hz, 4H), 7.31 (dd, J = 8.4, 6.7 Hz, 4H), 7.25 – 7.19 
(m, 2H), 3.62 (d, J = 13.6 Hz, 2H), 3.51 (d, J = 13.6 Hz, 2H), 2.54 (ddd, J = 12.8, 9.0, 6.4 Hz, 1H), 
2.46 (ddd, J = 12.7, 9.1, 5.1 Hz, 1H), 1.74 (ddt, J = 12.7, 9.2, 6.0 Hz, 1H), 1.54 – 1.39 (m, 1H), 
0.84 (d, J = 6.6 Hz, 3H), 0.79 – 0.64 (m, 1H), 0.50 – 0.38 (m, 1H), 0.36 – 0.28 (m, 2H), 0.02 – -







13C NMR (125 MHz, CDCl3) δ: 140.14, 128.98, 128.23, 126.83, 58.36, 51.49, 36.71, 34.59, 19.89, 
18.35, 4.49, 3.23. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H28N, 294.2222; found, 294.2220. 
 
(R)-4-(3-(2-(benzyloxy)ethyl)heptyl)morpholine (5f): Prepared 
according to General procedure A from (E)-3-(2-(benzyloxy)ethyl)-N,N-
diethylhept-2-en-1-amine (4f) with morpholine (2a) in 66% isolated 
yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 15 : 1 hexanes/ EtOAc with 0.5% 
MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.31 (m, 4H), 7.30 – 7.26 (m, 1H), 4.49 (s, 2H), 3.70 (t, J 
= 4.7 Hz, 4H), 3.49 (t, J = 6.9 Hz, 2H), 2.47 – 2.38 (m, 4H), 2.35 – 2.28 (m, 2H), 1.60 (qd, J = 6.8, 
1.4 Hz, 2H), 1.53 – 1.49 (m, 1H), 1.48 – 1.42 (m, 2H), 1.29 – 1.23 (m, 8H), 0.88 (t, J = 6.8 Hz, 
3H). 
13C NMR (125 MHz, CDCl3) δ: 138.75, 128.48, 127.76, 127.64, 73.07, 68.70, 67.15, 57.10, 54.06, 
33.93, 33.66, 33.34, 30.59, 28.84, 23.17, 14.25.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H34NO2, 320.2590; found, 320.2598. 
 
(S)-4-(3-phenyl-3-(p-tolyl)propyl)morpholine (5g): Prepared 
according to General procedure A from (E)-N,N-diethyl-3-phenyl-3-(p-








Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.26 (m, 3H), 7.25 – 7.24 (m, 1H), 7.21 – 7.14 (m, 3H), 
7.12 – 7.08 (m, 2H), 3.98 (t, J = 7.4 Hz, 1H), 3.77 – 3.68 (m, 4H), 2.46 – 2.37 (m, 4H), 2.32 (s, 
3H), 2.30 – 2.27 (m, 2H), 2.27 – 2.20 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ: 145.19, 141.90, 135.81, 129.29, 128.57, 127.90, 127.81, 126.23, 
67.19, 57.46, 53.94, 48.74, 32.61, 21.12. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H26NO, 296.2014; found, 296.2006. 
 
(S)-4-(3-(4-methoxyphenyl)-3-phenylpropyl)morpholine (5h): 
Prepared according to General procedure A from (E)-N,N-diethyl-3-
(4-methoxyphenyl)-3-phenylprop-2-en-1-amine (4h) with morpholine 
(2a) in 81% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 8 g H2O, 10 : 1 hexanes/ EtOAc with 1.0% 
MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.29 – 7.26 (m, 1H), 7.25 – 7.21 (m, 3H), 7.20 – 7.13 (m, 3H), 
6.89 – 6.76 (m, 2H), 3.95 (t, J = 7.6 Hz, 1H), 3.77 (s, 3H), 3.71 (t, J = 4.7 Hz, 5H), 2.49 – 2.36 (m, 
4H), 2.31 – 2.24 (m, 2H), 2.24 – 2.15 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ: 158.06, 145.32, 137.04, 128.85, 128.57, 127.85, 126.22, 113.96, 
67.18, 57.45, 55.35, 53.94, 48.27, 32.74. 







(5i): Prepared according to General procedure A from (E)-N,N-diethyl-
3-phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine (4i) with 
morpholine (2a) in 78% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.53 (d, J = 7.9 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.33 – 7.27 (m, 
2H), 7.25 – 7.18 (m, 3H), 4.17 – 4.03 (m, 1H), 3.71 (t, J = 4.7 Hz, 4H), 2.50 – 2.34 (m, 4H), 2.32 
– 2.16 (m, 4H). 
13C NMR (125 MHz, CDCl3) δ: 149.05, 143.86, 128.80, 128.65 (q, J = 32.4 Hz), 128.31, 127.94, 
126.74, 125.56 (q, J = 3.8 Hz), 124.36 (q, J = 271.8 Hz), 67.16, 57.02, 53.90, 48.81, 32.34, 29.85. 
19F NMR (471 MHz, CDCl3) δ: -62.75. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H23 NOF3, 350.1732; found, 350.1729. 
 
(R)-N,N-dibenzyl-2-(2,3-dihydro-1H-inden-1-yl)ethan-1-amine (5j): 
Prepared according to General procedure A from (E)-2-(2,3-dihydro-1H-
inden-1-ylidene)-N,N-diethylethan-1-amine (4j) with dibenzylamine (2f) in 
69% isolated yield.  
Column Chromatography Condition: silica gel, 99 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.42 – 7.36 (m, 4H), 7.32 (t, J = 7.5 Hz, 4H), 7.24 (t, J = 7.4 Hz, 
2H), 7.21 – 7.17 (m, 1H), 7.15 – 7.08 (m, 2H), 7.07 – 7.03 (m, 1H), 3.69 (d, J = 13.5 Hz, 2H), 3.52 
(d, J = 13.6 Hz, 2H), 3.16 (ddd, J = 12.0, 9.9, 6.0 Hz, 1H), 2.84 (ddd, J = 15.8, 8.6, 4.5 Hz, 1H), 






1H), 2.16 – 2.07 (m, 1H), 2.03 (dtt, J = 12.4, 7.9, 4.1 Hz, 1H), 1.61 – 1.55 (m, 1H), 1.47 (dq, J = 
12.4, 8.0 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ: 147.77, 144.07, 140.03, 129.06, 128.33, 126.97, 126.32, 126.14, 
124.50, 123.59, 58.58, 51.70, 42.74, 32.64, 32.22, 31.52. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C25H28N, 342.2222; found, 342.2221. 
 
(S)-N,N-dibenzyl-2-(chroman-4-yl)ethan-1-amine (5k): Prepared 
according to General procedure A from (E)-2-(chroman-4-ylidene)-N,N-
diethylethan-1-amine (4k) with dibenzylamine (2f) in 77% isolated yield.  
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.39 (d, J = 7.1 Hz, 4H), 7.33 (dd, J = 8.4, 6.7 Hz, 4H), 7.28 – 7.23 
(m, 2H), 7.11 – 7.03 (m, 1H), 7.02 – 6.94 (m, 1H), 6.83 – 6.74 (m, 2H), 4.05 (dd, J = 6.5, 4.3 Hz, 
2H), 3.74 (d, J = 13.5 Hz, 2H), 3.48 (d, J = 13.5 Hz, 2H), 2.94 (dq, J = 9.9, 5.0 Hz, 1H), 2.61 (dt, 
J = 12.9, 7.6 Hz, 1H), 2.51 (ddd, J = 12.7, 7.3, 4.7 Hz, 1H), 2.06 (dtd, J = 14.0, 7.7, 4.1 Hz, 1H), 
1.84 – 1.70 (m, 1H), 1.62 (dddd, J = 14.2, 10.0, 7.0, 4.6 Hz, 1H), 1.51 – 1.40 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ: 154.64, 139.89, 129.12, 129.08, 128.38, 127.24, 127.07, 126.96, 
120.24, 116.83, 63.54, 58.75, 50.54, 34.08, 31.06, 26.58. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C25H28NO, 358.2171; found, 358.2171. 
 
(S)-4-(2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl)ethyl)morpholine 
(5l): Prepared according to General procedure A from (Z)-N,N-diethyl-2-
(6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ylidene)ethan-1-amine (4l) with 







Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, Benzene-d6) δ: 7.13 (dd, J = 7.5, 1.8 Hz, 1H), 7.10 (td, J = 7.2, 1.8 Hz, 1H), 
7.06 (td, J = 7.1, 1.8 Hz, 1H), 7.03 (dd, J = 7.4, 1.8 Hz, 1H), 3.61 (t, J = 4.8 Hz, 4H), 2.90 (qd, J = 
7.1, 2.3 Hz, 1H), 2.82 – 2.73 (m, 1H), 2.71 – 2.64 (m, 1H), 2.19 – 2.11 (m, 6H), 1.91 (dq, J = 13.8, 
7.4 Hz, 1H), 1.79 – 1.44 (m, 7H). 
13C NMR (125 MHz, CDCl3) δ: 145.14, 142.59, 130.03, 128.03, 126.06, 126.04, 67.15, 57.99, 
54.02, 43.20, 36.26, 33.40, 29.85, 29.72, 28.22. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO, 260.2014; found, 260.2017. 
 
(S)-N,N-dibenzyl-4,4,4-trifluoro-3-phenylbutan-1-amine (5m): 
Prepared according to General procedure A from (E)-N,N-diethyl-4,4,4-
trifluoro-3-phenylbut-2-en-1-amine (4m) with dibenzylamine (2f) in 63% 
isolated yield.  
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.27 (m, 9H), 7.25 – 7.18 (m, 4H), 7.01 (dd, J = 7.5, 1.8 
Hz, 2H), 3.67 (d, J = 13.5 Hz, 2H), 3.43 – 3.34 (m, 1H), 3.32 (d, J = 13.5 Hz, 2H), 2.37 (ddd, J = 
12.1, 8.6, 6.1 Hz, 1H), 2.33 – 2.27 (m, 1H), 2.27 – 2.19 (m, 1H), 2.02 – 1.88 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ: 139.41, 134.82 (q, J = 1.9 Hz), 129.15, 129.13, 128.60, 128.39, 
127.97, 127.31 (q, J= 279.5 Hz), 127.09, 58.46, 50.19, 47.49 (q, J = 26.6 Hz), 26.95 (q, J = 1.7 
Hz). 
19F NMR (471 MHz, CDCl3) δ: -69.58 (d, J = 9.8 Hz). 












Prepared according to General procedure A from (Z)-N,N-diethyl-4,4,4-
trifluoro-3-phenylbut-2-en-1-amine (4n) with dibenzylamine (2f) in 71% 
isolated yield.  
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.35 – 7.24 (m, 9H), 7.24 – 7.17 (m, 4H), 7.08 – 6.95 (m, 2H), 
3.67 (d, J = 13.4 Hz, 2H), 3.44 – 3.34 (m, 1H), 3.32 (d, J = 13.5 Hz, 2H), 2.43 – 2.33 (m, 1H), 2.32 
– 2.20 (m, 2H), 1.94 (dtd, J = 15.2, 6.8, 3.3 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ: 139.41, 134.82 (q, J = 1.8 Hz), 129.15, 129.13, 128.60, 128.39, 
127.97, 127.31 (q, J= 279.0 Hz), 127.09, 58.47, 50.19, 47.49 (q, J = 26.6 Hz), 26.96 (q, J = 1.8 
Hz). 
19F NMR (471 MHz, CDCl3) δ: -69.58 (d, J = 9.8 Hz).  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H25NF3, 384.1939; found, 384.1952. 
 
(R)-N,N,3-tribenzyl-4,4,4-trifluorobutan-1-amine (5o): Prepared 
according to General procedure A from (E)-3-benzyl-N,N-diethyl-4,4,4-
trifluorobut-2-en-1-amine (4o) with dibenzylamine (2f) in 59% isolated 
yield. 
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.30 (dd, J = 8.1, 6.8 Hz, 4H), 7.26 – 7.15 (m, 9H), 7.04 – 6.99 
(m, 2H), 3.54 – 3.46 (m, 2H), 3.38 (d, J = 13.6 Hz, 2H), 2.94 – 2.81 (m, 1H), 2.54 – 2.45 (m, 2H), 
















13C NMR (125 MHz, CDCl3) δ: 139.40, 138.26, 129.28, 129.02, 128.58, 128.44 (q, J = 280.4 Hz), 
128.33, 127.05, 126.61, 58.14, 50.53, 42.39 (q, J = 24.8 Hz), 34.40 (q, J = 2.9 Hz), 24.96 (q, J = 
1.8 Hz). 
19F NMR (471 MHz, CDCl3) δ: -70.26 (d, J = 8.3 Hz). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C25H27NF3, 398.2096; found, 398.2090. 
 
(R)-N,N,3-tribenzyl-4,4-difluorobutan-1-amine (5p): Prepared 
according to General procedure A (E)-3-benzyl-N,N-diethyl-4,4-
difluorobut-2-en-1-amine (4p) with dibenzyl-amine (2f) in 70% isolated 
yield. 
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.28 (m, 7H), 7.26 – 7.22 (m, 4H), 7.21 – 7.16 (m, 1H), 
7.08 – 7.02 (m, 2H), 5.54 (td, J = 56.7, 2.9 Hz, 1H), 3.57 – 3.48 (m, 2H), 3.44 (d, J = 13.4 Hz, 2H), 
2.67 (dd, J = 13.9, 6.9 Hz, 1H), 2.49 – 2.47 (m, 1H), 2.45 (t, J = 6.8 Hz, 2H), 2.33 – 2.11 (m, 1H), 
1.83 – 1.67 (m, 1H), 1.53 – 1.46 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ: 139.60, 139.00, 129.28, 129.11, 128.60, 128.37, 127.09, 126.42, 
117.96 (t, J = 241.7 Hz), 58.37, 50.35, 41.73 (t, J = 19.1 Hz), 33.89 (dd, J = 6.2, 3.6 Hz), 24.20 (t, 
J = 3.9 Hz). 
19F NMR (471 MHz, CDCl3) δ: -124.91 (ddd, J = 277.9, 56.8, 15.6 Hz), -126.24 (ddd, J = 277.8, 
56.7, 17.6 Hz). 











Prepared according to General procedure A from (Z)-3-
(dimethyl(phenyl)silyl)-N,N-diethyl-3-phenylprop-2-en-1-amine (4q) with 
morpholine (2a) in 75% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.42 – 7.36 (m, 2H), 7.39 – 7.28 (m, 3H), 7.23 – 7.15 (m, 2H), 
7.12 – 7.05 (m, 1H), 6.98 – 6.91 (m, 2H), 3.65 (t, J = 4.7 Hz, 4H), 2.32 – 2.23 (m, 5H), 2.20 (ddd, 
J = 12.1, 7.9, 6.0 Hz, 1H), 2.11 (dt, J = 12.1, 7.7 Hz, 1H), 1.90 (dt, J = 8.1, 7.0 Hz, 2H), 0.25 (s, 
3H), 0.16 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ: 142.71, 137.57, 134.24, 129.19, 128.20, 128.00, 127.75, 124.75, 
67.11, 58.83, 53.86, 34.51, 26.45, -3.73, -5.29. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H30NOBSi, 340.2097; found, 340.2091. 
 
 (S)-1-(2-(chroman-4-yl)ethyl)-4-(3,4-
dimethoxyphenyl)piperidine (Terikanlant): Prepared 
according to General procedure A from (E)-2-(chroman-4-
ylidene)-N,N-diethylethan-1-amine (4k) with 4-(3,4-dimethoxyphenyl) piperidine7 in 75% 
isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 12 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 6 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.20 (d, J = 7.6 Hz, 1H), 7.13 (ddd, J = 8.7, 7.4, 1.7 Hz, 1H), 6.90 










– 3.06 (m, 2H), 2.94 (dq, J = 10.2, 5.3 Hz, 1H), 2.55 (t, J = 7.7 Hz, 2H), 2.49 (dt, J = 11.7, 4.2 Hz, 
1H), 2.21 – 2.03 (m, 4H), 1.95 – 1.75 (m, 6H). 
13C NMR (125 MHz, CDCl3) δ: 154.61, 148.92, 147.42, 139.23, 129.22, 127.47, 126.34, 120.27, 
118.66, 116.95, 111.25, 110.24, 63.62, 56.71, 56.03, 55.91, 54.85, 54.43, 42.50, 33.91, 33.89, 
33.85, 32.19, 27.24. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H32NO3, 382.2382; found, 382.2375.  
 
Enantioselective Synthesis of (R)-Tolterodine 
 
Vinyl bromide 6 was prepared from trans-cinnamyl chloride according to literature.20 
Suzuki coupling: To a oven-dried 100 ml round bottom flask was charged with a stir bar, purged 
with N2 three times then added 11 mg Pd(OAc)2 (0.050 mmol, 1.0 mol %), 26 mg PPh3 (0.10 
mmol, 2.0 mol %), 0.560 g KOH (10 mmol, 2.0 equiv), starting material vinyl bromide (1.48g, 5 
mmol, 1.0 equiv) ,0.996 g (2-methoxy-5-methylphenyl)boronic acid 7(6.5 mmol, 1.3 equiv) and 
20 mL THF and 20 mL MeOH. The reaction was stirred at rt overnight followed by dilution with 
EtOAc, and washed by 1 N NaOH solution and brine. Acid-base extraction: the organic layer was 
concentrated in vacuo, re-dissolved in Et2O, and extracted with 3 
N HCl solution three times. The resulting acidic aqueous layer was 
then basified by the addition of 5N NaOH solution until the pH > 
11, followed by the extraction with DCM. The combined organic 
layers was then dried over MgSO4, concentrated in vacuo, purified 8 
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by Al2O3 column chromatography: 200 g Al2O3 + 8 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% 
MeOH as eluent to afford allylic amine 8 in 91% isolated yield. For 1n: 1H NMR (500 MHz, 
CDCl3) δ: 7.30 – 7.26 (m, 2H), 7.24 – 7.19 (m, 1H), 7.18 – 7.14 (m, 2H), 7.06 – 7.00 (m, 2H), 6.72 
(d, J = 8.0 Hz, 1H), 5.89 (t, J = 6.4 Hz, 1H), 3.51 (s, 3H), 3.28 (d, J = 6.4 Hz, 2H), 3.06 (p, J = 6.5 
Hz, 2H), 2.29 (t, J = 0.8 Hz, 3H), 0.96 (d, J = 6.6 Hz, 12H). 13C NMR (125 MHz, CDCl3) δ: 
155.24, 141.08, 138.59, 134.18, 133.49, 131.64, 129.79, 129.20, 128.69, 127.55, 126.42, 111.95, 
55.99, 48.96, 43.99, 20.96, 20.62. The geometry of double bond was confirmed by NOE 
experiment (See Supplementary Figure 64 for details). 
 
 
Tolterodine synthesis: [Rh(COD)Cl]2 (4.0 mg, 0.75 mol %), (S)-BINAP (9.6 mg, 1.5 mol %), 
NaBAr4
F (12.8 mg, 1.5 mol %), and 1,4-dioxane (0.8 mL) were added to a 20 mL vial equipped 
with a stir bar in the glove box under nitrogen atmosphere. To the vial was added allylic 
diisopropylamine (8, 1.0 mmol, 1.0 equiv). The resulting solution was allowed to stir for 10 h at 
100 °C. After 10 h, formic acid (3.0 mmol, 3.0 equiv) was added into reaction vial via syringe and 
the reaction was allowed to stir for another 5 h at 100 °C. The reaction crude was then diluted in 
DCM, filtered through basic alumina, and concentrated in vacuo (to get rid of 1,4-dioxane solvent). 
The residue was then transferred into another 20 mL vial, followed by the addition of HBr solution 
(2.2 mL, 13.2 equiv) and HOAc (2.0 mL), and allowed to stir at 115 °C for 4 h. After 4 h, the 
reaction crude was then diluted in water, extracted with EtOAc three times. Combined organic 
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layers were washed with 1 N NaOH solution three times. The pH of last basic wash was verified 
to be >10. The organic layer was washed with brine, dried over MgSO4, concentrated in vacuo and 
then purified by basic alumina chromatography to afford the desired product (R)-Tolterodine in 
88% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 5 g H2O, 15 : 1 hexanes/ EtOAc with 0.5% 
MeOH to 8 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 10.33 (brs, 1H), 7.33 (d, J = 4.3 Hz, 4H), 7.23 (h, J = 4.3 Hz, 1H), 
6.85 (dd, J = 8.2, 2.1 Hz, 1H), 6.80 (d, J = 8.1 Hz, 1H), 6.53 (d, J = 2.5 Hz, 1H), 4.49 (dd, J = 11.3, 
4.0 Hz, 1H), 3.23 (p, J = 6.7 Hz, 2H), 2.73 (dt, J = 12.7, 3.6 Hz, 1H), 2.50 – 2.25 (m, 2H), 2.12 (s, 
3H), 2.10 – 2.03 (m, 1H), 1.13 (d, J = 6.7 Hz, 6H), 1.08 (d, J = 6.6 Hz, 6H). 
13C NMR (125 MHz, CDCl3) δ: 153.34, 144.88, 132.55, 129.53, 128.78, 128.66, 128.42, 127.88, 
126.28, 118.32, 48.03, 42.21, 39.46, 33.37, 20.91, 20.10, 19.69. 













4.7.6 Control Experiment of Enamine Reduction 
 
Figure 4.7. Control experiments  
Procedure: A pre-made geranyl diethyl enamine was subjected to reduction conditions with and 
without the rhodium catalyst as shown above. After 2 hours, the reaction crude was concentrated 




4.7.7 HPLC Separation 
 
25% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 75% hexanes, 1.0 mL/min, 
CHIRALPAK® IA3 
er = 96.2:3.8 
[α]D













10% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 90% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 95.5:4.5 
[α]D













15% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 85% hexanes, 0.5 mL/min, 
CHIRALPAK® IA3 
er = 97.9:2.1 
[α]D













35% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 65% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 97.1:2.9 
[α]D















25% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 75% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 95.8:4.2 
[α]D














50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 95.8 : 4.2 
[α]D














50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 99.8:0.2 
[α]D

























1.8% area if integrated  





50% (95% hexanes, 5% EtOH, 0.3%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® IB3 
er = 97.9:2.1 
[α]D





























10% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 90% hexanes, 0.5 mL/min, 
CHIRALCEL® OJ-H 
er = 96.6:3.4 
[α]D













15% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 85% hexanes, 0.5 mL/min, 
CHIRALCEL® OJ-H 
er = 96.9 : 3.1 
[α]D















3j was hydrogenated to H2-3j for the determination of er 
8% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 92% hexanes, 0.8 mL/min, CHIRALCEL® 
OJ-H 
er = 96.1 : 3.9, [α]D













15% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 85% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 97.1 : 2.9 
[α]D














50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® ID3 
er = 98.7:1.3 
[α]D





















100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALCEL® OJ-H 
er = 98.7:1.3 
[α]D















50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® IA3 
er = 99.1:0.9 
[α]D













30% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 70% hexanes, 0.8 mL/min, 
CHIRALPAK® IA3 
er = 97.8:2.2 
[α]D














10% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 90% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 98.9 : 1.1 
[α]D










50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 98.1 : 1.9 
[α]D











50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 96.5 : 3.5  
[α]D










100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALCEL® OJ-H 
er = 97.6 : 2.4 
[α]D









50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® IA3 
er = 98.6 : 1.4 
[α]D












100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALPAK® IB3 
er = 92.5 : 7.5 
[α]D










100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALPAK® IB3 
er = 97.2 : 2.8 
[α]D









50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® IB3 
er = 96.0 : 4.0 
[α]D









100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALCEL® OJ-H 
er = 98.6 : 1.4 
[α]D
















100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALCEL® OJ-H 
er = 98.2 : 1.8 
[α]D

















25% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 75% hexanes, 0.8 mL/min, 
CHIRALCEL® OJ-H 
er = 97.1 : 2.9 
[α]D















100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALPAK® IB3 
er = 97.2 : 2.8 
[α]D
















50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 0.8 mL/min, 
CHIRALPAK® IA3 
er = 98.8 : 1.2 
[α]D














100% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 0.8 mL/min, CHIRALPAK® IB3 
er = 96.7 : 3.3 
[α]D











50% (95% hexanes, 5% EtOH, 0.2%TFA, 0.1%DEA), 50% hexanes, 1.0 mL/min, 
CHIRALCEL® OJ-H 
er = 96.0 : 4.0 
[α]D
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CHAPTER 5: INTRODUCTION TO PART II 
 
This chapter has been adapted from the following publication: 
Greenlee, A. J.; Wendell, C. I.; Cencer, M. M.; Laffoon, S. D.; Moore, J. S. Kinetic and 
Thermodynamic Control in Dynamic Covalent Synthesis. Trends Chem. 2020 [online early 
access] doi: 10.1016/j.trechm.2020.09.005 
 
5.1 Abstract 
In recent years, dynamic covalent chemistry (DCC) has seen the synthesis of increasingly 
complex cyclooligomers, polymers, and diverse compound libraries. The reversible formation of 
covalent bonds characteristic of DCC reactions favors thermodynamic product distributions for 
simple unitopic reactions; however, kinetic effects are increasingly influential in reactions of 
multitopic precursors. This chapter discusses the interplay between thermodynamic and kinetic 
considerations in DCC synthesis with a focus on alkyne metathesis 
 
5.2 Dynamic Covalent Chemistry (DCC) 
DCC is an efficient synthetic strategy that utilizes multitopic precursors designed to form 
reversible covalent bonds, combining advantages of error correction during synthesis with the 
stability of a covalent compound as the final product. It has enabled the synthesis of a variety of 
molecular architectures, often isolated as a single, discrete species, including macrocycles,1 cages,2 
and covalent organic frameworks.3,4 Reversible bonds commonly in use include imine, boronic 




Figure 5.1. Common exchangeable bonds employed in DCC. 
found applications in host-guest chemistry,5 organic electronic materials,6 information storage and 
retrieval,7 catalysis,8 biological applications,9 chemical sensing,10 and as building blocks for other 
materials, such as nanofibers.11 
Most targets of DCC are constructed from a small number of different types of repeating 
units. Thus, DCC is commonly a cyclooligomerization process. The combination of a bimolecular 
oligomerization and intramolecular cyclization in the same reaction represents one challenge of 
dynamic covalent synthesis. Another challenge stems from the multitopic nature of DCC 
precursors. While the individual bond forming events are reversible, incorrectly joined structures 
may require multiple bond breakages to release an incorrectly placed precursor. Some erroneous 
structures fall out of dynamic equilibrium with the rest of the reaction network. Nonetheless, 
overcoming these challenges enables the synthetic efficiency of DCC reflected by the number of 
bonds made per operational step. Moreover, DCC product yields may approach quantitative, 
whereas cyclooligomerizations relying on strong irreversible bond formations tend to give low 
yields of final product, presumably because error correction is key to synthetic success.12 
Due to the reversibility of each bond forming event, DCC is generally thought to operate 
under thermodynamic control. However, as DCC advances to increasingly complex targets, there 
is good reason to suggest that kinetic factors may become more important. The concatenation of 
multitopic precursors gives rise to a large number of structures on the way to the target product. 
These structures include polyhedra, polymers, and networks, and they may have very similar 
energies. This suggests a flat energy landscape, but complexes exhibiting multiple persistent bonds 
are stabilized, which produces a vast landscape with somewhat regular variation. Given the 
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complexity of DCC reaction networks and associated energy landscapes, synthetic intuition is 
unsuited to predict the outcome. Failures in experimental DCC often come at a high cost because 
multitopic, complex precursors require considerable structural optimization and synthetic 
overhead.8 Predicting outcomes is therefore essential and may require computational modeling to 
ensure a full understanding of the underlying factors that shape the energy landscape.  
 
5.3 Thermodynamic Control in DCC 
The ability of dynamic systems to undergo reversible component exchange is key to the 
utility of DCC. Under thermodynamic control, even off-pathway intermediates typically error 
correct toward favorable product distributions on the timescale of the reaction (Figure 5.2).13 In an 
example of thermodynamically driven alkyne metathesis, arylene ethynylene macrocycles are 
formed both by alkyne metathesis cyclooligomerization and by depolymerization-
macrocyclization of linear poly(arylene ethynylene) species.14 The product distribution is not 
dependent on reaction pathway which is a necessary condition to classify a given product 
distribution as thermodynamic rather than kinetic.  
A depolymerization strategy was showcased in the synthesis of homochiral, BINOL based 
macrocyces through self-sorting alkyne metathesis DCC.15 A heterochiral arylene ethynylene 
polymer containing both R- and S-BINOL repeating units was subjected to alkyne metathesis at 
RT resulting in formation of only homochiral R/S dimeric macrocycles. This selectivity was 
hypothesized to be a result of the difference in symmetry between hetero- and homochiral 
macrocycles. Calculations revealed that the enthalpic difference between the hetero- and 
homochiral structures is relatively small. However, the entropic difference between macrocycles 




Figure 5.2. Reaction network of ladder formation under DCC. In-registry intermediates and products have 
correctly matched rungs where outer rungs bond to other outer rungs, and center rungs bond to other center rungs 
between two strands. Out-of-registry products have mismatched rung formation. Mismatched intermediates revert to 
free strands if rung scission is faster than intramolecular rung formation. Reproduced from reference 16. 
reaction indicating thermodynamic selectivity.  
Alkyne metathesis has become an increasingly popular tool of DCC as highly active and 
functional group tolerant catalyst systems have been developed. Alkyne metathesis has found wide 
application in both total synthesis and materials chemistry.17 Alkyne metathesis is commonly 
catalyzed through the use of Schrock alkylydine complexes of molybdenum and tungsten (Figure 
5.3). The catalytic cycle of AM is analogous to that of olefin metathesis and proceeds through 




Figure 5.3. Reaction mechanism of alkyne metathesis with Schrock alkylidyne complexes. 
alkyne metathesis is key to its utility in DCC; however, the equilibrium must be driven forward to 
obtain high yields of desired products. Propynylated precursors release volatile 2-butyne after 
metathesis which can be removed through high vacuum. To circumvent the need for vacuum 
driven conditions, the Moore group reported an efficient precipitation driven strategy to drive 
alkyne metathesis reactions to completion.18 A key breakthrough in the development of alkyne 
metathesis DCC was made by Furstner and coworkers who have reported that alkyne metathesis 
can be efficiently driven forward by using propynylated substrates in conjunction with 5Å 
molecular sieves (MS) which effectively remove 2-butyne.19 This strategy allows for more simple 
preparation of metathesis precursors and alleviates the need for bulky precipitating groups or a 
vacuum-driven system. 16a,20 
The reversibility of alkyne metathesis is key to its proclivity for self-correction. In AM-
DCC using multitopic precursors, these reactions often proceed through initial formation of higher 
molecular weight oligomeric/polymeric products which then convert to a discrete product.21,22 The 
Moore group has demonstrated that discrete macrocycles can be generated from polymeric 
precursors through a depolymerization-macrocyclization strategy. Polymer 1 was prepared 
through Sonogashira polymerization and determined to have a molecular weight (MW) of 11.4 
kDa and polydispersity index of 1.8 (Figure 5.4).23 Subjecting this polymer to alkyne metathesis 
conditions afforded macrocycle 2 in 70% yield after 24 hours.  
Systems under thermodynamic control favor distributions that maximize entropy by 




Figure 5.4. Synthesis of arylene(ethynylene) macrocycles via alkyne metathesis depolymerization. 
strain of the resultant structures. These principles have enabled the intuitive design of a wide 
variety of cyclic molecular architectures on the basis of precursor topicity and geometry.24 
Furthermore, in systems with very flat energy landscapes, slight differences in thermodynamic 
stability lead to self-sorting and large amplifications of product concentrations, which can be 
further improved by increased catalyst loading and thermal cycling.14,25-28  
While design principles such as precursor geometry and topicity are generally reliable 
predictors of product topology and stability, the complexity of DCC energy landscapes can lead to 
unpredicted reaction outcomes. Cooper and coworkers recently designed a computational 
screening procedure to predict the major products of imine condensation reactions based on 
product stability.29 While many combinations of aldehyde and amine precursors produced the 
predicted imine cages, several pairings of precursors led to structures with unexpected topologies. 
In these cases, the less thermodynamically favored product was observed, and the energetic 
preference for the predicted structures was small (around 5 kJ mol-1) compared to the observed 
products. The Zhang group reported similar phenomena in the synthesis of arylene ethynylene 
cages.30 Slight variations in monomer size yielded structures with drastically different topologies, 
despite a consistent face-to-edge angle between substrates. Taken together, these results suggest 
that intuitive design rules are unreliable predictors of complex reaction outcomes, and that 
pathway-dependence may contribute to DCC syntheses in largely unexplored ways.   
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5.4 Kinetical Control in DCC  
The reversible bonds used in DCC enable systems to undergo error correction. The faster 
the rate of exchange, the less prone the resulting system is to kinetic traps (Figure 5.5). In the 
synthesis of molecular ladders, hydrogen bonded rungs demonstrate much higher fidelity (98% vs. 
62%) than an imine-linked ladder with an identical backbone, due in part to the high exchange rate 
of hydrogen bonding.31,32 However, while rapid exchange speed rescues a system from a putative 
kinetic trap, all covalent bonds are susceptible to trapping under some circumstances. Rigid 
complex architectures, such as COFs and cages, typically synthesized via DCC tend to be 
predisposed towards kinetic control due to precursor multitopicity. Macrocycles with ditopic 
precursors require two bond breakage events before a precursor is released. After the first bond 
breakage, the two resulting reactive moieties are in close proximity and have a faster rate of  
 
Figure 5.5. Generic energy landscape of ladder formation. In reactions with complex energy landscapes, species 
can become kinetically trapped even if reversible chemistry is used. Kinetic traps can persist if small barriers funnel 
material back to the trapped structure rather than out of the kinetic trap and toward a thermodynamic minimum. In the 
case of molecular ladders, out-of-registry products may be kinetic traps if rung scission is immediately followed by 
reformation of the rung. Kinetic factors such as proximity-induced high effective concentration prevent error 
correction in a dynamic system where the thermodynamic product is desired. Reproduced from reference 16. 
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recombination than two unlinked precursors, an effect which is exacerbated by the rigidity of the 
structures. If the rate of bond reformation is faster than the breakage of the second bond, the 
macrocycle may behave as a kinetic trap. Kinetic trap behavior is even more likely for structures 
which require three or four bond breakages, where precursors are tritopic or tetratopic and the 
partially broken structures have higher rigidity.2,33 This is apparent in the synthesis of ladder 
compounds, which generally have [n]-topic precursors, where n is the number of rungs. These 
studies show that beyond a certain number of rungs the structures can no longer undergo error 
correction and tend to form myriad mismatched products instead.7,34,35  
The Moore group has recently reported the synthesis of kinetically trapped tetrahedral 
organic cages through alkyne metathesis of tritopic precursors (Figure 5.6).36 Precursor 3 was 
prepared as a structural analog of similar compounds which have been shown to have an alternating 
‘up-down-up’ configuration of the 1,3,5-substitution of hexasubstituted arenes.37 This 
conformation preorganizes 3 to undergo metathesis to adopt a conformation that favors formation  
 
Figure 5.6. Synthesis of a kinetically trapped tetrahedral organic cage from a tritopic precursor under alkyne 
metathesis. 
of a tetrameric organic cage.36 Subjecting 3 to alkyne metathesis using only 5 mol% molybdenum 
catalyst afforded the tetrahedral cage 4 in near quantitative yield. Tetrahedral cage 4 was 
determined to be a kinetic trap and no longer dynamic under the alkyne metathesis conditions used 
for its synthesis.36  
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Precursor rigidity influences reaction outcomes by rendering certain transition states 
geometrically inaccessible. This is particularly relevant for reactions with conformationally 
restrictive transition states, such as the transition state leading to the metallacyclobutadiene 
intermediate in alkyne metathesis. Chapter 6 details the synthesis of a molecular Möbius strip 
under total kinetic diastereoselectivity arising from strain in the key metallacylobutadiene 
transition state.37 
 Solubility is often utilized as a tool for kinetically directing DCC synthesis. Heavily 
conjugated structures are common because they are rigid enough to be shape-persistent, but large, 
planar π surfaces contribute to insolubility due to π-π stacking, removing the compound from 
dynamic equilibrium and promoting its formation. Dichtel and coworkers developed a system 
which produces macrocycle only when it is insoluble in the reaction solvent; dissolving the 
macrocycle and allowing it to re-enter dynamic equilibrium leads to conversion into polymer, the 
putative thermodynamic product.1 Many DCC syntheses are driven by precipitation.38-40 Adding 
solubilizing groups or changing the size and planarity of the π surface allows modulation of 
solubility. Northrop and coworkers produce a planar and non-planar version of the same boronate 
ester cage by inserting ethynylene units into a biaryl backbone with a 90° twist.38 They demonstrate 
that the more planar version is less soluble and more stable to protic solvents. The Moore group 
and others have the reported the synthesis of a number of novel macrocycles and cages through 
AM-DCC.20,41-43 Precipitation-driven alkyne metathesis enabled the synthesis of macrocycle 6 as 
a precursor to a cycloparaphenyleneacetylene which effectively binds to C70.
44 Macrocycle 6 is 





Figure 5.7. Precipitation driven cyclooligomerization alkyne metathesis. 
In addition, supramolecular structures that form between cages and other complex products 
affect exchange rates. Dichtel and coworkers report an imine macrocycle that assembles into 
nanotubes which prevent further imine exchange, and Otto and coworkers report a similar 
effect.11,45 In the synthesis of knots and catenanes from a DCL, multiple products are kinetically 
trapped as a result of intramolecular π-π stacking in ambiphilic molecules, analogous to the 
hydrophobic effect in protein folding.46 
While kinetic traps may introduce synthetic obstacles, they sometimes provide products in 
higher yields than the same system under thermodynamic control. In some cases, the kinetic trap 
is also the thermodynamic product.2,47 In other cases, the pathway-dependence of kinetically 
controlled systems can be leveraged. Multiple products may be accessible from the same 
precursors under different conditions, especially useful given the high synthetic overhead of DCC 
precursors.11 Otto and coworkers have provided evidence that mechanical agitation has a strong 
influence on product distribution.10,48 Slow addition of monomer has been demonstrated to produce 
COFs with larger crystal domains than a single-addition protocol.49  
Scott and coworkers show that a high-fidelity synthesis of an information-bearing five rung 
imine ladder is only achieved by increasing and then decreasing the concentration of scandium 
(III) triflate, commonly used to promote imine exchange.35 Maintaining catalyst concentration at 
consistent substoichiometric levels throughout the reaction leads to mismatched byproducts 
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instead; this dependence on pathway suggests that the information-bearing ladders are kinetic 
products. Lehn and coworkers have developed libraries of acyl hydrazones and imines generated 
from simple aldehyde, acyl hydrazine, and aniline building blocks.7 In the presence of a metal 
cation with the appropriate coordination geometry, kinetically trapped species were favored. Upon 
precipitation of the directing metals, the libraries were expected to return to equilibrium, favoring 
formation of the more stable acyl hydrazone. However, because the exchange rate of imines and 
acyl hydrazones is on the order of weeks, the composition of the DCL remained unchanged on a 
relevant laboratory timescale, or until it was erased by thermal cycling. Furthermore, the library 
could be trained to adopt an altered kinetic equilibrium through the addition of a different metal 
cation, demonstrating the versatility of a simple system for information storage. In this case, kinetic 




 While dynamic covalent chemistry is a relatively young field, consensus has already 
emerged around the importance of predicting reaction outcomes. Reversible covalent bonds 
combine the stability of covalent products with rapid error correction. However, not all linkages 
necessarily reversibly equilibrate and multitopicity of the resulting structures leads to complex 
reaction networks and energy landscapes. Unfortunately, the high overhead required to conceive 
of and develop precursors raises the cost of unpredictable outcomes.7 Many researchers tend to 
overemphasize thermodynamic factors when planning a synthesis based on reversible covalent 
linkages even though the desired geometric complexity, rigidity, and extended conjugation often 
subject the synthesis to kinetic control. In response, computation has enhanced human intuition. 
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New approaches have begun to incorporate kinetic factors into computation shedding light on COF 
nucleation, ladder formation and trapping, and other processes with observable kinetic effects.33,50 
However, few studies to date have incorporated both kinetic and thermodynamic factors in 
computational prediction. Computational models will be vital to developing new precursor 
structures in the future of DCC.  
 
The author thanks Oleg Davydovich and Dorothy Loudermilk for their contributions to the figures in this chapter. 
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CHAPTER 6: KINETIC CONTROL IN THE SYNTHESIS OF A 
MOLECULAR MÖBIUS STRIP USING ALKYNE METATHESIS 
 
This chapter has been adapted from the following publication: 
Jiang, X.; Laffoon, S. D.; Chen, D.; Pérez-Estrada, S.; Danis, A. S.; Rodríguez-López, J.; Garcia-Garibay, 
M. A.; Zhu, J.; Moore, J. S. “Kinetic Control in the Synthesis of a Möbius Tris((ethynyl)[5]helicene) 
Macrocycle Using Alkyne Metathesis,” J. Am. Chem. Soc. 2020, 142, 6493–6498. 
 
6.1 Abstract 
The synthesis of conjugated Möbius molecules remains elusive since twisted and 
macrocyclic structures are low entropy species sporting their own synthetic challenges. Here we 
report the synthesis of a Möbius macrocycle in 84% yield from the alkyne metathesis of 2,13-
bispropynyl[5]helicene. MALDI-MS, NMR, and X-ray diffraction indicated a trimeric product of 
two-fold symmetry with PPM/MMP configurations in the helicene subunits. Alternatively, a three-
fold symmetric, PPP/MMM structure was determined by DFT calculation to be more 
thermodynamically stable, illustrating remarkable kinetic selectivity for this alkyne metathesis 
cyclooligomerization. Computational studies provided insight into the kinetic selectivity, 
demonstrating a difference of 15.4 kcal/mol in activation barriers between the PPM/MMP vs. 
PPP/MMM diastereodetermining steps. Computational (ACID and EDDB) and experimental (UV-
Vis and fluorescence spectroscopy and cyclic voltammetry) studies revealed weak conjugation 
between the alkyne and adjacent helicene groups, as well as the lack of significant global 





6.2 Background and Motivation 
Dynamic covalent chemistry (DCC) is a powerful synthetic strategy for assembling 
complex structures via reversible reactions from simple building blocks. Such reactions, including 
alkyne metathesis, imine condensation, disulfide exchange, and boronic acid condensation have 
facilitated the preparation of organic architectures such as macrocycles, catenanes, cages, and 
extended frameworks.1 Thermodynamically controlled DCC reactions enable error correction of 
intermediates along multiple reaction pathways, offering facile access to intricate connectivity and 
topology beyond the reach of conventional synthesis. We and others have developed alkyne 
metathesis cyclooligomerization2 as a useful method for the efficient preparation of conjugated 
and shape-persistent molecules where step-wise synthetic strategies have fallen short.3  
Limited examples of Möbius structures have been reported due to the challenges associated 
with synthesizing macrocycles and twisted structures.4 Among them, many feature porhpyrinoid 
scaffolds due in part to the heightened structural rigidity offered by pyrrole moieties.5 Two non-
porphyrinoid Möbius structures with writhe-bearing subunits have been recently reported by 
Rissanen, Herges, and Durola, (Figure 6.1) with different synthetic strategies regarding the order 
of macrocyclization and writhe-formation.6 While their successes are inspiring to theoretical and 
experimental chemists, both synthetic routes are lengthy with low overall yields (~1%). Very 
 




recently, Tanaka synthesized Möbius [n]cycloparaphenylene (CPP) analogues utilizing [2+2+2] 
cyclization with great enantioselectivity yet low overall yield.7 To circumvent the limitations 
associated with stepwise macrocycle construction, we investigated a DCC-based assembly of 
simple monomers into molecular Möbius strips in a single step. We pursued a route toward a fully 
conjugated structure via alkyne metathesis given the influence Möbius topology holds over the 
aromaticity of an annulene.8,9 Herein, we report the efficient synthesis of Möbius macrocycle 2 
from the metathesis of 2,13-bispropynyl[5]helicene 1 (Figure 6.2). 
 
Figure 6.2 Synthesis of a Möbius tris((ethynyl)[5]helicene) macrocycle under Mo-catalyzed alkyne metathesis. 
 
6.3 Reaction Conditions 
Bispropynyl[5]helicene 1, prepared from 2,13-dibromo[5]helicene10 (90% yield), features 
a low inversion barrier of 25.6 kcal/mol, similar to that of the parent [5]helicene11 (23.4 kcal/mol, 
see Table 6.9.1). The dynamic helicity makes 1 an ideal candidate for cyclooligomerization as 
chirality matching is allowed in the final ring closure step. Compound 1 was first subjected to 
alkyne metathesis conditions with 10 mol % of [EtC≡Mo(OSiPh3)3] at room temperature and 5 
mM in CHCl3. MALDI-MS analysis of the crude reaction mixture revealed that in addition to 
unconsumed starting material, ring-opened dimer, and higher molecular weight oligomers, a peak 
with m/z = 900.2838 (Figure 6.3A) corresponding to a ring-closed trimer (2) was observed. The 
ring-closed dimer 3 was never observed. Under the above reaction conditions, the trimeric product 
was formed in 23% yield as determined by NMR. To limit the formation of oligomeric products, 
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we diluted the reaction to 1 mM and increased the temperature to 40 °C, obtaining the ring-closed 
trimer in 38% NMR yield. Increasing the temperature to 60 °C at the same reaction concentration 
led to the optimized conditions giving an 84% yield by NMR. Solvent effect was also briefly 
explored, and reactions in toluene gave significantly lower yields at elevated temperatures due to 
competing precipitation. 
 
6.4 Characterizing Product Symmetry  
Regarding the symmetry of the macrocyclic product, four stereoisomers are possible, 
namely the PPM and MMP enantiomeric pair of 2 and the PPP and MMM enantiomeric pair of 4 
(Figure 6.3B). Both diastereomers are twisted structures with Möbius topology. The PPP/MMM 
pair features three-fold symmetry and is triply twisted, while the PPM/MMP pair is C2 symmetric 
and singly twisted. Single point energy calculations (M06-2X, B3LYP, and PBE0, at def2-TVZP  
 
Figure 6.3. (A) MALDI-TOF mass spectrometry established the formation of a ring-closed trimeric species. (B) 
Space-filling models of DFT calculated structures of 2PPM and 4PPP. (C) 13C NMR spectrum showing 36 carbon signals. 
(D) Crystal structure of 2PPM (left) and the unit cell (right). Solvent molecules omitted for clarity. 
244 
 
level of theory, Table 6.2) showed that 2 is less stable than 4 by 1−2 kcal/mol, suggesting that 4 is 
the thermodynamically favored product. However, the 13C NMR spectrum of the product is 
consistent with the exclusive formation of 2, showing 33 aromatic and 3 alkynyl carbon resonances 
(Figure 6.3C). The unexpected kinetic selectivity and the PPM/MMP stereochemistry of the 
product were confirmed by X-ray diffraction (XRD) of single crystals grown from a hot ethyl 
acetate solution. The crystal structure of 2 was solved in the orthorhombic P21/n space group, with 
two pairs of PPM/MMP enantiomers in each unit cell (Figure 6.3D). The XRD structure is very 
close to the DFT minimized structure, except that two of the three triple bonds deviate slightly 
from linearity (averaged bond angles 175°, 176°, and 178°). 
 
6.5 Rationalizing Kinetic Diastereoselectivity 
Since DCC reactions are typically under thermodynamic control, we were surprised that 
the less stable product 2 was formed exclusively in the reaction. In fact, thermodynamic driving 
forces are typically the sole factors considered when planning a DCC synthesis. To elucidate the 
origin of kinetic selectivity, DFT calculations (B3LYP/6-31G(d)/SDD) of the intermediates and 
transition states leading to structures 2PPM and 4PPP were performed (Figure 6.4). The rate 
determining steps in both pathways are the initial formation of metallacyclobutadiene (TS1). The 
activation energy for TS1PPP formation is 37.0 kcal/mol, whereas the barrier for TS1PPM formation 
is 21.6 kcal/mol. The 15.4 kcal/mol difference in activation energy accounts for the remarkable 
kinetic control in the synthesis. Notably, a single metallacyclobutadiene intermediate IMPPM was 
located after TS1PPM, which quickly undergoes cycloreversion to give 2PPM. This contrasts with 
the canonical observation of two discrete metallacyclobutadiene intermediates as were observed 




Figure 6.4. DFT calculated (B3LYP/6-31G(d)/SDD) relative Gibbs free energy and enthalpy (in parentheses) of 
intermediates and transition state structures in the formation of 2PPM and 4PPP. Energies in both pathways are relative 
to the open trimers O3PPM and O3PPP, respectively. Structures were optimized in the gas phase before the application 
of a solvation model (CH3Cl, SMD). The rate determining steps in both pathways are the formation of 
metallacyclobutadiene (TS1). A simplified Me3SiO- ligand was used in the calculation. The transition state structures 
were rendered in CYLview.12 The metallacyclobutadiene structures are highlighted in orange, and bond angles in TS1 
are labeled in blue. 
difference (an early transition state according to the Hammond Postulate) between IMPPM and 
TS2PPM (Figure 6.15). Free energy change from TS1PPM to 2PPM is –38.2 kcal/mol and is consistent 
with the observation that 2PPM is kinetically stable under metathesis conditions in the presence of 
excess 1-phenyl-1-propyne (Figure 6.8).  
Our experimental and computational studies illustrate unique kinetic sensitivity of alkyne 
metathesis, particularly for the preparation of rigid structures. This results from the strained four-
membered metallacycles in the intermediates and transition states leading to product and their 










distortion was observed in TS1PPP (138.7° and 117.4°) than TS1PPM (147.3° and 117.4°) (from 
CAr–Csp–Mo and CAr–Csp–Csp respectively), while no apparent difference was noticed in terms of 
dihedral angle or bond length (Figure 6.14). Therefore, seemingly stable and unstrained products 
may have surprisingly high energy barriers when constructed with alkyne metathesis. In the 
synthesis of 2, such kinetic selectivity affords complete diastereocontrol. 
 
6.6 Analyzing the Aromaticity of Compound 2 
The optical properties of 2 were explored to probe its electronic structure. The UV-Vis and 
fluorescence excitation spectra of 2 are slightly red-shifted as compared to those of 1, while the 
emission spectra were nearly identical (Figure 6.5). We attribute this to weak conjugation among 
the three helicene subunits in 2 and an increase of oscillator strength for the S0-S1 from 1 to 2. The 
S0-S1 transition and other low energy transitions of 1 are symmetry forbidden and extremely weak, 
but the oscillator strength of the same transitions is higher for 2 (Table 6.4). The S0-S1 electric 
transition dipole of 2PPM resembles the sum of those of the three helicene units, and the spatial 
arrangement of transition dipole moments of P- and M-helicene enables the otherwise forbidden 
transition (Figure 6.5C). The increased oscillator strength justifies the increased quantum yield of 
2 over 1 (2.7% and 1.3% respectively). To further probe the electronic structure, comparative 
voltammetric measurements of 1 and 2 were performed (Figures 6.9-13). For the reduction 
process, the magnitude of the normalized peak currents (with respect to concentration and redox 
equivalents) indicates a single three-electron voltammetric wave for 2 (Figure 6.13). The lack of a 
stepwise behavior suggests that three electrons were accepted in redox centers that act 





Figure 6.5. (A) UV-Vis and (B) fluorescence spectra of 1 and 2 in DCM. (C) The S0-S1 electric transition dipole 
moments (μe) of 2PPM (green arrow, the contribution of the acetylene carbons not includes) and the three helicene 
segments (blue arrows). Their absolute values are labeled (unit: Debye). 
The photophysical and electrochemical properties described above are consistent with our 
theoretical interrogations of 2PPM. The electron density of delocalized bonds (EDDB) plot shows 
that one set of p orbitals of the alkynes are parallel to the p orbitals of the adjacent helicenes, 
indicating significant conjugation between those moieties albeit less pronounced compared to the 
delocalization within the helicene units (Figure 6.6A, π-EDDB1, pink). As expected, the p orbitals 
orthogonal to the helicene plane contribute negligible electron density to overall electron 
delocalization (Figure 6.6A, π-EDDB2, yellow). While σ-delocalization is evident within the 
framework of the helicene fragments, almost zero σ-delocalization was observed along the 
bridging alkynyl bonds. Non-directional electron currents were observed at the alkynes in the 
anisotropic current (induced) density (ACID)14 plot showing minimal helicene-helicene 
interactions with no significant global aromaticity (Figure 6.6B). Similar results were observed for 
an analogous compound reported by Herges and Durola,6a and the authors argued their system 
features global Möbius aromaticity with concurrent diatropic and paratropic ring currents. A larger 
extent of delocalization was observed for the T1 excited state of 2, resulting in an increased level 




Figure 6.6. (A) Electron density of delocalized bonds (EDDB) of 2PPM showing π-EDDB1 (45.98e, pink) and π-
EDDB2 (0.32e, yellow) and σ-EDDB (9.06e, pink) with their isovalues labeled. (B) Anisotropy of the induced current 
density (ACID) plots of 2PPM showing directional electron currents within each helicene units and non-directional 
electron currents at the alkynes (isovalue 0.015 a.u.). The external magnetic field vector is perpendicular to the ACID 
plots and points outward. 
 
6.7 Future Directions and Conclusion 
Chiral separation of the enantiomers of 2 was achieved on an analytical HPLC with a chiral 
stationary phase column (CHIRALPAK IB-3). However, preparatory scale separation of 2 was 
unsuccessful due to its limited solubility. Modification of the alkynes was attempted to address the 
limited solubility and electrochemical stability of macrocycle 2. As shown in Figure 6.7, one of 
the three alkynes selectively reacts with tetrasubstituted cyclopentadienone 5, and the Möbius 
topology is largely preserved in the product 6. Subsequent cycloadditions were not observed, 
possibly due to the steric hindrance around the remaining alkynes. To examine the substrate scope 
of the reported synthetic strategy, alkyne metathesis was also attempted for two structurally related 
substrates. Compound 7 features an axially chiral binapthyl structure, which was key to the Möbius 
structure reported by Rissanen and Herges,6b and heterohelicene precursor 8 is structurally 




Figure 6.7. Cyclopentadienone 5 selectively reacted with one of the three alkynes in 2 to give compound 6 of pseudo 
2-fold symmetry. Compounds 7 and 8 failed to form macrocyclic oligomers. 
In conclusion, we demonstrate the use of alkyne metathesis in the preparation of Möbius 
tris((ethynyl)[5]helicene) macrocycle 2 through a synthetically efficient cyclooligomerization 
process. The high diastereoselectivity results from a 15.4 kcal/mol difference in activation energy 
during the cyclization step in favor of the PPM/MMP diastereomer. The findings reported here 
shed light on the kinetic aspects of alkyne metathesis cyclooligomerization that is different from 
other DCC reactions. While the lack of directional currents throughout the molecule in the ACID 
plot suggests a negligible global aromaticity, the alignment of p orbitals in the EDDB plots is set 
up for delocalization of π-electrons of the helicene and acetylene units in 2. 
 
6.8 Supporting Information 
General 
Unless stated otherwise, all compounds are used as received from commercial sources. 
Anhydrous chloroform and methanol were obtained from Sigma-Aldrich, and all other solvents 
were obtained from a solvent purification system. Reaction flasks are oven dried before cooled to 
room temperature under N2. Silica gel (40–63 µm, 60 Å, bulk or pre-packed columns) was obtained 
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from Silicycle. TLC plates with flourescent indicator F254 were used and visualized with UV 
lamps.  
Instruments 
All alkyne metathesis reactions were performed in an Ar-filled glovebox as the catalyst is 
sensitive to poisoning by N2. Solution 
1H and 13C NMR spectra were acquired on a Bruker 500 
MHz instrument with a 5-mm cryo probe. Mass spectra were obtained on Waters Q-TOF Ultima 
ESI (ESI-TOF) and Bruker Daltonics UltrafleXtreme MALDI TOFTOF (MALDI-TOF). DCTB 
(trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile) was used as the matrix, 
and C70 (840.0000) and [70]PCBM ([6,6]-phenyl C71 butyric acid methyl ester, 1030.0994) were 
used as MALDI standards for HRMS of 2. Infrared (IR) spectra were acquired on a PerkinElmer 
Frontier FT-IR instrument with a KRS5 thallium bromide/iodide universal attenuated total 
reflectance accessory, and the peaks are reported in wavenumbers (cm–1) together with their 
relative intensity (s = strong, m = medium, w = weak). EFOS Novacure UV Spot Curing System 
with a 100-W mercury lamp and light guide was used in the synthesis of dibromo[5]helicene.  
 
6.8.1 Synthesis and Characterization  
The synthesis of 2,13-dibromo-[5]helicene S4 was achieved following literature procedures15 with 
minor modifications: 
 
To a mixture of terephthalaldehyde (804 mg, 6.0 mmol) and (4-
bromobenzyl)triphenylphosphonium bromide (3.07 g, 6.0 mmol) in DCM (100 mL) in an ice bath 
was added 50% (w/w) NaOH (4.0 mL) slowly. The ice bath was removed after the addition, and 
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the reaction was stirred at r.t. for 3 h before water (100 mL) was added. The organic layer was 
separated from the aqueous layer, which was extracted with DCM (30 mL) twice. The organic 
layers were collected, dried over Na2SO4, and evaporated under vacuum to give a yellow solid. 
The crude mixture was passed through a short plug of silica, and S1 (mixture of cis/trans isomers) 
was used in the next step without further purification.  
S1 was dissolved in benzene (800 mL), and propylene oxide (20 mL) and iodine (500 mg) 
were added to the flask. The solution was degassed by bubbling N2 for 1h. A Pyrex (50% 
transmission at 320 nm) tube was inserted into the flask to insulate the optical guide of the UV 
light. After 50 h of irradiation, the solvent was removed and the residue was passed through a short 
plug of silica. Pure S2 was obtained by washing the solid with hot ether; the mother liquor was 
concentrated to give brown solids, which were subjected to another cycle of photoreaction. The 
overall yield of S2 was 737 mg (44%, over two steps).  
 
 
To a mixture of S2 (550 mg, 1.99 mmol) and (4-bromobenzyl)triphenylphosphonium bromide 
(1.11 g, 2.17 mmol) in DCM (50 mL) in an ice bath was added 50% (w/w) NaOH (2.2 mL) slowly. 
The ice bath was removed after the addition, and the reaction was stirred overnight before water 
(50 mL) was added. The organic layer was separated, and the aqueous layer was extracted with 
DCM (20 mL) twice. The combined organic layers were dried over Na2SO4 and evaporated under 
vacuum to give a yellow solid. Triphenylphosphine oxide was removed by passing the crude 
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mixture through a short plug of silica, and S3 (mixture of cis/trans isomers) was used in the next 
step without further purification.  
S3 was dissolved in benzene (500 mL) in a brown bottle, and propylene oxide (10 mL) and 
iodine (300 mg) were added to the solution. The solution was degassed by bubbling N2 for 1h. A 
Pyrex (50% transmission at 320 nm) tube was inserted into the flask to insulate the optical guide 
of the UV light. The cyclization of S3 was much faster than that of S1, presumably because of the 
presence of two bromine atoms in the molecule. After 5 h of irradiation, the solvent was removed 
to give a brown solid. Flash column chromatography (20% DCM in hexanes) gave 2,13-dibromo-
[5]helicene (657 mg, 76% over two steps).  
 
  
To a solution of 2,13-dibromo-[5]helicene S4 (109 mg, 0.25 mmol) and PdCl2(dppf) (11 mg, 
0.015 mmol, 6 mol %) in 2 mL THF was added propynylmagnesium bromide (0.5 M in THF, 2 
mL, 1.0 mmol) under nitrogen atmosphere. The reaction mixture was stirred overnight at 60 ˚C 
before it was quenched with saturated NH4Cl. The reaction mixture was extracted with EtOAc, 
and the combined organic layers were washed with brine and dried over MgSO4. After the removal 
of solvent in vacuo, flash column chromatography (10–20% DCM in hexanes) gave the desired 
product 1 (80 mg, 90%) as an off-white solid. 
1H NMR (500 MHz, CDCl3) δ 1.99 (s, 6H), 7.51 (dd, J = 8.3, 1.4 Hz, 2H), 7.90–7.81 (m, 8H), 
8.57 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 4.5, 80.1, 85.7, 120.5, 126.5, 126.6, 127.2, 127.3, 
127.7, 129.2, 130.5, 131.6, 131.7, 132.5. IR υ (cm−1): 843 (s), 1438 (w), 1502 (w), 1606 (w), 2223 
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(w), 2847 (w), 2912 (w), 3048 (w). HRMS (ESI-TOF, m/z): calculated for C28H19 [MH]
+: 
354.1408; found: 354.1400. 
 





13C NMR spectrum of 1 at 126 MHz in CDCl3. 
 
 
In an argon-filled glovebox, [Mo] (5.61 mg, 0.0085 mmol, 0.1 equiv) and triphenyl silanol 
(14.0 mg, 0.0508 mmol, 0.6 equiv) were added to a 7.5-mL vial (I) with a stir bar followed by 
CHCl3 (3 mL). The solution was stirred at room temperature for 15 min to allow for catalyst pre-
activation. Monomer 1 (30 mg, 0.085 mmol), 5 Å molecular sieves (168 mg, 1 gram per mmol of 
alkyne), and CHCl3 (82 mL) were added to a separate flask (II) equipped with a stir bar. After 
stirring, the catalyst solution in vial I was transferred to flask II via syringe. The flask was capped 
with a new septum which was secured with electrical tape. The flask was brought out of the 
Figure 1. Efficient Möbius Macrocycle Synthesis. Möbius macrocycles were previously
prepared through lengthy synthesis with low overall yields. Here we report a one-step, 84%
yield synthesis by the alkyne metathesis of [5]-helicene 1.
Previous Möbius Macrocycles:
Herges 2014
7 steps, ~ 1%
Herges & Durola  2018
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glovebox and stirred at 60 °C overnight (no gas inlet). The reaction mixture was then cooled to 
r.t., filtered over celite, and concentrated to yield a brown solid. The crude solid was purified using 
flash column chromatography eluting with DCM in hexanes (10% to 30%). The product was 
obtained as a pale yellow solid (18.1 mg, 71% yield). 
1H NMR (500 MHz, CDCl3) δ 7.73–7.79 (m, 4H), 7.80–7.89 (m, 12H), 7.91 (d, J = 4.1 Hz, 
2H), 7.92 (dd, J = 8.5, 2.2 Hz, 4H), 7.89 (d, J = 7.9 Hz, 2H), 7.96 (d, J = 8.4 Hz, 2H), 8.02 (d, J = 
8.6 Hz, 2H), 8.06 (dd, J = 8.1, 1.4 Hz, 2H), 8.10 (d, J = 8.1 Hz, 2H), 8.45 (s, 2H), 8.83 (s, 2H), 
8.88 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 90.4, 90.7, 90.7, 119.2, 119.7, 120.3, 126.4, 126.5, 
126.5, 126.7, 127.1, 127.1, 127.2, 127.3, 127.4, 127.4, 127.6, 127.8, 127.8, 128.0, 128.1, 129.4, 
129.6, 129.6, 129.8, 129.9, 130.7, 131.0, 131.9, 132.0, 132.1, 132.1, 132.2, 132.3, 132.6, 132.8. 
IR υ (cm−1): 3043 (w), 2922 (w), 2851 (w), 2203 (w), 2032 (w), 1892 (w), 1608 (m), 1505 (m), 






1H NMR spectrum of 2 at 500 MHz in CDCl3. 
 





To a solution of 3,5-dihydoxyphenylacetic acid S5 (5.27 g, 29.0 mmol) and 1-bromohexane 
(15.4 mL, 18.1 g, 110 mmol) in anhydrous DMF (50 mL) was added potassium carbonate (19.0 g, 
137 mmol) and potassium iodide (1.0 g, 6.0 mmol), and the mixture was stirred at 90°C overnight. 
TLC analysis showed that the reaction was incomplete, so an additional 5.0 mL of 1-bromohexane 
(36 mmol) was added to the reaction, which was heated to 100°C for 24 h before the heating bath 
was removed, and water (100 mL) was added to the reaction. The product was extracted with ethyl 
acetate (200 mL), and the organic layer was subsequently washed with water, 1M LiCl solution, 
and brine, and dried over Na2SO4. The solvent was removed in vacuo, and the crude oil was subject 
to flash column chromatography (5−10% ethyl acetate in hexanes) to give the desired S6 as a 
yellowish oil (9.50 g, 99%). 
1H NMR (500 MHz, CDCl3) δ 0.90 (t, J = 6.4 Hz, 6H), 1.29−1.38 (m, 8H), 1.40−1.49 (m, 4H), 
1.75 (app. quint, J = 7.1 Hz, 4H), 3.54 (s, 2H), 3.69 (s, 3H), 3.92 (t, J = 6.6 Hz, 4H), 6.36 (t, J = 
2.2 Hz, 1H), 6.41 (d, J = 2.2 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 14.0, 22.6, 25.7, 29.2, 31.6, 
41.5, 52.0, 68.0, 100.0, 107.7, 135.8, 160.3, 171.8. IR υ (cm−1): 685 (w), 832 (w), 1061 (m), 1169 
(s), 1460 (m), 1595 (s), 1741 (m), 2858 (w), 2930 (m). HRMS (ESI, TOF, m/z): calculated for 
C21H35O4 [MH]









13C NMR spectrum of S6 at 126 MHz in CDCl3. 
 
 
To a mixture of S6 (4.17 g, 11.9 mmol), MeOH (1 mL), and water (30 mL) was added KOH 
(3.84 g, 68.5 mmol), and the reaction was heated to reflux overnight. The reaction mixture was 
allowed to cool down to rt before conc. HCl was slowly added to adjust its pH (< 3). The product 
was extracted with ethyl acetate, and the organic layer was washed with water and brine, and dried 
over Na2SO4. The solvent was removed in vacuo, and the crude S7 was passed through a short 
plug of silica (EA) before it was concentrated and used in the next step.  
To a solution of S7 and DMAP (1.66 g, 13.6 mmol) in anhydrous DCM (25 mL) was added a 
slurry of EDC·HCl (2.61 g, 13.6 mmol) in anhydrous DCM (30 mL), and the reaction was stirred 
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overnight. A large portion of the solvent was removed, and celite was added to the flask. The 
resulting slurry was filtered through a plug of silica, and the solution was concentrated to give a 
brown oil. Flash column chromatography (2−10% ethyl acetate in hexanes) gave S8 (972 mg, 27% 
over two steps) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 0.91 (t, J = 6.8 Hz, 12H), 1.29−1.38 (m, 16H), 1.40−1.49 (m, 
8H), 1.75 (app. quint, J = 7.1 Hz, 8H), 3.61 (s, 4H), 3.89 (t, J = 6.7 Hz, 8H), 6.28 (t, J = 2.1 Hz, 
4H), 6.35 (d, J = 2.1 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 14.0, 22.6, 25.7, 29.2, 31.6, 49.2, 
68.0, 100.0, 107.9, 135.9, 160.5, 205.6. IR υ (cm−1): 831 (w), 1059 (m), 1166 (s), 1456 (m), 1594 
(s), 1713 (w), 2858 (w), 2930 (m). HRMS (ESI, TOF, m/z): calculated for C39H63O5 [MH]
+: 
611.4676, observed: 611.4677.   
 









To a solution of S8 (224 mg, 0.367 mmol) and benzil (77 mg, 0.367 mmol) in anhydrous THF 
(3 mL) was added a 5% (w/v) KOH solution in MeOH (0.25 mL), and the resulting mixture was 
stirred at r.t. for 48 h before it was concentrated under reduced pressure to give a dark violet crude. 
Flash column chromatography (5−10% ethyl acetate in hexanes) gave the desired product 5 as a 
violet oil (128 mg, 44%).  
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1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 12H), 1.23−1.38 (m, 24H), 1.60−1.68 (m, 
8H), 3.71 (t, J = 6.6 Hz, 8H), 6.33 (t, J = 2.2 Hz, 2H), 6.35 (d, J = 2.2 Hz, 4H), 6.95 (app. dd, J = 
7.8, 1.5 Hz, 4H), 7.15−7.25 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 14.0, 22.6, 25.6, 29.1, 31.5, 
67.9, 102.0, 108.3, 125.3, 128.0, 128.4, 129.3, 132.1, 133.2, 154.6, 159.7, 199.9. IR υ (cm−1): 697 
(m), 846 (w), 1059 (m), 1159 (s), 1278 (m), 1432 (m), 1589 (s), 1712 (m), 2858 (w), 2929 (m). 
HRMS (ESI, TOF, m/z): C53H68O5 [MH]
+: 785.5145, observed: 785.5154. 
 





13C NMR spectrum of 5 at 126 MHz in CDCl3. 
 
 
To a 5-mL vial was charged 2 (10.1 mg, 11.2 μmol), cyclopentadieneone 5 (47.3 mg, 
60.2 μmol), and mesitylene (0.4 mL) under N2. The vial was sealed and the reaction was heated to 
120°C for 72 h. The mixture was directly adsorbed onto silica (> 2 g) and purified via flash column 
chromatography (2−10% ethyl acetate in hexanes). The fractions containing the desired product 
were collected and concentrated to give a pale yellow solid, which was subject to another round 
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of flash column chromatography (20−60% DCM in hexanes). The product was obtained as an off-
white solid (13.8 mg, 74%). 
1H NMR (500 MHz, CDCl3) δ 0.94 (t, J = 7.2 Hz, 6H), 1.00 (t, J = 7.3 Hz, 6H), 1.08−1.15 (m, 
4H), 1.20−1.42 (m, 24H), 1.45−1.52 (m, 4H), 1.88 (dt, J = 8.8, 6.7 Hz, 8H), 2.55 (dt, J = 8.8, 6.6 
Hz, 8H), 3.34 (dt, J = 9.5, 6.8 Hz, 2H), 3.51 (dt, J = 9.4, 6.8 Hz, 2H), 4.83 (s, 2H), 5.51 (s, 2H), 
5.60 (t, J = 2.2 Hz, 2H), 6.47−6.57 (m, 4H), 6.61 (dd, J = 8.4, 1.1 Hz, 2H), 6.62−6.67 (m, 6H), 
6.69 (dd, J = 8.3, 1.4 Hz, 2H), 7.36 (d, J = 8.4 Hz, 2H), 7.49 (dd, J = 8.3, 1.5 Hz, 2H), 7.53 (d, J = 
8.7 Hz, 2H), 7.59 (d, J = 8.7 Hz, 2H), 7.64 (s, 2H), 7.78 (dd, J = 11.9, 8.3 Hz, 4H), 7.81−7.97 (m, 
10H), 8.09 (d, J = 8.5 Hz, 2H), 8.19 (s, 2H), 8.31 (s, 2H), 8.50 (s, 2H). 13C NMR (126 MHz, 
CDCl3) δ 14.1, 14.2, 22.7, 22.8, 25.6, 28.9, 29.2, 31.5, 31.9, 66.8, 68.0, 90.2, 91.1, 99.9, 107.6, 
110.5, 119.0, 121.8, 124.5, 124.9, 125.9, 126.0, 126.2, 126.2, 126.4, 126.5, 126.6, 126.8, 126.9, 
127.0, 127.1, 127.2, 127.4, 127.7, 127.8, 128.0, 128.6, 129.5, 130.3, 130.6, 131.0, 131.3, 131.5, 
131.5, 131.6, 131.7, 131.7, 132.0, 132.0, 132.2, 134.0, 134.3, 138.0, 138.4, 139.5, 140.3, 141.4, 
141.5, 157.8, 158.0. IR υ (cm−1): 3047 (w), 2927 (w), 2857 (w), 1592 (m), 1435 (w), 1378 (w), 
1155 (m), 842 (s). LRMS (MALDI, TOF, m/z): C124H104O4 [M]
+: 1656.8 (75%), 1657.8 (100%), 















PdCl2(dppf) (53 mg, 0.06 equiv, 0.07 mmol) was added to a dry flask followed by 2,2'-
dibromo-1,1'-binaphthalene S9 (500 mg, 1.2 mmol) which was then placed under inert atmosphere. 
THF (24 mL) was transferred to the flask via syringe with stirring. 1-Propynyl-1-magnesium 
bromide solution (0.5 M in THF, 14.4 mL, 6.0 equiv, 7.2 mmol) was transferred to the reaction 
mixture dropwise via syringe. The reaction flask was then heated to 60 °C overnight. After cooling 
to rt, a saturated NH4Cl (aq) solution was added to the reaction to quench any remaining 
organometallic species. The reaction mixture was extracted three times with ethyl acetate. The 
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combined organic layers were washed with brine then dried over MgSO4. The solution was filtered 
followed by the removal of solvent in vacuo. The product 7 was purified via flash column 
chromatography eluting with DCM/Hexanes to give an off-white solid (365 mg, 92%).  
1H NMR (500 MHz, CDCl3) δ 1.63 (s, 6H), 7.13 (d, J = 8.4 Hz, 2H), 7.25 (ddd, J = 8.2, 6.7, 
1.3 Hz, 2H), 7.43 (ddd, J = 8.1, 6.7, 1.2 Hz, 2H), 7.63 (d, J = 8.5 Hz, 2H), 7.86 (d, J = 8.8 Hz, 2H), 
7.88 (d, J = 7.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 4.3, 79.1, 89.5, 122.3, 125.9, 126.3, 126.4, 
127.5, 127.8, 129.0, 132.5, 132.6, 139.5. IR υ (cm−1): 750 (s), 817(s), 1375 (w), 1500(m), 1592(w), 
2226(w), 2846 (w), 2913 (w), 3056 (w). HRMS (EI, TOF, m/z): C26H18 [M]









13C NMR spectrum of 7 at 126 MHz in CDCl3. 
 
The synthesis of S1016 and S1117 was achieved using literature procedures with minor 
modifications: 
 
7-bromonaphthalen-2-ol (2.0 g, 9.0 mmol) along with CuCl2 (2.4 g, 2.0 equiv, 18.0 mmol) was 
transferred to a dry 3-neck flask topped with an addition funnel and placed under inert atmosphere. 
Anhydrous MeOH (48 mL) was transferred to the flask via syringe and the solution was stirred at 
room temperature for 15 min. A solution of tert-butylamine (7.5 mL) in MeOH (27 mL) was added 
to the reaction mixture over 30 min via addition funnel. The reaction mixture stirred at rt overnight. 
The reaction was quenched at 0 °C by the addition of a 6 M solution of HCl until all solids 
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dissolved. Most of the MeOH was removed in vacuo followed by extraction of the solution into 
ethyl acetate three times. The combined organic layers were washed with brine and dried over 
Na2SO4. The mixture was filtered and concentrated in vacuo. The crude brown oil was dissolved 
in boiling toluene. The hot solution was filtered over a coarse glass frit. The filtrate was cooled to 
–20 °C overnight. White crystals of product were filtered out of the solution while still cold. The 
crystals were rinsed with cold (–20 °C) toluene and dried over vacuum. The product S10 was 
collected as a white solid (First crop: 750 mg; second crop: 413 mg; 58% combined). 
S10: 1H NMR (500 MHz, CDCl3) δ 5.01 (s, 2H), 7.23 (d, J = 1.8 Hz, 2H), 7.40 (d, J = 9.0 Hz, 
2H), 7.48 (dd, J = 8.7, 1.9 Hz, 2H), 7.78 (d, J = 8.7 Hz, 2H), 7.97 (d, J = 8.9 Hz, 2H). 13C NMR 
(126 MHz, CDCl3) δ 153.76, 134.76, 131.91, 130.33, 128.12, 127.91, 126.09, 122.60, 118.43, 
109.61. 
 
7,7'-dibromo-[1,1'-binaphthalene]-2,2'-diol S10 (200 mg, 0.45 mmol) was added to a dry flask 
which was then placed under inert atmosphere. Dry benzene (8 mL) was transferred to the flask 
via syringe, and the reaction mixture was cooled to 0 °C. Triflic acid (302 μL, 1.8 mmol, 4.0 equiv) 
was added to the reaction mixture via syringe. (Note: No product was formed when the procedure 
in Ref. 3 was followed and TFA was used instead of TfOH) A solution of triflic anhydride (160 μL, 
1.8 mmol, 4.0 equiv) in benzene (2 mL) was transferred to the reaction mixture dropwise via 
syringe. The reaction mixture was warmed to room temperature and allowed to stir overnight. The 
reaction mixture was quenched with saturated NaHCO3 solution and extracted with CH2Cl2. The 
combined organic layers were dried over MgSO4. The solvent was removed in vacuo to yield an 




S11: 1H NMR (500 MHz, CDCl3) δ 9.25 (d, J = 1.4 Hz, 2H), 7.93 (dd, J = 8.8, 3.2 Hz, 4H), 
7.84 (d, J = 8.9 Hz, 2H), 7.69 (dd, J = 8.7, 1.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 155.01, 
131.16, 129.73, 129.67, 128.53, 128.07, 128.01, 121.06, 118.52, 113.24. 
 
 
To a dry flask was added 2,12-dibromodinaphtho[2,1-b:1',2'-d]furan S11 (88 mg, 0.21 mmol) 
then PdCl2(dppf) (9.2 mg, 0.0126 mmol, 0.06 equiv). The flask was placed under inert atmosphere 
followed by the addition of anhydrous THF (3 mL). 1-Propynyl-1-magnesium bromide solution 
(0.5 M in THF, 2.52 mL, 1.26 mmol, 6.0 equiv) was then transferred to the flask via syringe. The 
reaction mixture was heated to 60 °C overnight. After cooling to room temperature, the reaction 
was quenched with a saturated NH4Cl solution and extracted with EtOAc. The combined organic 
layers were dried over MgSO4, and the solvent was removed in vacuo. The product was purified 
using flash column chromatography eluting with DCM/Hexanes. Pure product was obtained as a 
pale yellow solid (57 mg, 81%). 
1H NMR (500 MHz, CDCl3) δ 2.18 (s, 6H), 7.57 (dd, J = 8.4, 1.1 Hz, 2H), 7.80 (d, J = 8.8 Hz, 
2H), 7.91 (d, J = 8.8 Hz, 2H), 7.97 (d, J = 8.4 Hz, 2H), 9.26 (s, 2H). 13C NMR (126 MHz, CDCl3) 
δ 4.5, 80.3, 86.8, 112.9, 119.0, 122.0, 127.0, 128.1, 128.2, 129.2, 129.3, 130.2, 154.7. HRMS (ESI, 
TOF, m/z): C26H17O [MH]
















Scrambling experiments under alkyne metathesis conditions demonstrated the kinetic stability 
of 2 (mixture of both enantiomers) over other linear- or cyclic-oligomers. Trimer 2 was subjected 
to the alkyne metathesis conditions described above in the presence of 12 equiv. 1-phenyl-1-
propyne. After 24 hours, no evidence of trimer ring-opening was observed by 1H or 13C NMR 
studies (Figure ). Meanwhile, the formation of diphenylacetylene was observed, indicating that 







Figure 6.8. (A) The overlaid 1H NMR and (B) 13C NMR spectra of 2 (chestnut) and the crude product (cyan) 
of the scrambling experiment. 
 
Crystallization and Single Crystal X-Ray Diffraction 
A solution of trimer 2 in ethyl acetate in a vial was heated to reflux and was allowed to cool 
down on a stable shelf. Bright yellow crystals suitable for X-ray diffraction were formed overnight. 
A short prism of the crystal was covered in oil (Paratone-N, Exxon) before mounted onto a 0.3 




UV-Vis and Fluorescence Spectroscopy 
UV-Vis spectra of 1 and 2 were obtained in spectrophotometric grade DCM at 9.0 and 3.0 μM, 
respectively. Fluorescence excitation and emission spectra of 1 and 2 were obtained in spectra 
grade DCM at ca. 3.0 and 1.0 μM, respectively. The solutions were purged with N2 for 3 min to 
remove dissolved oxygen before each measurement. Diphenylanthracene in cyclohexane (90%) 
was used as the standard for quantum yield measurements.  
 
Chiral HPLC Separation 
Separation of enantiomers of 2 was achieved on an analytical HPLC by injection onto a 
ChiralPak IB-3column eluting with 2% to 10% IPA/Hexane over 20 minutes. Unfortunately, due 
to its limited solubility, the prep scale separation of 2 was not successful, and CD spectra of 2PPM 




6.8.2 Electrochemical Studies  
 
Figure 6.9. Cyclic voltammetry (CV) examining the first oxidation (A) and first reduction (B) of helicene 1.  
CV was performed using solutions of 1.37 mM monomer and 0.125 M TBAPF6 in MeCN 
(black trace) or 0.125 M TBAPF6 in MeCN (red trace) in a glovebox under argon. The 
electrochemistry was performed at a scan rate of 100 mV/s utilizing a 2 mm Pt disc as a working 
electrode, a metal/ polypyrrole quasi-reference electrode (ppy/ppy+), and a Pt wire as a counter 
electrode. Figure A displays an oxidative wave with an anodic peak at 1.675 V vs ppy/ppy+, and 
the corresponding reverse cathodic wave is absent. Figure B displays a cathodic peak at -2.066 V 
vs ppy/ppy+ and a smaller corresponding anodic peak at -1.972 V vs ppy/ppy+. This equates to an 
approximate half wave potential for the 1st reduction of -2.019 V vs ppy/ppy+. The current 





Figure 6.10. CV comparing the effect of scan rate on the 1st oxidation (A) and reduction (B) of helicene 1.  
CV was performed with varying scan rates using a solution of 1.37 mM monomer and 
0.125 M TBAPF6 in MeCN in a glovebox under argon. The electrochemistry was performed 
utilizing a 2 mm Pt disc as a working electrode, ppy/ppy+ reference electrode, and a Pt wire as a 
counter electrode. The 1st oxidation (A) demonstrated a large shift in potential upon increasing the 
scan rate and an absence of a corresponding cathodic peak even with probing at higher scan rates. 
In contrast, the 1st reduction (B) demonstrated very little shift upon increasing the scan rate and at 
faster scan rates the reverse anodic peak becomes more prominent. This indicates that the 
electrochemical products of the reduction are relatively more stable than the electrochemical 




Cyclic Voltammetry and Scan Rate Investigation of 2 
 
Figure 6.11. CV examining a prominent oxidative surface process (A) and the first reduction (B) of macrocycle 
2.  
CVs were performed using solutions of 376 µM of 2 and 0.125 M TBAPF6 in MeCN (black 
trace) or 0.125 M TBAPF6 in MeCN (red trace) in a glovebox under argon. The electrochemistry 
was performed at a scan rate of 100 mV/s utilizing a 2 mm Pt disc as a working electrode, ppy/ppy+ 
reference electrode, and a Pt wire as a counter electrode. The oxidative process displayed an anodic 
peak at 0.914 V vs ppy/ppy+, which is roughly 600 mV less anodic than the monomers 1st oxidation 
(Figure S1A). The y-offset in the blank is most likely due to a difference in sensitivity setting 
during the two measurements. Regardless, no peaks are observed in the blank, which indicates the 
observed process is faradaic. The 1st reduction (B) displays a cathodic peak at -1.938 V vs ppy/ppy+ 
and corresponding anodic peak at -1.853 V vs ppy/ppy+. This equates to an approximate half wave 
potential of 1.896 V vs ppy/ppy+ for the 1st reduction. This is less 100 mV less cathodic than the 





Figure 6.12. CV comparing the effect of scan rate on the oxidative surface process and 1st reduction of 
macrocycle 2.  
CVs were performed using a solution of 376 µM macrocycle 2 and 0.1 M TBAPF6 in 
MeCN in a glovebox under argon. The electrochemistry was performed at varied scan rates 
utilizing a 2 mm Pt disc as a working electrode, a ppy/ppy+ reference electrode, and a Pt wire as a 
counter electrode. Unlike Figure S19A displaying a faradaic oxidation, the oxidative surface 
process observed for 2 (A) demonstrates a complex mixture of absorption and precipitation. 
Similar to Figure S19B, increasing the scan rate for the trimer reduction wave (B) causes the 
corresponding anodic peak to become more prominent. 
 




Normalization was performed through dividing the current by the product of the number 
of moles in solution and the hypothesized number of redox active centers (monomer equal to one 
and trimer equal to three). The close correlation in normalized currents for the monomer and 
macrocycle CVs, as well as the presence of a single three-electron wave indicates that the global 
macrocycle structure is capable of accepting three electrons in redox centers that act independently 
of each other. 
 
 
6.8.3 Computational Studies 
General 
All the DFT calculations in this study were carried out using the Gaussian 09 software 
package.18 EDDB calculations were based on density matrix of natural atomic orbitals (NAOs) 
obtained using the NBO 6.0 program,19 analyzed by the RunEDDB script.20 Visualization of 
transition dipole moments was implemented by Multiwfn (v3.7)21 and VMD (v1.9.3)22 programs.  
Unless stated otherwise, all DFT calculation were performed at B3LYP/6-31G(d) level of 
theory for C, H, O, and Si atoms, and B3LYP/SDD for Mo. Frequency calculations were performed 
to confirm that all optimized structures were minima and every transition state has only one 
imaginary frequency. Intrinsic reaction coordinate (IRC) calculations23 confirmed the transition 
states are saddle points in the proposed potential energy surfaces (PES). SMD solvation models24 
were used for C, H, O, and Si atoms in PES calculations (CHCl3), and the Stuttgart MWB28 
pseudopotential and basis set were applied to only molybdenum atoms in the solvation models.25 
The SMD model (DCM) was also used in the TD-DFT calculation. The long-range corrected 
CAM-B3LYP functional26 was used in the time-dependent DFT (TD-DFT)27,28 and electron 
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density of delocalized bonds (EDDB)29 calculations, in conjunction with basis sets 6-31G(d) for 
TD-DFT and 6-311G(d,p) for EDDB. 
 
[5]Helicene Helicity Inversion Barrier 
DFT calculation (in vacuum) suggests that the barriers of inversion at 298.15 K are essentially 
the same for [5]helicene and 2,13-diproprynyl-[5]helicene 1. Coordinates of both compounds at 
the ground and transition states are in SI Appendix. 
Table 6.1. Inversion barrier of parent and substituted [5]helicene. 
 Inversion barrier (kcal mol-1) 
 ΔE ΔH ΔG  
[5]helicene 24.3(8) 23.6(0) 24.3(5) 
2,13-diproprynyl-[5]helicene 1 24.4(4) 23.6(1) 25.6(1) 
 
2PPM and 4PPP Thermodynamic Stability 
Both macrocycles 2 and 4 are optimized at B3LYP/6-31G(d) level of theory. High-level single-
point energy calculations were performed on the optimized structures, suggesting that 4PPP is 
thermodynamically more stable than 2PPM by 1−2 kcal/mol. Minimal entropy/temperature 
contribution to the relative stability was observed (less than 0.1 kcal/mol over 100 K). (ΔE = EPPP 
– EPPM ) 
Table 6.2. Thermodynamic stabilities of cyclic trimers 2 and 4. 
Methods 
Relative energy differences (kcal/mol) 
ΔE ΔZPE ΔH ΔG 
M06-2X/def2-TVZP -1.1 -1.2 -1.2 -0.9 
B3LYP/def2-TZVP -2.9 -3.0 -3.0 -2.8 




Mechanism for PPM/PPP Selectivity 
The energy barriers of the last step of macrocyclic 3mer formation were studied. Basis set 
superposition error (BSSE) values calculated in gas phase for 2PPM···Mo and 4PPP···Mo are 
0.00425 a.u. and 0.00332 a.u., respectively. The BSSE correction has been applied to the sum of 
product energies. Uncorrected energies are provided in parentheses. 
Table 6.3. Relative energies of intermediates and transition states of 2PPM and 4PPP formation. 
 O3 TS1 IM1(IM) IM2 TS2 3mer + Mo 
2PPM G 
(kcal/mol) 
0.0 21.6 13.6 - - -16.5 (-13.8) 
2PPM H 
(kcal/mol) 
0.0 15.1 5.5 - - -4.2 (-1.6) 
4PPP G 
(kcal/mol) 
0.0 37.0 26.0 24.5 28.2 -14.4 (-12.3) 
4PPP H 
(kcal/mol) 
0.0 29.9 18.8 18.6 21.2 -3.1 (-1.0) 
 
 
Figure 6.14. Key structure parameters, including bond angles (blue), bond length (purple), and dihedral 





Figure 6.15. Relaxed potential energy surface (PES) scan (a) with fixed C2-C3 distances (b).  
Imaginary frequencies correspond to the C2-C3 stretching vibration, and the values are 
given in cm-1. Transition state searches based on the points including the one with the most 
negative imaginary frequency (C2-C3: 2.0 Å) and the one with highest energy (C2-C3: 2.4 Å), 
all failed to locate the TS2 of PPM but directly lead to the product. 
UV and ECD Spectra Prediction 
The TD-DFT calculation was performed at CAM/6-31G(d) level of theory. A total of 10 and 
50 states were calculated for the monomer and 3mer. The SMD was also applied to TD-DFT 
calculations in the singlet electronic state (solvent: DCM). The ECD of 2PPM is predicted to have 
a (+) peak at around 300 nm, and a (-) peak at approximately 380 nm. 
 





Figure 6.17. Electric transition dipole moments (S0 → S1) of 2PPM (left) and 4PPP (right). Unit: Debye. Blue arrows 
indicate the contribution of transition dipole moments from helicene fragments, not including bridging moieties.  
 








1 3.4224 362.5237 0.0073  1 3.6675 338.29614 0 
2 3.6167 343.04783 0.3322  2 3.8187 324.90143 0.1997 
3 3.6219 342.55532 0.2537  3 4.1565 298.4966 0.3642 
4 3.6354 341.28324 0.0002  4 4.3328 286.35088 0.0609 
5 3.6694 338.12097 0.5353  5 4.4539 278.5651 0.506 
6 3.6887 336.35186 0.8579  6 4.5023 275.57051 0.6415 
7 3.9902 310.93707 0.7701  7 4.7618 260.55296 0.021 
8 4.0003 310.15201 1.0035  8 4.9199 252.18015 0.2637 
9 4.0444 306.77013 0.0353  9 5.0559 245.39669 0.1907 
10 4.1825 296.64103 0.2784  10 5.0928 243.61866 0.5567 
11 4.2127 294.51447 0.5901      
12 4.2611 291.16921 0.0311      
13 4.2654 290.87567 0.0011      
14 4.299 288.60226 0.7402      
15 4.3461 285.47459 0.0179      
16 4.3493 285.26455 0.3253      
17 4.3828 283.08412 0.1002      
18 4.4678 277.69844 0.149      
19 4.4836 276.71985 0.2453      
20 4.4926 276.16549 0.0602      
21 4.5168 274.68586 0.0375      
22 4.5825 270.74765 0.0099      
23 4.7096 263.44087 0.0266      
24 4.7138 263.20614 0.1152      
25 4.741 261.69608 0.2973      
26 4.7567 260.83232 0.0155      
27 4.7774 259.70216 0.8144      
28 4.8161 257.61531 0.1038      
29 4.8831 254.08063 0.1246      
30 4.8992 253.24565 0.3653      
31 4.919 252.22629 0.0063      
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Table 6.4. (cont.)      
32 4.9381 251.2507 0.199      
33 4.9573 250.27759 0.0111      
34 5.0022 248.03109 0.0043      
35 5.03 246.66026 0.0115      
36 5.0328 246.52303 0.0064      
37 5.0658 244.91711 0.0146      
38 5.0898 243.76225 0.0047      
39 5.1036 243.10312 0.0452      
40 5.1774 239.63787 0.005      
41 5.1845 239.30969 0.1345      
42 5.2045 238.39007 0.0623      
43 5.219 237.72774 0.306      
44 5.2192 237.71864 0.0356      
45 5.2645 235.67311 0.2188      
46 5.2813 234.92343 0.3211      
47 5.2828 234.85672 0.012      
48 5.3131 233.51736 0.0028      
49 5.3593 231.50432 0.009      
50 5.3681 231.12481 0.047      
 
 
ACID and EDDB Plots 
Anisotropy of the induced ring current density (ACID)30,31 calculations were performed at the 
B3LYP/6-311G(d,p) level, using the continuous set of gauge transformation (CSGT)32 method. 




Figure 6.18. The ACID and EDDP plots of 2PPM showing a higher level of conjugation through one of the three 
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